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ABSTRACT OF THE DISSERTATION 
Developing New Methodologies for Crosslinked Polymeric Nanostructure Syntheses, 
Chemoselective Modifications, and Applications as Imaging and Delivery Agents 
 
By 
Guorong Sun 
Doctor of Philosophy in Chemistry 
Washington University in Saint Louis, 2009 
Professor Karen L. Wooley, Chairperson 
 
The overall emphasis of this dissertation research includes the syntheses of 
amphiphilic block copolymers bearing functional groups through controlled radical 
polymerization techniques, followed by the aqueous assembly of these block copolymer 
precursors to construct polymeric nanostructures with different sizes and morphologies.  
Further chemical modification of the nanostructures afforded functional crosslinked 
nano-objects with reporting probes for imaging and biocompatible “stealth” materials for 
tuning the in vivo fate of nanostructures. 
Amphiphilic block copolymers poly(acrylic acid)-block-polystyrene (PAA-b-PS) 
with well-defined structures were prepared through nitroxide-mediated radical 
polymerization (NMP).  Using novel pre-functionalization strategies, these block 
copolymer precursors were functionalized with DOTA for chelating 64Cu and were then 
assembled into micelles and crosslinked throughout the micelle shell domain to afford the 
shell crosslinked nanoparticles (SCKs), containing large numbers of effective DOTAs per 
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particle for 64Cu radiolabeling  These 64Cu–complexed nanoparticles showed impressive 
specific activities (ca. 400 μCi μg-1), which suggest that they will serve as highly 
sensitive in vivo positron emission tomography (PET) tracers at low administering doses. 
The “pre-grafting” strategy was further extended to accomplish SCKs with 
variable biodistributions.  PAA-b-PS amphiphilic block copolymers were modified with 
varying numbers of poly(ethylene oxide) (PEO) chains, together with DOTA, before 
assembling into block copolymer micelles and crosslinking throughout the micellar shell 
regions.  After chelation of 64Cu tracers, the in vivo fate of PEGylated SCKs was 
evaluated by means of biodistribution experiments and PET imaging.  The blood 
retention of PEGylated-SCKs exhibited tunabilities, depending on the mPEG grafting 
density and the nanoparticle surface properties. 
Various bi-functional pyrazine-based chromophores were used as crosslinkers to 
probe directly their incorporation efficiencies into the shells of block copolymer micelles, 
which further determined the actual crosslinking extents ─ a critical factor for developing 
SCKs as PET imaging agents.  The micelles were made to carry poly(N-
acryloxysuccinimide) (PNAS) as pre-installed amine-reactive functionalities along 
amphiphilic triblock copolymer precursors (PEO-b-PNAS-b-PS) prepared through 
reversible addition-fragmentation chain transfer (RAFT) radical polymerizations.  The 
incorporation/crosslinking efficiencies were dependent upon the type of crosslinker and 
the applied stoichiometries. 
The intrinsic reactivity of aldehyde motivated the developments of well-defined 
polymers having reactive carbonyl side chain substituents.  Amphiphilic block 
copolymers bearing poly(4-vinyl benzaldehyde) (PVBA) block segments with controlled 
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molecular weights and low polydispersities were obtained through RAFT 
polymerizations and assembled into polymeric vesicles and micelles.  The vesicles were 
crosslinked and functionalized with fluorescent molecules through chemoselectively-
reductive amination and were shown to display interesting in vitro cell association 
behaviors.  The micelles were modified with near-infrared fluorescent dyes and 
crosslinked with diamino crosslinkers, each via reductive amination, to prepare robust 
nanoparticles with optimized luminescent characteristics for in vivo optical imaging. 
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Chapter 1 
 
Introduction 
 
The groundbreaking lecture by Richard Feynman in 1959,1 “There’s Plenty of 
Room at the Bottom”, triggered the campaign to study and manipulate matters over 
atomic and/or molecular scale and opened the “Nano-window” to natural scientists.  
Different from conventional science and technology, in which the size of objects usually 
are below 0.1 nm, the targets of nanoscience and technology are focused onto the 
“things” from molecular-based assemblies and/or objects with size scales between 0.1 nm 
to 100 nm, as well as single atoms and molecules.  During the past 50 years, through the 
efforts and devotions from several generations of scientific researchers, nanoscience and 
technology have achieved significant innovations in academic and industrial laboratories, 
across disciplines, and become a robust and well-accepted scientific field.2, 3  Meanwhile, 
profound impacts of nanoscience and technology have been growing explosively 
worldwide in the manufacturing and R&D areas such as miniaturization of electronic and 
memory devices, design and synthesis of more robust and efficient catalysts, 
development of more accurate and effective diagnostic procedures, and exploration of 
more potent drugs with “smart” abilities to recognize and attack only the diseased sites. 
In modern nanotechnology, there are two basic approaches to realize the 
syntheses of nanostructures, the Top-down and Bottom-up approaches.  The Top-down 
approach is based on physics and lithography techniques,4-10 while the Bottom-up is 
mainly influenced by chemical principles.11-18  Both approaches provide specific 
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capacities that can be implemented by the other.19-23  However, the relatively broader 
substrate scope and more precise tuning of chemical binding strength and orientations 
offer extra driving forces for the Bottom-up approach to evolve and advance 
nanotechnology. 
The self assembly of amphiphilic polypeptides into proteins with intricate 
supramolecular structures and variety of functionalities represents one of the elegant 
manners in constructing complex assembles by Nature.  This phenomenon inspired 
scientists to exploit nano-scale material mimics having unique optical, electric, catalytic, 
and biological properties.24, 25  Utilizing synthetic amphiphiles as assembly components, 
many nanostructures ranging from atomic to supramolecular dimensions have been 
assembled through weak non-covalent interactions, which included van der Waals, 
electrostatic, hydrophobic interactions, hydrogen and coordination bonds,26-30 via a 
balanced reversible process.31-33  These nano-assembles exhibited diverse non-spherical 
morphologies, such as belt,34 cylinder,35 fiber,36-39 helix40-42, lamella43, and vesicle,44-46 
depending upon the intrinsic compositions and physical properties of the amphiphiles and 
the assembly conditions. 
Among the synthetic amphiphiles, amphiphilic block copolymers have gained 
significant attentions recently by both academic and industry investigators.47-49  In 
contrast to small surfactants, the amphiphilic block copolymer systems exhibit the 
following advantages: the facile tuning of dimensions, compositions, and components; 
the easier introduction of functionalities; the much larger phase segregation tendency;50, 51 
the significantly slower assembly kinetics;52 and the enhanced robustness and 
morphological variation of resulting structures.  Amphiphilic block copolymers can 
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construct a wide range of supramacromolecular assemblies including conventional 
morphologies like spheres (the most common morphology), cylinders/worms53-59 and 
vesicles,60-70 and many other novel morphologies such as bamboos,71 bowls,72 discs,73 
helices,74 and toroids.75  Moreover, the spherical micelles can undergo higher-order 
segregation in inter- and/or intra-micellar fashion to create Janus,76-78 
multicompartment,79-81 and onion82, 83 micelles.  The versatility in composition and 
assembly behaviors offer a rich selection of building blocks for the construction of 
nanostructured materials as well as their use in biomedical and catalytic applications. 
Advances in living polymerization techniques, especially in the development of 
controlled radical polymerizations (CRP)84 have dramatically improved the availability of 
well-defined block polymers, thereby facilitating the numbers and types of 
nanoassemblies that can be prepared and studied.  Using different CRP techniques, atom 
transfer radical polymerization (ATRP),85, 86 nitroxide-mediated radical polymerization 
(NMP),87, 88 and reversible addition-fragmentation chain transfer (RAFT) 
polymerization,89-91 various kinds of polymers having narrow molecular weight 
distributions, controlled architectures, and low polydispersities can be produced.  
Moreover, CRP realizes better tolerance of functionalities during the polymerization 
process, which enables the facile preparation of functional polymers allowing for post-
modifications.92 
The heightened impact of nanotechnology in healthcare generates a specific filed 
─ Nanomedicine,93-100 the medical applications of nanotechnology to improve the 
properties of existing therapeutic and diagnostic modalities and to establish novel 
modalities for diagnostics, treatment, and therapy of diseases.  Block copolymer 
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micelles101-105 and vesicles104, 106-109 have already been widely applied in nanomedicine 
and found promising applications in both therapeutic agent delivery and diagnostics.  
However, both self-assembled entities are equilibrium products formed in solution and 
under diluted conditions (concentrations below the critical micelle/vesicle concentrations, 
which usually at the order of 10-7 M), their ordered structures will collapse and re-
organization of the unimer (amphiphilic block copolymer precursor) will occur.  
Covalent110-115 and non-covalent116 crosslinkings have been introduced to micellar 
assemblies to enforce the structural stability of and obviate the self correction.  Several 
new classes of materials termed shell crosslinked (SCK) nanoparticles and core 
crosslinked (CCK) nanoparticles have been constructed, depending upon the location 
inside the micellar structure where the crosslinking reaction is conducted.  The same 
strategy has also been applied to vesicular structures where the crosslinking was confined 
into the wall domains.70, 117-119 
The advantage of crosslinking is not limited only for providing robust 
nanostructures.  Recent reports highlighted that core crosslinking could enhance the cargo 
“holding” ability of nanostructures120 and the increasing of shell crosslinking extents 
prolonged the blood retention time of nanoparticles.121  Moreover, functionalized 
nanostructures can be directly derived by using crosslinkers bearing diverse 
functionalities,122, 123 in addition to their structural roles.  This dissertation is focused on 
the design, synthesis, and characterization of functionalizable crosslinked nanostructures 
(micelles and vesicles) bearing characteristics allowed for chemoselective modification 
and their utilizations as nanoplatforms for molecular imagings. 
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Previous studies on shell crosslinked knedel-like nanoparticle (SCKs) suggest that 
these materials can serve as good templates for biomedical applications.124  To render the 
SCKs functional, post-modification of pre-established SCKs with functionalities stands a 
versatile and straightforward method that allows for multiple numbers and types of 
ligands to be attached onto a well-defined scaffold.125-127  However, the reaction 
efficiency usually suffers a variety of factors, especially the steric and electrostatic 
factors, due to the fact that most of the SCK modification reactions are conducted in 
aqueous media.  As found during the study of post-functionalization of SCKs with DOTA 
(1,4,7,10-tetraazocyclododecane-N,N′,N′′,N′′′-tetraacetic acid) derivatives having 
different features, even a “tiny” structural difference (one carboxylate and 4 atoms) 
caused ca. 7- to 10-fold of reaction efficiency variations.128  Chapter 2 of this 
dissertation is focus on the development of new synthetic strategy for preparation of SCK 
nanoparticles having “high-dense” functionalities as potential positron emission 
tomography (PET) imaging129-132 contrast agents through Bottom-up pathway.  The 
DOTA-functionalized SCKs in chapter 2 were constructed through a “pre-grafting” 
approach, which involved coupling the functionalities to amphiphilic block copolymer 
precursor before assembly into nanostructures, in order to reduce the complexity of 
nanostructure functionalization.  This strategy provided easier quantification of 
functionalities per nanostructure, but also was demonstrated as a facile and effective 
methodology for incorporation of highly sensitive in vivo PET tracers into nanoscale 
frameworks to allow for administration of low doses in vivo. 
The determination of the in vivo distribution of nanoparticulate carriers following 
systemic administration and the development of imaging modalities for visualizing the 
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biodistribution over time take top priority in nanomedicine.133  In chapter 3, 
monomethoxy-terminated poly(ethylene glycol) (mPEG) and radionuclide 64Cu chelator 
were sequentially installed onto the block copolymer precursor prior to assembly and 
crosslinking to afford SCK nanoparticles with different surface characteristics.  The in 
vivo fates of these SCKs were then evaluated through the combination of biodistribution 
and PET imaging techniques.  This study represented extension of applying the “pre-
grafting” strategy for construction of multifarious nanostructures having quantifiable 
functionalities, but also demonstrated the biodistributions of nanovectors can be 
manipulated in tunable fashion.  A semi-quantitative model of the density of mPEG 
surface coverage as a function of in vivo behavior was applied to enhance the 
understanding of this system.  The distance between exposed mPEG molecules on 
nanoparticle surface was found to determine the blood retention time of the 
corresponding SCK nanoparticles through opposing blood protein absorption mechanism 
and the calculated results were consistent with the theoretical predictions proposed by de 
Gennes and co-workers.134, 135 
Because the general methodology for the preparation of SCKs involves 
crosslinking reactions between polymer chain segments that constitute the corona of 
block copolymer micelles, the nature of the crosslinking agent and the degree to which 
crosslinking is conducted allows for tuning of the SCK surface characteristics and the 
shell permeability.  In fact, the phenomena that higher crosslinking extent caused a 
reduction of the radiolabeling efficiency (chapter 2), but benefited the in vivo fate 
(chapter 3) have already been noticed.  Therefore, a precise balance between the above 
issues needs to be managed for developing SCK nanoparticles as potential imaging 
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agents.  Research presented in chapter 4 describes the fundamental investigations for 
exploring the incorporation efficiencies of crosslinkers into the shells of block copolymer 
micelles, which further determines the actual crosslinking extents, by utilizing pyrazine-
based crosslinkers as reporting probes.  In order to minimize other factors related with the 
carbodiimide-mediated amidation, the block copolymer micelles were made to carry pre-
installed reactive functionalities (N-acryloxysuccinimide, NAS) along the central block of 
amphiphilic triblock copolymer as amidation sites.  It was revealed that the 
incorporation/crosslinking efficiencies were dependent upon the intrinsic properties of 
crosslinker, the conditions used for crosslinking, and the applied stoichiometries.  In the 
meantime, unique photo-physical properties of the optical-active SCKs at lower 
crosslinking extents (13% to 20%) were observed.  Compared with the crosslinkers as 
small molecules, the maximum absorption peaks of SCKs exhibited blue-shifts of ca. 35 
to 40 nm.  More interestingly, SCKs showed dual emissions of the fluorescence (498 nm 
and 555 nm, respectively) while the fluorogenic probes only afforded single emissions at 
555 nm without the internal nanostructure environment. 
Chapter 5 depicts the development of well-defined homopolymer and block 
copolymer systems bearing pendant benzaldehyde functionalities through RAFT 
polymerizations.  The motivation of this work comes from the intrinsic reactivity of 
benzaldehyde, one of the most reactive and diverse electrophiles that undergoes reaction 
under mild conditions.  By taking advantage of the higher functional group tolerance in 
RAFT polymerization, poly(4-vinyl benzaldehyde)s (PVBA) with controlled number-
average molecular weight (Mn) and low polydispersity (PDI < 1.17) were obtained.  The 
controlled characteristic of the RAFT polymerization process was confirmed by the 
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linearity between the Mn values of PVBA and monomer conversions.  Well-defined 
PVBA was further used as a macromolecular chain transfer agent (macro-CTA) in RAFT 
polymerization of styrene (St), and a block copolymer PVBA-b-PSt with relatively low 
polydispersity (PDI = 1.20) was successfully synthesized. 
Work towards biological applications of nanoscale objects with PVBA as reactive 
hydrophobic block segments continues in chapter 6 and chapter 7.  Chapter 6 
illustrates the aqueous describe assembly of block copolymer poly(ethylene oxide)-block-
poly(4-vinyl benzaldehyde) precursors into polymeric vesicles with tunable sizes and the 
following chemoselctive post-modifications through the reductive amination chemistry.  
Different from most literature reported60-70 AB diblock copolymer precursors (A 
represents for the hydrophilic block segment while B for the hydrophobic segment) for 
preparing vesicular nanostructures, in which a longer hydrophobic B block segment was 
required, the unimer used in this study, PEO45-b-PVBA26, had a relative shorter B block.  
The morphology transformation during vesiculation process was investigated and 
variations from traditional trend (sphere-rod-vesicle), including the forming of vesicles at 
lower water contents and the “absence” of rods, were noticed from the transmission 
electron microscopy (TEM) measurements.  It was also found that small vesicles could be 
obtained from the same block copolymer precursor through a “kinetic trapping” protocol, 
as characterized through a combination of TEM and dynamic light scattering (DLS).  The 
reactivity of the benzaldehyde functionalities was verified by crosslinking the vesicles, 
and also by a one-pot sequential functionalization and crosslinking approach to further 
render the vesicles fluorescent, each via reductive amination.  In vitro studies found these 
labelled vesicles underwent cell membrane associations, as indicated by the confocal 
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microscopy, which might be related with the interactions between the membrane proteins 
and the leftover aldehydes. 
The last research part of this dissertation (chapter 7) introduces the model-
predictable optimizations of luminescence efficiency (quantum yield, QY) of fluorescent 
nanomaterials for the core crosslinked micelles, prepared from PEO-b-PVBA through the 
established one-pot sequential functionalization and crosslinking protocol.  Both the 
experimental and model-predicted data revealed that the nanoparticle QY was related 
with the dye “loading” stoichiometry and the size of core domain.  These two factors 
determined the distance between adjacent fluorophores, which further decided the extent 
of non-radiatively transferred energy. 
This introduction has encompassed the successes and complications in attempting 
to develop functionalized crosslinked nanostructures which exhibit selective biological 
activities, interesting optical properties and other physicochemical properties that are 
being exploited for tissue selective imaging applications in vivo.  Moreover, the 
fundamental strategy behind this dissertation, i.e., synthesizing well-defined amphiphilic 
block copolymers bearing diverse functionalities; following by assembly the resulting 
precursors into polymeric nanoscopic objects with various morphologies; and 
subsequently exerting internal and/or external functionalization/crosslinking through 
varying methodologies to achieve discrete functional nanomaterials with improved 
robustness and stability, will remain on the forefront of nanotechnology field. 
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Chapter 2 
 
Strategies for Optimized Radiolabelling of Nanoparticles for in vivo 
PET Imaging 
[Portions of this work have been published previously as Guorong Sun, Jinqi Xu, Aviv 
Hagooly, Raffaella Rossin, Zicheng Li, Dennis A. Moore, Craig J. Hawker, Michael J. 
Welch and Karen L. Wooley Adv. Mater. 2007, 19(20), 3157-3162.] 
 
Abstract 
Driven by the motivation for optimizing 64Cu radiolabelling efficiency of 
nanoparticles for in vivo PET imaging, a new strategy has been developed.  This strategy 
involved a complete redesign of the nanoparticle system, utilizing macromolecular 
precursors that were pre-loaded with labelling sites and programmed for supramolecular 
assembly into discrete, functional nanoscale objects.  A series of shell crosslinked 
nanoparticles (SCKs) have been constructed by grafting a copper chelating agent 
(DOTAlysine) onto amphiphilic block copolymers (PAA-b-PS), self assembling the 
functionalized block copolymer precursors into micelles, and crosslinking the micellar 
corona to afford the expected nanoobjects.  These pre-DOTAlysine-SCKs showed 
impressive results on 64Cu radiolabelling (~ 400 copper atoms per spherical nanoparticle). 
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Introduction 
Among the molecular imaging modalities, positron emission tomography (PET) is 
widely used as a powerful diagnostic tool by clinicians and scientists.1-3  Compared with 
other imaging methods, it bears the advantages of high sensitivity (the level of detection 
approaches 10-11 M of tracer) and isotropism (i.e., ability to detect expression accurately, 
regardless of tissue depth), which provide reliability for quantitative imaging analyses of 
in vivo abnormalities.  As the pharmaceutical industry began applying PET imaging for 
assisting drug discovery,4-10 small animal PET scanners with spatial resolution up to 1 
mm were developed and have been considered to be one of the major achievements for 
PET technology during the past two decades.11  64Cu is an attractive radionuclide for PET 
imaging because of its suitable half-life (t1/2 = 12.7 h) and positron emission energy (0.65 
MeV), as well as the relatively convenient radiolabelling via coordination with specially 
designed ligands (chelators).12-15  The formation of thermodynamically-stable metal 
complexes reduces the copper binding with plasma proteins which minimizes its non-
specific background activity and its accumulation and resultant toxicity in the liver and 
kidney.16  Under the present instrumental conditions, optimizations and improvements of 
the specific activity of radiopharmaceuticals are of special interest to 64Cu-based PET 
systems for achieving high quality images even at low doses, especially when the targets 
can be readily saturated in vivo.  One practical resolution is to encapsulate or conjugate 
the chelating agents with nanocarriers, which have already been utilized by many 
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research groups17-21 including ourselves22, 23 and have been found to exhibit exciting 
potential in both high loading capacities and re-direction of the bio-distributions of small 
molecule ligands (e.g. for tissue targeting) or guests (e.g. for pharmaceutical effect).24 
Our research has focused upon shell crosslinked knedel-like nanoparticles 
(SCKs)25 as the nanoscale framework for the attachment of macrocyclic chelators and 
labelling by 64Cu radionuclides.  SCKs have been established from the self assembly of 
amphiphilic block copolymers to afford micelles with core-shell morphology that are 
then covalently crosslinked throughout the shell domain.  Recently, it was confirmed that 
by tuning the nanoparticle properties, especially the size and rigidity, increased in vivo 
circulation times and improved bio-distributions could be reached for 64Cu-TETA SCK 
conjugates.23  Although these preliminary results are promising, several challenges 
require further investigations.  Among them, efficient radiolabelling takes the highest 
priority.  Previously, the direct conjugation of macrocyclic chelators onto pre-established 
SCKs afforded limited coupling and radiolabelling yields, due to steric and electrostatic 
factors.23, 26  As part of our ongoing efforts, we now report an alternative strategy to 
construct chelator-SCK conjugates with high radiolabelling efficiencies, which is 
expected to lead to nanoscale objects that can be administered in small quantities for 
ultra-sensitive PET imaging. 
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Results and Discussion 
SCKs used in this study were comprised of polystyrene (PS) and poly(acrylic 
acid) (PAA), a particle composition previously demonstrated to have long blood 
circulation times23 and characteristic low cytotoxicity and low immunogenicity when 
crosslinked with 2,2’-(ethylenedioxy)-bis(ethylamine).27  The particle sizes were 
controlled by the relative balance of hydrophobic PS block length vs. the hydrophilic 
PAA segment.28, 29  The amphiphilic block copolymer precursors (PAA-b-PS) were 
acquired via sequential living radical polymerization of tert-butyl acrylate and styrene, 
followed by acidolysis of the tert-butyl ester protecting groups.  In all cases, the block 
copolymers had well-defined structures and narrow polydispersities (PDI < 1.20). 
As shown in Scheme 2.1, a lysine derivative of 1,4,7,10-tetraazocyclododecane-
N,N′,N″,N′″-tetraacetic acid (DOTA), DOTAlysine, was grafted onto the amphiphilic 
PAA-b-PS block polymer precursors, with a fixed hydrophilic PAA segment length (DPn 
= 60) and varied hydrophobic PS segment lengths (DPn = 30, 60, 140).  Conventional 
amidation chemistry was employed in organic solvent to afford ca. 65 to 75% isolated 
yield, for which the coupling yields were > 85%.  After purification by dialysis against 
water and lyophilization, the numbers of DOTAlysines per polymer chain were 
determined by 1H NMR spectroscopy analyses.  For PAA60-b-PS30 and PAA60-b-PS60 
block copolymers, the grafting numbers were 2, 4, and 7, for three different samples.  
Grafting more DOTAlysines (> 10 DOTAlysines/chain) was also attempted, but the 
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resulting DOTAlysine-g-copolymers suffered from poor solubility in organic solvents 
and generated nanoparticles with broad size distributions.  The same problem was 
encountered for the PAA60-b-PS140 after coupling 7 DOTAlysines, so only 2 and 4 
DOTAlysines/chain were studied. 
 
Scheme 2.1.  A two-step synthetic route was developed for the preparation of pre-
DOTAlysine-SCKs:  (1) labelling of three different amphiphilic block copolymers, 
PAA60-b-PSp, with three different levels of DOTAlysine;  (2) their self assembly into 
micelles in water and shell crosslinking to two different extents.  Overall, eight micelles 
and sixteen SCKs resulted from this scheme (see also Table 2.1). 
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Each amphiphilic block copolymer was assembled into micelles in aqueous 
solution by a standard micellization protocol30, 31 and crosslinked throughout the shell 
layer to differing degrees (20% and 50%, according to the chemical stoichiometry).  A 
series of micelles and SCKs having different dimensions and shell properties 
(electrostatic character, permeability, and residual carboxylic acid concentrations) was 
obtained and characterized by dynamic light scattering (DLS) and transmission electron 
microscopy (TEM) (Table 2.1 and Figure 2.1). 
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Table 2.1.  Characterization data for pre-DOTAlysine-SCKs and control SCK samples 
(lacking DOTA functionalities). 
Samplea 
(Extents of 
Crosslinking) 
(Dh)nb 
(nm) 
Davc 
(nm) 
(DOTAlysinem-g-PAAn)-b-PSp 
Nagge 
m n p 
SCK1 (20%) 21 ± 3 11 ± 1 2 58 30 125 
SCK2 (20%) 21 ± 3 16 ± 2 2 58 60 240 
SCK3 (20%) 21 ± 6 11 ± 2 2 58 140 40 
SCK4 (20%) 21 ± 3 12 ± 2d 4 56 30 160d 
SCK5 (20%) 47 ± 7 19 ± 2d 4 56 60 340d 
SCK6 (20%) 17 ± 2 11 ± 2 4 56 140 40 
SCK7 (20%) 26 ± 6 11 ± 2 7 53 30 125 
SCK8 (20%) 25 ± 6 19 ± 2 7 53 60 400 
SCK9 (50%) 21 ± 3 11 ± 1 2 58 30 125 
SCK10 (50%) 24 ± 3 16 ± 2 2 58 60 240 
SCK11 (50%) 13 ± 4 12 ± 2 2 58 140 40 
SCK12 (50%) 22 ± 4 15 ± 2d 4 56 30 160d 
SCK13 (50%) 43 ± 5 18 ± 3d 4 56 60 340d 
SCK14 (50%) 17 ± 4 13 ± 2 4 56 140 40 
SCK15 (50%) 24 ± 5 11 ± 2 7 53 30 125 
SCK16 (50%) 28 ± 4 19 ± 2 7 53 60 400 
Control1 (50%) 18 ± 2 11 ± 1 0 60 30 125 
Control2 (50%) 22 ± 1 17 ± 1 0 60 60 240 
Control3 (50%) 34 ± 4 25 ± 1 0 60 140 330 
a All samples were dispersed in 5.0 mM pH 7.3 PBS (with 5.0 mM NaCl) buffer 
solutions.  b The number-averaged hydrodynamic diameters ((Dh)n) were determined by 
DLS.  Samples were passed through PVDF filters with 220 nm average pore size before 
conducting DLS measurements.  c The TEM average diameter (Dav) values were 
measured for the nanoparticle cores.  d Only spherical nanoparticles were counted.  e The 
aggregation numbers (Nagg) were calculated based upon TEM micrographs. 
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Figure 2.1.  TEM micrographs of 50% crosslinked SCKs prepared from DOTAlysinem-
g-PAAn-b-PSp block copolymer precursors:  (a), (b), (c), and (i) are images of SCK9, 
SCK12, SCK15, and Control1, prepared from PAA60-b-PS30 with 2, 4, 7, and 0 
DOTAlysine grafts, respectively;  (d), (e), (f), and (j) are images of SCK10, SCK13, 
SCK16, and Control2, prepared from PAA60-b-PA60 with 2, 4, 7, and 0 DOTAlysine 
grafts, respectively;  (g), (h), and (k) are images of SCK11, SCK14, and Control3, 
prepared from PAA60-b-PA140 with 2, 4, and 0 DOTAlysine grafts, respectively.  Scale 
bars in (i), (j), and (k): 100 nm. 
 
Based upon the TEM image analysis, the number of grafting DOTAlysines 
greatly influenced the morphologies of the nanoparticles.  All pre-DOTAlysine-SCKs 
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constructed from the three different amphiphilic block copolymers, each having 2 
DOTAlysines/polymer chain (SCK1-3 having undergone 20% crosslinking, and SCK9-
11, with 50% crosslinking) exhibited spherical morphologies with relatively narrow 
particle size distributions.  This similarity could be attributed to the fact that the small 
percentage of modification (< 4%) across the PAA backbone did not generate significant 
variation over the entire block copolymer properties, i.e. the balance between the 
hydrophilic and hydrophobic blocks remained little affected.  When p = 30 or 60, the pre-
DOTAlysine2-g-PAA58-b-PSp polymers gave uniform assembly (SCK1, SCK2, SCK9, 
and SCK10) to afford SCK dimensions that were in agreement with control SCKs 
(Figure 2.1i and 2.1j), prepared from PAA60-b-PS30 and PAA60-b-PS60, respectively.  In 
these cases, the loss of hydrophilicity (i.e., transformation of carboxylic acid to amide 
linkage) and the increased steric repulsion caused by the rigid macrocyclic moiety of 
DOTAlysine could be partially compensated by the ca. 10% increase of carboxylic acid 
residues (from DOTAlysine) over the length of the PAA60 segments.  In contrast, the 
DOTAlysine-functionalized amphiphilic block copolymers with the longest PS chain 
segment, DOTAlysine2-g-PAA58-b-PS140 underwent assembly into unusually small 
micelles to afford SCK3 and SCK11 that were significantly smaller in size and 
aggregation number than was the control assembly from PAA60-b-PS140 (Figure 2.1k)  
We are still investigating the reasons for the atypical assembly for these block 
copolymers. 
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For pre-DOTAlysine-SCKs with ca. 4 DOTAlysines/chain (20% crosslinking for 
SCK4-6 and 50% crosslinking for SCK12-14), their morphologies became much more 
complex.  As the DOTAlysine4-g-PAA56-b-PS30 was assembled, in addition to the major 
spherical morphology (> 80%), small rod-like structures appeared with ca. 60 nm length 
(Figure 2.1b).  Such unusual observation became extreme for SCKs prepared from 
DOTAlysine4-g-PAA56-b-PS60, in which half of the nanoobjects were rods with average 
lengths of ca. 100 nm (Figure 2.1e).  It is unclear whether the sphere-to-rod 
morphological transition results from interruptions on the local Coulombic interactions 
within the nanostructures, a hydrophilicity change in the shell domain, or a combination 
of these factors.  Detailed studies to better understand the “driving force” of this 
uncommon morphological transition are currently underway.  In the case of SCKs from 
DOTAlysine4-g-PAA56-b-PS140 (SCK6 and SCK14), spheres still remained dominant, 
but their particle size distributions were broad (Figure 2.1h). 
Interestingly, as the grafting DOTAlysine number continued to increase, the four 
SCKs (SCK7, SCK8, SCK16, and SCK17) from DOTAlysine7-g-PAA53-b-PS30(60) 
returned to the more thermodynamically favourable spherical morphology.  It is 
surprising that, even at this high proportion of modification (i.e., the introduction of ca. 
21 additional carboxylic acid groups per hydrophilic chain segment and the concomitant 
increased hydrophilic ratio and increased steric effects) along the polymer backbones, 
their assembly sizes and shapes remained similar to the control SCKs.  Again, the block 
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copolymer having the longest PS block length and coupling of ca. 7 DOTAlysines per 
polymer was unusual, in that it experienced poor solubility and could not be assembled 
into uniform micelles. 
Radiolabelling of these micelles and their corresponding SCKs with 64Cu were 
investigated thoroughly.  All the pre-DOTAlysine-SCKs/micelles exhibited high specific 
activity (Figure 2.2) compared with the SCKs prepared by coupling the DOTA onto pre-
established nanoparticles (post-DOTA-SCKs, Control4 in Figure 2.2).26  The specific 
activities of the pre-DOTAlysine-SCKs increased by 10 to 40 fold.  This high 
radiolabelling on a per particle basis creates an opportunity for reliable use with 
administration of a minimum amount of polymeric nanoparticles for in vivo PET 
imaging. 
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Figure 2.2.  Radiolabelling results for pre-DOTAlysine-SCKs:  (a) SCKs from 
functionalized PAA60-b-PS30;  (b) SCKs from functionalized PAA60-b-PS60;  (c) SCKs 
from functionalized PAA60-b-PS140.  The numbers of effective DOTAlysines/particle 
(with ± 5% standard deviation) were obtained from the numbers of effective 
DOTAlysines/polymer chain (determined from isotopic dilution experiments, see 
Experimental Section) and the calculated particle aggregation number (Table 2.1).  
Control4 were post-DOTA-SCKs.26 
 
The specific activity and the number of effective DOTAlysines per SCK did not 
follow the expected tendency, which would be an increase in labelling with an increase in 
DOTAlysine grafting density.  Rather, it appeared that the proportion of DOTAs 
available for 64Cu chelation reached a “saturation point” after 4 DOTAlysine grafts per 
polymer chain.  Since not all grafting DOTAlysines were located on the particle surface, 
the membrane-like structures within the shell regions of SCKs29 might hinder the 
formation of 64Cu-DOTAlysine complexes due to steric crowding and prevention of the 
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DOTAlysine macrocyclic from assuming a configuration amenable to stable 64Cu 
coordination.32  It is uncertain whether morphological differences (sphere vs. rod) also 
play a role. 
Moreover, for SCKs prepared from a fixed DOTAlysine graft number per 
polymer chain (Figure 2.2), it was found that: (i) as the extents of crosslinking increased 
(from 0% to 50%), less DOTAlysines were available for coordinating with copper; (ii) as 
the proportion of the hydrophilic PAA comprising the entire nanostructure decreased, so 
did the number of effective DOTAlysines and the overall specific activity.  The lower 
permeability within the shell domains of the SCKs having higher extents of crosslinking29 
could hinder the diffusion of 64Cu to approach the DOTAlysine chelators located 
throughout the sub-surface and deep-shell areas.  For instance, the number of effective 
DOTAlysines per DOTAlysine7-g-PAA53-b-PS30 chain determined by isotopic dilution 
experiments (see Experimental Section) was ca. 2.8, much lower than 7.0, which was 
determined by 1H NMR analysis.  The second trend observed further suggests the 
complexities on the self-assembly behaviour of DOTAlysine-g-PAA-b-PS block 
copolymers.  The lower radiolabelling efficiency on micelles and SCKs established from 
the longer hydrophobic PS block (while the DOTAlysine-g-PAA segment was invariable) 
could be related with their atypical morphological characteristics (vide supra).  
Nevertheless, all micelles and SCKs prepared from DOTAlysine-g-PAA-b-PS exhibited 
high radiolabelling results, providing a library of nanoparticles with varying 
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characteristic parameters to be employed for PET imaging when a minimum amount of 
imaging agent is needed. 
It is noteworthy that this grafting strategy affords nanoobjects with remarkably 
improved radiolabelling efficiencies, relative to the post-functionalization of pre-
established SCKs,26 but also introduces complications with the assembling process, 
presenting unusual morphologies in some cases.  More efforts are being devoted to 
investigate these morphological variations.  Although micelles give the highest 
radiolabelling, their stability concerns, i.e., stable architectures exist only above their 
critical micelle concentrations, remain challenging for in vivo applications.23  Considering 
both the radiolabelling results and the SCK morphological properties, we conclude, 
tentatively, that the current optimum sample for in vivo PET imaging are SCKs having 
20% shell crosslinking and prepared from PAAn-b-PSp containing ca. 2 DOTAlysine per 
polymer chain. 
 
Conclusions 
In summary, we have developed a new strategy to construct shell crosslinked 
nanoparticles, containing large numbers of DOTAlysines per particle (> 400) that were 
accessible for 64Cu radiolabeling.  These nanoparticles originated from conveniently 
prepared DOTAlysine-g-PAA-b-PS block copolymer precursors.  The morphology of 
these pre-DOTAlysine-SCKs was, however, complicated by the number of DOTAlysine 
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grafts per polymer chain.  Nonetheless, the 64Cu–complexed pre-DOTAlysine-SCK 
nanoparticles showed impressive specific activities (ca. 400 μCi μg-1), which suggest that 
these nanoparticles might be used to develop highly sensitive in vivo PET tracers at low 
administering doses.  This “pre-grafting” strategy may also be employed to couple other 
molecules for targeting interested epitopes and/or for improving the in vivo bio-
distribution of nanoobjects. 
 
Experimental Section 
PAA-b-PS Block Copolymer Synthesis.  All block copolymers were synthesized by 
acidolysis of PtBA-b-PS precursors, which were prepared by sequential polymerization 
of tert-butyl acrylate and styrene via nitroxide mediated radical polymerization (NMP), 
with trifluoroacetic acid (TFA) as reported in the literature.33 
General Procedure for DOTAlysine-g-PAA-b-PS Synthesis.  Grafting 
DOTAlysines onto PAA-b-PS by amidation involved the following: To a round-bottom 
flask equipped with a magnetic stir bar, was added a sample of PAA-b-PS block 
copolymer and anhydrous N,N-dimethylformamide (DMF).  The mixture was stirred for 
1 h at room temperature to ensure that a clear and homogeneous solution was obtained.  
To this solution, was added 1-[3’-(dimethylamino)propyl]-3-ethylcarbodiimide 
methiodide (EDCI) and 1-hydroxybenzotriazole (HOBt) and the reaction mixture was 
allowed to stir for 1 h at rt.  Finally, a pre-mixed solution of DOTAlysine·TFA and N,N-
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diisopropylethylamine (DIPEA) in anhydrous DMF was added and the reaction mixture 
was further stirred for 20 h at rt.  The reaction mixture was then transferred to pre-soaked 
dialysis tubing (MWCO ca. 6,000 to 8,000 Da) and dialyzed against nano-pure H2O (18.0 
MΩ cm, pre-treated with Chelex100®) for 4 d to remove the organic solvent and small 
molecule by-products.  The aqueous solution was then lyophilized to afford the product 
as white solid. 
General Procedure for the Micellization of DOTAlysine-g-PAA-b-PS.  To a 
round-bottom flask equipped with a magnetic stir bar, was added DOTAlysine-g-PAA-b-
PS, followed by anhydrous DMF.  The mixture was sonicated for 10 min and stirred for 2 
h at rt to ensure that a clear and homogeneous solution (final concentration, ca. 1.0 
mg/mL) had formed.  To this solution, was added dropwise via a syringe pump at a rate 
of 15.0 mL/h, an equal volume of nano-pure H2O (18.0 MΩ cm) and the mixture was 
further stirred for 16 h at rt.  Finally, the solution was transferred to pre-soaked dialysis 
tubing (MWCO ca. 6,000 to 8,000 Da) and dialyzed against nano-pure H2O (18.0 MΩ 
cm, pre-treated with Chelex100®) for 4 d to afford a clear solution of micelles. 
General Procedure for the Preparation of Pre-DOTAlysine-SCKs.  To a 250 mL 
round-bottom flask equipped with a magnetic stir bar, was added a solution of 
DOTAlysine-g-PAA-b-PS micelles in nano-pure H2O (18.0 MΩ cm) (50.0 mL, 0.054 
mmol of carboxylic acid residues).  To this solution was added dropwise over 10 min, a 
solution of 2,2'-(ethylenedioxy)-bis(ethylamine) (0.9 mg, 0.006 mmol for 20% 
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crosslinking extent; or 2.2 mg, 0.015 mmol for 50% crosslinking extent) in nano-pure 
H2O (18.0 MΩ cm) (2.0 mL).  The reaction mixture was allowed to stir for 2 h at rt.  To 
this solution was added, dropwise via a syringe pump over 1 h, a solution of EDCI (4.0 
mg, 0.014 mmol for 20% crosslinking extent; or 10.0 mg, 0.034 mmol for 50% 
crosslinking extent) in nano-pure H2O (18.0 MΩ cm) (2.0 mL) and the reaction mixture 
was further stirred for 16 h at rt.  Finally, the reaction mixture was transferred to pre-
soaked dialysis tubing (MWCO ca. 6,000 to 8,000 Da) and dialyzed against 5.0 mM PBS 
(pH 7.3, with 5.0 mM NaCl, pre-treated with Chelex100®) for 5 d to remove the small 
molecule by-products and afford aqueous solutions of pre-DOTAlysine-SCKs. 
64Cu labelling and isotopic dilution experiments of the pre-DOTAlysine-SCKs.  
A 100 μL pre-DOTAlysine-SCK solution in 5.0 mM PBS (pH 7.3, with 5.0 mM NaCl, 
0.2-0.3 mg/mL) was diluted with 100 μL of 0.1 M ammonium acetate buffer (pH 5.5) and 
to this solution, 64Cu(OAc)2 was added (ca. 1.0 mCi).  The resulting solution was 
incubated at 43 °C for 2 h, and then subjected to DTPA challenge.  The labelling yield 
was determined by radio-TLC on ITLC-SG plates using methanol/CH3CO2NH4 (aq) as 
eluent.  The number of effective DOTAlysines/polymer chain was determined by isotopic 
dilution experiments.  A series of known amounts of “hot plus cold” copper (Cu2+ 
solution spiked with 64Cu) were added to several 100 μL SCK solutions respectively.  
After a 2 h incubation at 43 °C and DTPA challenge, each solution aliquot was analyzed 
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by radio-ITLC to determine the number of effective DOTAlysine per polymer chain, as 
previously reported.23 
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Chapter 3 
 
Facile, Efficient Approach to Accomplish Tunable Chemistries and 
Variable Biodistributions for Shell Crosslinked Nanoparticles (SCKs) 
[Portions of this work have been published previously as Guorong Sun, Aviv Hagooly, 
Jinqi Xu, Andreas M. Nyström, Zicheng Li, Raffaella Rossin, Dennis A. Moore, Karen L. 
Wooley and Michael J. Welch Biomacromolecules 2008, 9(7), 1997-2006.] 
 
Abstract 
The in vivo behavior of shell crosslinked knedel-like (SCK) nanoparticles is 
shown to be tunable, via a straightforward and versatile process that advances SCKs as 
attractive nanoscale carriers in the field of nanomedicine.  Tuning of the 
pharmacokinetics was accomplished by grafting varied numbers of methoxy-terminated 
poly(ethylene glycol) (mPEG) chains to the amphiphilic block copolymer precursors, 
together with chelators for the radioactive tracer and/or therapeutic agent 64Cu, followed 
by self assembly into block copolymer micelles and chemical crosslinking throughout the 
shell regions.  64Cu-radiolabeling was then performed in order to evaluate the SCKs in 
vivo by means of biodistribution experiments and positron emission tomography (PET).  
It was found that the blood retention of PEGylated SCKs could be tuned, depending on 
the mPEG grafting density and the nanoparticle surface properties.  A semi-quantitative 
model of the density of mPEG surface coverage as a function of in vivo behavior was 
applied to enhance the understanding of this system. 
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Introduction 
There are many types of nanoparticle platforms that are undergoing investigation 
as multi-functional agents for packaging, transport and delivery of imaging and 
therapeutic agents in the broad field of nanomedicine.1-6  Many such nanostructures 
derive from the supramolecular assembly of small molecule or polymer components.  For 
any new agent, it is critical that the composition, structure and properties be well-defined 
and controlled.  The multimolecular association of amphiphilic block copolymers into 
core-shell micellar nanoassemblies has received particular attention.7-10  Covalent 
crosslinking throughout the shell domains of spherical micelles, which are established 
from the self assembly of amphiphilic block copolymers, can afford shell crosslinked 
knedel-like (SCK) nanoparticles as discrete nanoscale objects.11, 12  With the benefits of 
robust character, offered via the crosslinking, and the amphiphilic core-shell morphology, 
imposed by the self assembly process, SCKs, and also internally-crosslinked block 
copolymer micelles, have received significant attention as sophisticated hosts for 
purposes of diagnosis and therapy toward acute vascular injury, acute lung injury and 
cancer.13, 14  In each case, it is important that the nanostructures be able to circulate for a 
sufficient period in the bloodstream to increase their probability to target specific tissues. 
It is well known that systemically-administered nanoparticles tend to be 
sequestrated by the mononuclear phagocyte system (MPS), and accumulate mainly in the 
liver and spleen.  Clearance from the bloodstream begins with the adsorption of plasma 
proteins onto the nanoparticle surface (opsonization), which triggers complement 
activation and macrophage recognition, and depends on particle size, surface chemistry 
and other factors.15, 16  Surface modification with polyethylene glycol (PEG) based units 
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is one of the most successful techniques to avoid nanoparticle opsonization and, 
therefore, to slow down macrophage recognition.15-17  PEG is water-soluble, non-toxic, 
and gives low immunogenic response.18, 19  It can be adsorbed onto or chemically 
conjugated with bioactive agents, leading to improvement of their in vivo stability and 
enhancement of their pharmacokinetic profiles.20, 21  Also, surface PEGylation of 
polymeric nanoparticles was shown to decrease aggregation and to prolong blood 
circulation times.1, 7, 8, 10, 15-17  Although the mechanism is still controversial, many studies 
have suggested that the presence of PEG on the surface of a nanoparticle can exert 
entropic and steric repulsions to resist and minimize the adsorption of plasma proteins 
and the subsequent macrophage recognition.7, 8, 15-17  For each new nanostructured 
material under development, the chemical composition, together with size,22 shape,23, 24 
and flexibility,25 are believed to require tuning in order to determine their interactions 
with biomacromolecules and, therefore, their fate in vivo.  In general, entire “coverage” 
of the nanoparticle surface with PEG is considered to be vital to achieve “stealth” 
characteristics.26-36  Therefore, it is critical that chemical methodologies are available to 
control and confirm the number of PEG chains and density of PEGylation.  It is also 
important that the chemistry allows for the incorporation of probes that can track the 
nanoparticles and be used for imaging purposes.  In this work, we employ 64Cu-
radiolabeling for biodistribution evaluation and positron emission tomography (PET), as 
a highly sensitive and non-invasive imaging technique,37, 38 to assess the effect of 
PEGylation on blood retention and MPS uptake.39-41 
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Experimental Section 
Materials.  All reagents and solvents were obtained from commercial sources 
(Sigma-Aldrich, Acrose, and Fluka) and used without further purification unless 
otherwise noted.  64Cu was prepared on the Washington University Medical School CS-
15 Cyclotron by the 64Ni(p,n)64Cu nuclear reaction at a specific activity of 50–200 
mCi/μg at the end of bombardment.  The buffers used for dialysis after SCK preparation 
and during 64Cu-labeling were treated overnight with Chelex-100® resin (Bio-Rad 
Laboratories, Hercules, CA) before use. 
Measurements.  1H NMR spectra were recorded in solutions on a Varian Mogli 500 
spectrometer with the residual solvent signal as an internal standard.  Gel permeation 
chromatography (GPC) was conducted on a Waters 1515 HPLC (Waters 
Chromatography, Inc.) equipped with a Waters 2414 differential refractometer, a PD2020 
dual-angle (15° and 90°) light scattering detector (Precision Detectors, Inc.), and a 
three-column series PL gel 5μm Mixed C, 500 Å, and 104 Å, 300 × 7.5 mm columns 
(Polymer Laboratories Inc.).  The system was equilibrated at 35 °C in anhydrous 
tetrahydrofuran (THF), which served as the polymer solvent and eluent with a flow rate 
of 1.0 mL/min.  Polymer solutions were prepared at a known concentration (ca. 3 
mg/mL) and an injection volume of 200 μL was used.  Data collection and analysis were 
performed, respectively, with Precision Acquire software and Discovery 32 software 
(Precision Detectors, Inc.).  Interdetector delay volume and the light scattering detector 
calibration constant were determined by calibration using a nearly monodispersed 
polystyrene standard (Pressure Chemical Co., Mp = 90 kDa, Mw/Mn < 1.04).  The 
differential refractometer was calibrated with standard polystyrene reference material 
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(SRM 706 NIST), of known specific refractive index increment dn/dc (0.184 mL/g).  The 
dn/dc values of the analyzed polymers were then determined from the differential 
refractometer response. 
Samples for transmission electron microscopy (TEM) measurements were diluted 
with 1 wt% of phosphotungstic acid (PTA) stain solution (v/v, 1:1).  Carbon grids were 
exposed to oxygen plasma treatment to increase the surface hydrophilicity.  Micrographs 
were collected at 100,000× magnification and calibrated using a 41 nm polyacrylamide 
bead from NIST.  The number average particle diameters (Dav) and standard deviations 
were generated from the analysis of a minimum of 150 particles from at least three 
different micrographs. 
Hydrodynamic diameters (Dh) and size distributions for the SCKs in aqueous 
solutions were determined by dynamic light scattering (DLS).  The DLS instrumentation 
consisted of a Brookhaven Instruments Limited (Worcestershire, U.K.) system, including 
a model BI-200SM goniometer, a model BI-9000AT digital correlator, a model EMI-
9865 photomultiplier, and a model 95-2 Ar ion laser (Lexel, Corp.; Farmindale, NY) 
operated at 514.5 nm. Measurements were made at 20 ± 1 °C.  Prior to analysis, solutions 
were filtered through a 0.22 μm Millex®-GV PVDF membrane filter (Millipore Corp., 
Medford, MA) and then centrifuged in a model 5414 microfuge (Brinkman Instruments, 
Inc.; Westbury, NY) for 10 minutes to remove dust particles.  Scattered light was 
collected at a fixed angle of 90°.  The digital correlator was operated with 522 ratio 
spaced channels, and initial delay of 5 μs, a final delay of 100 ms, and a duration of 10 
minutes.  A photomulitplier aperture of 400 μm was used, and the incident laser intensity 
was adjusted to obtain a photon counting of between 200 and 300 kcps.  Only 
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measurements in which the measured and calculated baselines of the intensity 
autocorrelation function agreed to within 0.1 % were used to calculate particle size.  The 
calculations of the particle size distributions and distribution averages were performed 
with the ISDA software package (Brookhaven Instruments Company), which employed 
single-exponential fitting, cumulants analysis, non-negatively constrained least-squares 
(NNLS) and CONTIN particle size distribution analysis routines.  All determinations 
were made in triplicate and the data were presented as mean values ± standard deviations 
between runs. 
Zeta potential (ζ) values for the nanoparticle solution samples in 5 mM phosphate 
buffered saline (PBS) were determined with a Brookhaven Instrument Co. (Holtsville, 
NY) model Zeta Plus zeta potential analyzer.  Data were acquired in the phase analysis 
light scattering (PALS) mode following solution equilibration at 25 °C.  Calculation of ζ 
from the measured nanoparticle electrophoretic mobility (μ) employed the Smoluchowski 
equation: μ = εζ/η, where ε and η are the dielectric constant and the absolute viscosity of 
the medium, respectively.  Measurements of ζ were reproducible to within ± 2 mV of the 
mean value given by 16 determinations of 10 data accumulations. 
The aggregation number was calculated based upon the diameter measured from 
TEM by using the following equation: 
Naggr = A
n
N
M
r
×
ρπ 3
3
4
 
where r is the radius of the SCK, ρ is the density of polystyrene, Mn is the number-
average molecular weight of polystyrene block segment, and NA is the Avogadro 
constant. 
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A Bioscan 200 scanner (Bioscan, Washington, DC) was used to read the instant thin 
layer chromatography (ITLC) plates (Pall ITLC-SG plates, VWR International, Batavia, 
IL).  Fast protein liquid chromatography (FPLC) and radio-FPLC were performed using 
an ÄKTA FPLC system (GE Healthcare Biosciences) equipped with a Beckman 170 
Radioisotope Detector (Beckman Instruments, Fullerton, CA).  The radioactivity was 
measured in a Beckman gamma-counter 8000 (Beckman instrument, Irvine, CA) 
The imaging studies were carried out using the MicroPET® Focus (Siemens Medical 
Solutions Inc., Knoxville, TN) and the MicroCAT II (CTI-Imtek, Knoxville, TN) 
scanners. 
Preparation of mPEG2000-g-PAA-b-PS Block Copolymers.  The poly(acrylic 
acid)-b-polystyrene (PAA-b-PS, PAA60-b-PS60 for this work) block copolymer was 
prepared as previously published (for the PAA60-b-PS60 block copolymer precursor, 
poly(tert-butyl acrylate)-b-polysteyrene, PtBA60-b-PS60, Mn,GPC = 13,500 Da, Mw/Mn = 
1.2).42  Grafting mPEG2000 onto PAA-b-PS involved the following: to a solution of 
PAA60-b-PS60 block copolymer in anhydrous N,N-dimethylformamide (DMF), 1-[3’-
(dimethylamino)propyl]-3-ethylcarbodiimide methiodide (EDCI) and 1-
hydroxybenzotriazole (HOBt) were added and the reaction mixture was allowed to stir 
for 1 h at room temperature (rt).  Then, a solution of mono-amine terminated mPEG2000 
in anhydrous DMF was added and the reaction mixture was further stirred for 30 h at rt.  
The relative ratios of PAA60-b-PS60 block copolymer:EDCI:HOBt:mPEG-NH2 were 
varied to alter the grafting densities, whereby to achieve grafting densities of 1, 2.5 and 
5.5 mPEGs per macromolecule, the stoichiometries were 1.0:1.3:1.3:1.3, 1.0:3.5:3.5:3.5, 
and 1.0:7.0:7.0:7.0, respectively.  The final grafted block copolymers were isolated by 
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transferring the reaction mixtures to pre-soaked dialysis tubing (MWCO 6,000 to 8,000 
Da) and dialyzing against nano-pure H2O (18.0 MΩ cm) for 4 d to remove the organic 
solvent and the small molecule by-products.  The aqueous solutions were then 
lyophilized to afford the products as a white solid.  1H-NMR (500 MHz, CD2Cl2, ppm): δ 
1.20-2.40 (br, -CH2- and -CH- of the polymer backbone), 3.34 (s, mPEG terminal CH3O- 
Hs), 3.42-3.80 (br,  mPEG backbone -OCH2CH2O- Hs), 6.16-7.11 (br, aromatic Hs). 
mPEG20001-g-PAA59-b-PS60  PAA60-b-PS60 (110.0 mg, 10.4 μmol), EDCI (4.0 mg, 
13.5 μmol), HOBt (1.8 mg, 13.5 μmol), and mono-amine terminated mPEG2000 (27.0 
mg, 13.5 μmol) in anhydrous DMF (15.0 mL).  Yield: 72%. 
mPEG20002.5-g-PAA57.5-b-PS60  PAA60-b-PS60 (120.0 mg, 11.3 μmol), EDCI (11.8 
mg, 39.6 μmol), HOBt (5.4 mg, 40.0 μmol), and mono-amine terminated mPEG2000 
(79.2 mg, 39.6 μmol) in anhydrous DMF (15.0 mL).  Yield: 75%. 
mPEG20005.5-g-PAA54.5-b-PS60  PAA60-b-PS60 (110.0 mg, 10.4 μmol), EDCI (21.6 
mg, 72.8 μmol), HOBt (9.9 mg, 73.3 μmol), and mono-amine terminated mPEG2000 
(145.6 mg, 72.8 μmol) in anhydrous DMF (15.0 mL).  Yield: 75%. 
Preparation of mPEG2000-g-DOTAlysine-g-PAA-b-PS Block Copolymers.  The 
DOTAlysine (a lysine derivative for 1,4,7,10-tetraazocyclododecane-N,N′,N″,N′″-
tetraacetic acid, DOTA) was grafted onto mPEG2000-g-PAA-b-PS by following a 
procedure similar to that used to graft mPEG2000 (described above).  To a solution of 
mPEG2000-g-PAA-b-PS block copolymer (10.3 μmol) in anhydrous DMF (10.0 mL), 
EDCI (11.6 mg, 39.1 μmol) and HOBt (5.3 mg, 39.3 μmol) were added and the reaction 
mixture was allowed to stir for 1 h at rt.  Then, a solution of DOTAlysine (trifluoroacetic 
acid (TFA) salt, 23.1 mg, 39.2 μmol) and N,N-diisopropylethylamine (DIPEA, 25.4 mg, 
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19.6 mmol) in anhydrous DMF (2.0 mL) was added and the reaction mixture was further 
stirred for 30 h at rt.  The final grafted block copolymers were isolated by transferring the 
reaction mixtures to pre-soaked dialysis tubing (MWCO 6,000 to 8,000 Da) and dialyzing 
against nano-pure H2O (18.0 MΩ cm) for 5 d to remove the organic solvent and the small 
molecule by-products.  The aqueous solutions were then lyophilized to afford the 
products as a white solid. Yield: 65%.  1H-NMR (500 MHz, CD2Cl2 with 2 drops of 
CF3CO2D, ppm): δ 1.20-2.40 (br, -CH2- and -CH- of the polymer backbone, overlap with 
DOTAlysine Hs), 2.40-2.70 (br, DOTAlysine macrocyclic Hs), 3.34 (s, mPEG terminal 
CH3O- Hs), 3.42-3.80 (br, mPEG backbone -OCH2CH2O- Hs), 6.16-7.11 (br, aromatic 
Hs). 
Micellization of mPEG2000-g-DOTAlysine-g-PAA-b-PS.  To a solution of 
mPEG2000-g-DOTAlysine-g-PAA-b-PS in anhydrous DMF (ca. 1.0 mg/mL), was added 
dropwise an equal volume of nano-pure H2O via a syringe pump at a rate of 15.0 mL/h, 
and the mixture was further stirred for 16 h at rt.  The solution was then transferred to 
pre-soaked dialysis tubing (MWCO ca. 6,000 to 8,000 Da) and dialyzed against nano-
pure H2O for 4 d to afford a clear solution of micelles. 
Construction of mPEGylated DOTA-SCKs.  To a solution of mPEG2000-g-
DOTAlysine-g-PAA-b-PS micelles in nano-pure H2O was added a solution of 2,2'-
(ethylenedioxy)-bis(ethylamine) in nano-pure H2O dropwise over 10 min.  The reaction 
mixture was allowed to stir for 2 h at rt.  EDCI in nano-pure H2O was then added to the 
resulting solution, dropwise via a syringe pump over 1 h.  The general stoichiometry 
employed to achieve 20% nominal crosslinking was 9:2.2:1 for carboxylic acid 
units:EDCI:crosslinker, and to achieve 50% nominal crosslinking, the stoichiometry was 
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3.6:2.2:1.  The reaction mixture was further stirred for 16 h at rt.  Finally, the mixture was 
transferred to pre-soaked dialysis tubing (MWCO ca. 6,000 to 8,000 Da) and dialyzed 
against 5.0 mM PBS (pH 7.3, with 5.0 mM NaCl) for 5 d to remove the small molecule 
by-products and afford aqueous solutions of mPEGylated DOTA-SCKs. 
Preparation of SCK6. 
Synthesis of mPEG50003-g-PAA57-b-PS60 Block Copolymer  A similar procedure 
as grafting mPEG2000 described above was followed with a relative ratio of PAA60-b-
PS60 block copolymer:EDCI:HOBt:mPEG5000-NH2 = 1.0:4.0:4.0:4.0. 
Synthesis of mPEG50003-g-DOTAlysine2-g-PAA55-b-PS60 Block Copolymer  A 
similar protocol as the preparation of mPEG2000-g-DOTAlysine-g-PAA-b-PS block 
copolymers described above was followed. 
Micellization and crosslinking throughout the shell domain of the micelle to afford 
SCK6 were carried out following the same protocol as described above. 
Preparation of SCK7.  Monomethoxy poly(ethylene glycol) hydroxyl terminated 
(mPEG5000-OH), nominal molecular weight 5000 Da, was purified by flash column 
chromatography on silica gel eluted with methanol/DCM 5:95 (v/v).  Styrene and tert-
butyl acrylate (t-BA) were distilled over calcium hydride prior to use. 
Synthesis of Poly(ethylene glycol) Macroinitiator (mPEG5000Ini)  A dry 250 mL 
round bottom flask equipped with a stir bar was charged with mPEG5000-OH (16.5 g, 
3.30 mmol), triethylamine (TEA, 0.70 g, 6.93 mmol), 4-dimethylaminopyridine (DMAP, 
0.20 g, 1.64 mmol), and 200 mL of dichloromethane (DCM).  The solution was stirred at 
0 °C for 30 min after which 2-bromoisobutyryl bromide (1.52 g, 6.60 mmol) was added 
drop-wise to the reaction mixture with the aid of a dropping funnel.  The reaction was left 
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to proceed for 24 h after which the solution was filtered and the filtrate concentrated 
under vacuum.  The crude reaction mixture was redissolved in 300 mL of DCM and 
washed with a 10 w/w % sodium hydrogen sulfate solution (3 x 150 mL), followed by a 
10 w/w % sodium bisulfate solution (3 x 150 mL).  The organic phase was dried over 
magnesium sulfate (MgSO4), filtered, and concentrated in vacuum.  The crude product 
was purified by repeated precipitation in diethyl ether from DCM.  The product was 
collected by filtration and dried under vacuum to give mPEG5000Ini as a white solid 
(12.1 g, 71%).  1H NMR (CDCl3, ppm): δ 1.93 (s, 6H, -CO(CH3)2-Br), 3.38 (s, 3H, 
mPEG terminal CH3O- Hs), 3.42-3.80 (br, mPEG backbone-OCH2CH2O- Hs). 
Synthesis of mPEG5000-b-PtBA100 Block Copolymer  A dry 25 mL Schlenk flask 
equipped with a stir bar was charged with t-BA (8.36 g, 65.2 mmol), mPEG5000Ini (1.0 
g, 0.22 mmol), Cu(I)Br (62.0 mg, 0.43 mmol), anisole (5.0 g, 46.2 mmol), and THF (1.0 
g, 13.9 mmol).  After the reaction mixture was frozen in liquid nitrogen N,N,N′,N″,N″-
pentamethyldiethylenetriamine (PMDETA, 7.0 mg, 0.43 mmol) was added via a gas-tight 
syringe.  Three freeze-pump-thaw cycles were performed, and the mixture was back-
filled with nitrogen and brought to rt.  The flask was heated to 50 °C, and the reaction 
was let to proceed for 28 h (28 % conversion), and after which it was quenched by 
immersion of the reaction flask in liquid nitrogen.  The reaction mixture was then 
dissolved in THF, passed through a neutral aluminium oxide column, and concentrated 
under vacuum.  The reaction mixture was then dissolved in THF and transferred to pre-
soaked dialysis tubing (MWCO 6,000–8,000 Da) and dialyzed against a methanol/H2O 
mixture (30:70 by volume) for 4 d to remove the residual monomer.  The aqueous 
solution was then lyophilized to afford the product mPEG5000-b-PtBA100 as white solid 
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(2.0 g, 60 %).  Mn = 20.0 kDa, Mw/Mn = 1.20.  1H-NMR (CDCl3, ppm): δ 1.20-1.70 (br, 
meso and racemo -CH2- of the polymer backbone), 1.30-1.60 (br, (CH3)3C- of the tert-
butyl ester), 2.11-2.40 (br, -CH- of the polymer backbone), 3.38 (s, 3H, mPEG terminal 
CH3O- Hs), 3.42-3.80 (br, mPEG backbone -OCH2CH2O- Hs). 
Synthesis of mPEG5000-b-PtBA100-b-PS50 Block Copolymer  A dry 25 mL 
Schlenk flask equipped with a stir bar was charged with styrene (1.52 g, 14.6 mmol), 
mPEG5000-b-PtBA100 (1.0 g, 0.049 mmol), Cu(I)Br (20.9 mg, 0.15 mmol), and anisole 
(1.8 g, 16.7 mmol).  After the reaction mixture was frozen in liquid nitrogen PMDETA 
(25.0 mg, 0.15 mmol) was added via a gas-tight syringe.  Three freeze-pump-thaw cycles 
were performed, and the mixture was back-filled with nitrogen and brought to rt.  The 
flask was heated to 60 °C, and the reaction was allowed to proceed for 31 h (16.5 % 
conversion), and after which it was quenched by immersion of the reaction flask in liquid 
nitrogen.  The reaction mixture was then dissolved in THF, passed through a neutral 
aluminium oxide column, and concentrated under vacuum.  The reaction mixture was 
then dissolved in THF and transferred to pre-soaked dialysis tubing (MWCO 6,000–
8,000 Da) and dialyzed against a methanol/H2O mixture (30:70 by volume) for 4 d to 
remove the residual monomers.  The aqueous solution was then lyophilized to afford the 
product mPEG5000-b-PtBA100-b-PS50 as white solid (0.88 g, 71 %).  Mn = 24.0 kDa, 
Mw/Mn = 1.20.  1H-NMR (CDCl3, ppm): δ 1.15-1.65 (br, meso and racemo -CH2- of the 
polymer backbone), 1.30-1.60 (br,  (CH3)3C- of the tert-butyl ester), 2.11-2.40 (br, -CH- 
of the polymer backbone), 3.39 (s, 3H, mPEG terminal CH3O- Hs), 3.40-3.80 (br, mPEG 
backbone -OCH2CH2O- Hs), 6.15-6.83 (br, o-Ar), 6.85-7.11 (br, m,p-Ar). 
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Synthesis of mPEG5000-b-PAA100-b-PS50 Block Copolymer A 25 mL round 
bottom flask equipped with a stir bar was charged with mPEG5000-b-PtBA100-b-PS50 
(250 mg, 0.010 mmol), 5 mL of DCM and 5 mL of TFA.  The reaction was left to 
proceed at rt for 24 h after which it was concentrated under vacuum.  The crude product 
was then dissolved in THF and transferred to pre-soaked dialysis tubing (MWCO 6,000–
8,000 Da) and dialyzed against nano-pure H2O (18.0 MΩ cm) for 4 d to remove small 
molecule impurities.  The aqueous solution was then lyophilized to afford the product 
mPEG5000-b-PAA100-b-PS50 as white solid (0.18 g, 95 %).  1H-NMR (DMSO-d6, ppm): 
δ 1.10-2.05 (br, meso and racemo -CH2- of the polymer backbone), 2.11-2.21 (br, -CH- 
of the polymer backbone), 3.30 (s, 3H, mPEG terminal CH3O- Hs), 3.42-3.90 (br, mPEG 
backbone -OCH2CH2O- Hs), 6.12-6.80 (br, o-Ar), 6.90-7.20 (br, m,p-Ar), 11.0-14.0 (br, -
COOH). 
Synthesis of mPEG-b-(DOTAlysine7-g-PAA93)-b-PS50 Block Copolymer  Grafting 
of the DOTAlysines onto mPEG5000-b-PAA100-b-PS50 by amidation was achieved by 
the same procedure as described above. 
Micellization and crosslinking throughout the shell domain of the micelle to afford 
SCK7 were carried out following the same protocol as described above. 
General Method for 64Cu Labeling.  A solution of mPEGylated DOTA-SCK (ca. 
0.2–0.3 mg/mL) in 5.0 mM PBS (pH 7.3, with 5.0 mM NaCl) was diluted with an equal 
volume of 0.1 M ammonium acetate buffer (pH 5.5) and 64Cu-acetate (ca.30–500 μCi) 
was added.  A Tween-20 solution in PBS was added to prevent non specific adsorption of 
the labeled nanoparticles on the labeling vials and other laboratory glassware (0.1% 
Tween-20, v/v, in the final solution).  The labeling mixtures were incubated at 43 °C for 
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1 h, and then 5 μL of a 10 mM aqueous diethylenetriaminepentaacetic acid (DTPA) 
solution was added.  The sample was allowed to incubate for 10 min at rt.  The purity of 
the labeled samples was monitored by radio-ITLC using a 1:1 mixture (v/v) of 10 wt% 
ammonium acetate and methanol as developing solvent.  The samples were filtered 
through 0.45 μm PVDF filters (Millipore Corp., Medford, MA).  Samples with < 95 % 
radiochemical purity (RCP) were purified by using size exclusion cartridges (Zeba spin 
desalting column 2 mL, Pierce).  Using 10 mM PBS (pH 7.4) as elute (up to 500 μL total 
volume of sample and PBS).  The Zeba column has > 95% retention of salts and other 
small molecules (MW < 1000 Da) and tends to retain excess of DTPA.  Tween-20 with 
MW around 1,200 Da may also retain under this conditions.  Since the eluted sample was 
diluted for at least five times the reaction volume no more than 0.02% of Tween-20 was 
injected.  FPLC analysis was used to determinate the purity of the injected samples.  The 
purified samples were diluted with 10 mM PBS (pH 7.4) to prepare appropriate doses for 
bidistribution and imaging studies. 
General Method for FPLC Analysis.  A 50–100 μL of the labeled SCK was 
injected into a Superose 12 gel filtration column (GE Healthcare Biosciences) and eluted 
with 20 mM 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) with 150 mM 
NaCl (pH 7.3) at 0.8 mL/min.  The UV wavelength was preset to 280 nm and the 
radioactivity was monitored by an in-line radio-detector.  Under these conditions, the 
retention times of the native and radiolabeled SCKs were 10 min while the retention 
times of free 64Cu and 64Cu-DTPA were 20–22 min.  Samples with RCP > 95% were 
used for animal studies. 
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General Method for Specific Activity Measurement.  A 100 μL of mPEGylated 
DOTA-SCK solution (ca. 0.2–0.3 mg/mL) in 5.0 mM PBS (pH 7.3, with 5.0 mM NaCl) 
was diluted with 100 μL of 0.1 M ammonium acetate buffer (pH 5.5) and to this solution, 
64Cu-acetate was added (ca. 1 mCi).  The resulting solution was incubated at 43 °C for 2 
h, and then subjected to DTPA challenge.  The labeling yield was determined by radio-
TLC on ITLC-SG plates using methanol/CH3CO2NH4 (aq) as eluent.  The number of 
effective DOTAlysines/polymer chain was determined by isotopic dilution experiments.  
A series of known amounts of “hot plus cold” copper (Cu2+ solution spiked with 64Cu) 
were added to 100 μL SCK solution aliquots.  After 2 h incubation at 43 °C and DTPA 
challenge, each solution was analyzed by radio-ITLC to determine the number of 
effective DOTAlysine per polymer chain, as previously reported.39 
Biodistribution and small animal PET imaging studies of PEGylated SCKs.  All 
animal studies were performed in compliance with guidelines set by the Washington 
University Animal Studies Committee.  Normal female Sprague-Dawley rats (180–200 g, 
n = 4 per time point) were anesthetized with 1–2% vaporized isoflurane and injected with 
ca. 30 μCi of activity in 200 μL via the tail vein (ca. 20–25 μg/kg rat body weight).  At 
specific time points post injection, organs and tissues of interest were harvested, blotted 
dry, and the radioactivity was measured in a Beckman gamma-counter 8000 (Beckman 
instrument, Irvine, CA).  For blood and muscle, total activity was calculated assuming 
that these tissues constitute 6 and 41% of the total body weight, respectively.  Diluted 
standard doses (1:100) were prepared and counted along with the samples.  All the data 
were corrected for 64Cu decay.  The percent injected dose per gram tissue (%ID/g) values 
were calculated using the following equation:  
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One-way analysis of variance (ANOVA) and post-hoc multiple comparison 
(Bonferroni’s t-test) on the biodistribution data were performed by using Prism v. 4.00 
(Graphpad, San Diego, CA).  Groups with P < 0.05 were considered significantly 
different. 
Normal female Balb/c mice (n = 2) weighing 20–30 g were injected with ca. 100–200 
μCi of 64Cu-labeled SCK (0.15–0.3 mg/kg mouse body weight) in 150 μL via tail vein 
and anesthetized with 1–2% vaporized isoflurane for data collection at specific time 
points.  MicroPET and microCT image co-registration was accomplished using a 
landmark registration technique (by using fiducial markers directly attached to the animal 
bed) and AMIRA image display software (TGS Inc., Richmond, TX).  Data analysis of 
microPET images was performed using the manufacturer software (ASIPRO, Siemens 
Medical Solutions).  Data were calculated in terms of standardized uptake values (SUVs) 
in 3D regions of interests (ROIs) using the following equation: 
] Weight [gCi]/Animalose [Injected D
Ci/cc] ROI [tration inity ConcenRadioactivSUV μ
μ=
 
 
Results and Discussion  
Previous in vivo evaluation of SCKs led to the hypothesis that both size and core 
composition played a synergistic role in influencing the blood circulation times, while 
surface chemistry (i.e., PEGylation) was shown to have little effect on particle 
biodistribution.39  However, the synthetic route for the introduction of PEG onto pre-
established particles allowed for neither reliable reproducibility, because of the 
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complexity of aqueous amidation chemistry,43 nor accurate quantification of the degree of 
PEGylation, unless chromophore-functionalized PEG was used.44  In more recent studies, 
we have developed a new “pre-grafting” strategy, which couples the desired 
functionalities (metal chelators) onto block copolymer precursors from which SCKs are 
assembled.42  This methodology was shown to provide functionalized SCKs with 
enhanced labeling for potential application in molecular imaging.  Herein, the “pre-
grafting” strategy is applied to attach an accurate number of PEG chains onto the SCKs.  
The stealth properties of these nanoparticles were evaluated in vivo by means of 
biodistribution experiments and small animal PET imaging, focusing our attention on 
blood retention and accumulation in the main MPS organs (liver and spleen).  The results 
indicate that “pre-grafting” is a facile and practical method to obtain various degrees of 
PEGylated SCKs, making it feasible to retain the SCKs in blood up to 48 h after 
intravenous administration.  At the same time, pre-conjugation of chelators for 64Cu (t1/2 
= 12.7 h; β+ = 17.8%, Emax = 0.653 MeV), such as DOTA, followed by radiolabeling 
affords SCKs with high specific activity (greater than 100 μCi/µg polymer), which can be 
useful for PET imaging when signal intensity is of concern (i.e., when targeting low 
abundance molecular targets). 
Construction of mPEGylated DOTA-SCKs with High 64Cu Specific Activity.  
Mono-amine terminated methoxyPEG (mPEG-NH2, Mn = 2,000 Da, PDI = 1.06) and 
DOTAlysine (a lysine derivative of DOTA for 64Cu chelation),42, 43, 45 were grafted 
sequentially onto PAA60-b-PS60 block copolymer through conventional amidation 
chemistry in organic solvent (Figure 3.1, and see Experimental Section) with ca. 75% and 
65% isolated yield, respectively.  The numbers of mPEG grafts per block copolymer 
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chain were varied by the stoichiometry of mPEG-NH2 vs. PAA60-b-PS60, and were 
determined by 1H NMR spectroscopy for three samples as 1.0 (16 wt %), 2.5 (32 wt %), 
and 5.5 (51 wt %), respectively, using the proton resonances at 3.6-3.8 ppm (mPEG 
ethylene oxide backbone Hs) and 3.34 ppm (terminal methoxy Hs).  The number of 
DOTAlysines (ca. 2 per polymer chain, determined by comparison of the integration area 
of the aliphatic proton resonances at δ 1.20 – 2.70 ppm vs. the polystyrene aromatic 
protons resonating at 6.16-7.11 ppm, before and after DOTAlysine grafting) was held 
constant for all samples, as confirmed by 1H NMR spectroscopy.  Such extents of 
DOTAlysine grafting was shown to be sufficiently high for effective 64Cu complexation, 
while also being sufficiently low to allow polymer assembly into a globular morphology 
during the block copolymer micellization process.42 
 
Figure 3.1.  Schematic drawing of the synthetic route for the construction of 
mPEGylated SCKs. 
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The preparation of mPEGylated SCKs from these mPEG2000-g-DOTAlysine-g-
PAA-b-PS block copolymers was conducted by following an established standard 
protocol (Figure 1, and see Experimental Section).42, 43  These SCKs were characterized 
by DLS, TEM, and zeta potential measurements (Figure 3.2 and Table 3.1).  Compared 
with the non-mPEGylated SCK1, mPEGylated SCK2-5 showed similar particle sizes and 
nearly spherical morphology with relatively narrow polydispersity, which allowed for 
estimation of nanoparticle surface PEG density (vide infra).  64Cu-labeled SCK1-5 were 
obtained with high specific activities (> 100 μCi/μg polymer), which enabled the 
administration of low doses to normal rodents (ca. 5 μg per animal) for the in vivo 
studies. 
 
Figure 3.2.  TEM characterization of PEGylated SCKs.  a) TEM micrograph of SCK1 
(after negative stain with PTA).  b) TEM micrograph of SCK2 (after negative stain with 
PTA).  c) TEM micrograph of SCK3 (after negative stain with PTA).  d) TEM 
micrograph of SCK4 (after negative stain with PTA). 
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Table 3.1.  Physical properties of mPEGylated DOTA-SCKs.  SCK1-6 originated from 
mPEGx-g-DOTAlysine2-g-PAA58-x-b-PS60 block copolymer precursors, according to 
Scheme 1.  SCK7 originated from a triblock copolymer of mPEG-b-(DOTAlysine7-g-
PAA93)-b-PS50. 
Samplea mPEG2000 /Chain, x 
DOTA 
/Chain 
Crosslinking 
Extentsb 
(Dh)nc 
(DLS, nm) 
Davd 
(TEM, nm) 
Zeta Potential 
(mV) Polydispersity 
SCK1 0 2.0 20% 21 ± 3 16 ± 2 -38.5 ± 0.8 0.14 
SCK2 1.0 2.0 20% 20 ± 4 16 ± 2 -40.9 ± 0.6 0.20 
SCK3 2.5 2.0 20% 19 ± 4 14 ± 3 -31.9 ± 1.3 0.21 
SCK4 5.5 2.0 20% 20 ± 4 14 ± 2 -30.2 ± 0.5 0.20 
SCK5 5.5 2.0 50% 20 ± 4 15 ± 2 -20.8 ± 0.5 0.20 
SCK6 3.0f 2.0 20% 21 ± 4 16 ± 2 -14.6 ± 0.6 0.19 
SCK7 1.0 7.0 20% 22 ± 2 18 ± 2 -14.1 ± 1.3 0.09 
a Sample concentrations were 0.20-0.30 mg/mL in 5 mM PBS buffer (pH 7.2 with 5 mM 
NaCl).  b These values are based on the stoichiometry used during the crosslinking 
reaction.  c Number-average hydrodynamic diameters.  e Dav were measured for the SCK 
core domains, for at least 150 particles.  f mPEG5000 was used instead of mPEG2000. 
 
Semi-Quantitative Model for Estimation of mPEGylated SCK Surface 
Coverage.  Although quantitative values can be obtained for self-assembled monolayers 
from grafted polymers on flat substrates,46-56 the actual density of coverage for a 
nanostructure with a high degree of surface curvature is an unknown parameter.  Given 
the radius of gyration (Rg) of mPEG2000 (about 1.8 nm57), and the shell thickness of the 
nanoparticles (ca. 2.0 to 3.0 nm, based upon the DLS and TEM measurements), a 
hypothesis could be made that almost all of the terminal portions of the mPEG chains 
were exposed around the periphery of the mPEGylated SCKs, due to the fact that the 
thickness of the shell domain is less than 2×Rg.  The glassy PS block, which forms the 
hydrophobic core domain during the micellization process, was selected based upon the 
results from previous investigations39, 43, 58 that found the nanostructures to exist as rigid 
spheres that underwent little structural deformation, even upon adsorption onto a solid 
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substrate.58  Therefore, the PS-core SCKs should experience low degrees of structural 
deformation in rapidly flowing capillaries in vivo, so that they can be modeled as spheres.  
The surface coverage could be expressed via the average distance (D, see Figure 3.1 
insertion for illustration) between the exposed mPEG molecules,47 which was calculated 
through the following equation: 
D = 
N
D 2)( hπ  nm 
where N denotes the number of mPEGs per SCK nanoparticle (obtained from the number 
of mPEGs per polymer chain and the aggregation number of polymer chains estimated to 
be within each SCK nanoparticle), and Dh is the hydrodynamic diameter of the 
corresponding SCK. 
The results calculated based upon this hypothesis, summarized in Table 3.2, were 
consistent with zeta potential measurement data (Table 3.1).  As expected, a decrease in ζ 
value (SCK3 vs. SCK2) was observed as the mPEG surface coverage increased 
(decreased D values), indicating that both the surface negative charges and the mobility 
decreased.59  The similar ζ values for SCK4 and SCK3, in spite of a two-fold increase in 
mPEG grafts for SCK4 with respect to SCK3, might be associated with near complete 
surface coverage and/or reduced mPEG conformational degrees of freedom after a certain 
number of mPEG2000 grafts per polymer chain.  As expected, the consumption of a 
higher number of carboxylic acid groups during the crosslinking process resulted in a 
dramatic decrease of surface charge for SCK5 compared to SCK4. 
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Table 3.2.  Calculation of mPEG2000 surface coverage of mPEGylated SCK1-4, which 
originated from mPEG2000x-g-DOTAlysine2-g-PAA58-x-b-PS60 block copolymer 
precursors, according to Figure 3.1. 
Sample mPEG
a 
/Chain 
Dav 
(nm) Nagg 
mPEGa 
/SCK 
Dh 
(nm) 
Stb 
(nm2) 
(St/mPEG)c 
(nm2) 
Dd 
(nm) 
SCK1 0 16 ± 2 240 0 21 ± 3 1390 ± 130 0 0 
SCK2 1.0 16 ± 2 240 240 20 ± 4 1260 ± 160 5.3 ± 0.7 2.3 ± 0.2 
SCK3 2.5 14 ± 3 200 500 19 ± 4 1140 ± 140 2.3 ± 0.3 1.5 ± 0.1 
SCK4 5.5 14 ± 2 200 1100 20 ± 4 1260 ± 160 1.2 ± 0.2 1.1 ± 0.1 
a mPEG2000.  b Surface area of mPEGylated SCKs.  c Surface area per mPEG chain at 
the periphery of the SCK.  d Average distance between mPEG chains at the periphery of 
the SCK. 
 
Stealth Property of mPEGylated SCKs.  Although the influence of 
mPEGylation on SCK biodistribution cannot be predicted by simply evaluating the SCK 
surface PEG coverage, these calculations provided the rationale to explain the dramatic 
differences observed in vivo.  From the calculations performed by de Gennes and co-
workers,47, 48 the value of D should be ca. 1 nm to oppose the adsorption of small proteins 
(diameter ca. 2 nm) and ca. 1.5 nm for larger proteins (diameter ca. 6-8 nm).  Therefore, 
no or low PEG surface coverage would result in no resistance to opsonization, which can 
explain the rapid disappearance of SCK1 (no PEG) and SCK2 (D = 2.3 ± 0.2 nm) from 
the blood circulation (< 0.5 percent injected dose per gram (%ID/gram) at 10 min post 
injection) and their rapid uptake in the liver and spleen (Figure 3.3A).  The mPEG 
surface coverage of SCK3 (D = 1.5 ± 0.1 nm) is, theoretically, effective in limiting the 
adsorption of large proteins but not that of small ones.  In fact, SCK3 exhibited a slightly 
longer blood retention (1.2 ± 0.2 %ID/gram at 10 min post injection) compared to SCK1 
and SCK2 but was eliminated within one hour from the administration, and accumulated 
in the liver and spleen.  To maintain the SCKs in circulation, an exceptionally high 
amount of PEG is required, as confirmed by the in vivo behavior of SCK4 (D = 1.1 ± 0.1 
nm). 
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 Figure 3.3.  Biodistribution data for 64Cu-labeled mPEGylated SCKs (which originated 
from mPEG2000x-g-DOTAlysine2-g-PAA58-x-b-PS60 block copolymer precursors, 
according to Scheme 1) in Sprague-Dawley rats (ca. 25 μg/kg rat body weight).  Data are 
expressed as percent injected dose per gram (%ID/gram) ± one standard deviation (n = 4; 
ANOVA, p < 0.0001; *: p < 0.05, compared to SCK5).  (A) Biodistribution of SCK1-4 
at 10 min and 1 h post injection.  (B) Biodistribution of SCK4 up to 48 h post injection.  
(C) Biodistribution of SCK5 up to 48 h post injection. 
 
In fact, the presence of approximately 1100 mPEG2000 grafts per nanoparticle 
led to a nearly full surface coverage for SCK4, and gave a high retention in blood over 
the first few hours after administration (2.3 ± 0.1 %ID/gram at 4 h) and an effective 
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clearance thereafter (0.2 ± 0.1 %ID/gram at 48 h post injection, Figure 3.3B).  The 
prolonged circulation is the result of a low MPS uptake, reasonably due to slow 
opsonization and recognition by the macrophages of liver and spleen (up to 75% less 
dose in liver and spleen with respect to SCK1 at 48 h post injection).  As a note, the 
nonspecific binding of nanoscale objects with large vascular carrier proteins and red 
blood cells60 might also play important roles for the in vivo fate of the SCKs.  However, 
the latter issue could also be reduced because of the sufficient surface PEG coverage, 
which also directly related with their charge characteristics.  No significant uptake in 
lung, muscle and kidney was detected. 
mPEG Length Effect on Biodistribution.  Besides surface graft density, the 
length of the mPEG grafts has been reported to be of paramount importance in order to 
maintain nanoparticles in the blood stream.28, 30, 35, 41, 47, 61  Therefore, to assess whether 
PEG length effects also apply to SCKs, mPEGylated SCKs (SCK6) from mPEG50003-g-
DOTAlysine2-g-PAA55-b-PS60 block copolymer precursors were prepared, 64Cu-labeled 
and tested in normal rodents (Figure 3.4).  The use of mPEG5000 grafts produced a 
longer nanoparticle blood circulation time and a lower liver uptake compared to the 
mPEG2000-containing analog with similar grafting density (SCK3).  However, relative 
to SCK3, higher splenic accumulation was observed for SCK6 at both considered time 
points.  Noticeably, at 1 h, a nearly two-fold increase in spleen uptake was observed.  
Furthermore, clearance of SCK6 from the bloodstream was faster than that observed for 
the SCKs with higher surface density of mPEG2000 grafts (SCK4 and SCK5).  The 
observation that PEG grafting density is more important than PEG length is supported by 
a recently report from Li and coworkers62 on long circulating core crosslinked 
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nanoparticles (t1/2,β = 46.2 h) with hydrophilic shell domains constructed from very short 
PEG chains (nine ethylene oxide repeating units)  
 
Figure 3.4.  Biodistribution data of 64Cu-labeled SCK3, 4, (from mPEG2000-g-
DOTAlysine-g-PAA-b-PS block copolymer precursors) and 6 (from mPEG5000-g-
DOTAlysine-g-PAA-b-PS block copolymer precursors) in Sprague-Dawley rats (ca. 25 
μg/kg rat body weight) at 10 min and 1 h post injection.  Data are expressed as percent 
injected dose per gram (%ID/gram) ± one standard deviation (n = 4). 
 
mPEG Location: Block Copolymer Structural Backbone vs. Pendent Grafts.  
A different approach for constructing PEGylated nanoparticles from triblock copolymers 
containing one PEG chain as the terminal unit (SCK7, Figure 3.5) could not achieve the 
prolonged blood circulation time obtained for SCK4-6 (Figure 3.5C).  From the intrinsic 
properties of PEG and the SCK PS core domain, as reported by Caldwell et al.,63 a 
portion of the PEG chains may adsorb onto the PS core and not extend to the nanoparticle 
surface.  The multiple PEG grafts in SCK4-6 provides an excess for PEG coverage of the 
surface.  Moreover, a combination of short and long PEG segments can be expected to 
extend from the surface of SCK4-6, based upon the chemical methodology used for the 
preparation of these particles which involved the introduction of mPEG along the block 
copolymer hydrophilic chain segment prior to nanoparticle assembly.  In fact, a mixture 
of mPEG lengths have been found to provide a more effective steric barrier against 
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protein adsorption compared to a homogeneous population of longer chains.64, 65  Further 
studies are needed in order to correlate the improved biodistribution for the SCKs, with 
the combination of effects such as the variation in mPEG chain length, decreased 
negative charge, increased nanoparticle rigidity, decreased mobility, and conformational 
degrees of freedom66 for the mPEG grafts. 
 
Figure 3.5.  Preparation, TEM characterization, and in vivo evaluation of SCK7.  (A) 
Schematic drawing of the preparation of SCK7 from DOTA7-g-PEG5000-b-PAA93-b-
PS50.  (B) TEM micrograph of SCK7 (after negative stain with PTA).  (C) 
Biodistribution of 64Cu-labeled SCK7 in Sprague-Dawley rats (ca. 25 μg/kg rat body 
weight; data are expressed as percent injected dose per gram (%ID/gram) ± one standard 
deviation, n = 4). 
 
Crosslinking Extents (Surface Property) Effects.  The influence of shell 
crosslinking extents on SCK bioavailability was also investigated.  In general, increasing 
the crosslinking extent provides a more robust nanostructure with fewer negative charges 
(carboxylates) remaining on the surface.  A slightly anionic surface was found to exert 
beneficial effects on nanoparticle blood circulation and MPS sequestration due to a 
reduction of non-specific binding of plasma opsonins.67  However, high surface charge 
was found to have negative impact on the biodistribution, and several studies have 
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concluded that neutral particles exhibit lower rates of opsonization.15, 16, 68  SCK5 having 
ca. 50% surface charge reduction relative to SCK4, exhibited significantly higher 
retention in blood and lower accumulation in liver and spleen compared to SCK4 at each 
time point evaluated (Figure 3.3C). 
Small Animal PET Imaging Evaluation.  Except for the spleen uptake, the 
results of small animal PET imaging (Figure 3.6A-3.6F and Table 3.3) showed a general 
concordance with the biodistribution findings.  Little activity was detected in the heart of 
normal mice injected with 64Cu-labeled SCK1 at 4 and 24 h post injection (Figure 3.6A-
3.6B), suggesting that no significant amounts of particles were circulating in blood at 
these time points.  On the contrary, when imaging mice injected with 64Cu-labeled SCK4 
(Figure 3.6C-3.6D) and SCK5 (Figure 3.6E-3.6F), the heart of the mice was clearly 
visible up to 4 and 24 h post injection, respectively, as a consequence of the long blood 
retention.  No significant activity was detected in kidneys and bladder of all the mice 
used for the imaging study, due to the lack of urinary excretion, while the presence of 
diffuse signal in the abdominal area suggested slow elimination through the intestine.  
Interestingly, SCK5 exhibited the highest splene standardized uptake value (SUV) 
among the evaluated particles, suggesting high splenic uptake.  This contradictory result 
between biodistribution and PET data is possibly due to a different interaction between 
nanoparticles and macrophage receptor populations in different animal species (rat vs. 
mouse).16 
  
74 
 
 Figure 3.6.  Co-registered small animal PET/CT images (coronal slices) of Balb/C mice 
(n = 2) injected with 64Cu-labeled, mPEGylated SCKs (ca. 100 – 200 μCi of 64Cu-labeled 
SCKs (0.15 – 0.3 mg/kg mouse body weight in 150 μL via tail vein).  (A-B) SCK1 at 4 
and 24 h post injection, respectively.  (C-D) SCK4 at 4 and 24 h post injection, 
respectively.  (E-F) SCK5 at 4 and 24 h post injection, respectively.  The image intensity 
is decay corrected and scaled by max/min frame.  White arrows indicate heart, liver and 
spleen. 
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Table 3.3.  Comparative organ-by-organ standardized uptake values (SUVs) for the 64Cu-
radiolabeled SCKs from the quantitation of small animal PET images in normal Balb/c 
mice. 
 
Sample 
SUVa
Heart Liver Spleen 
4 h p.ib 24 h p.i 4 h p.i 24 h p.i 4 h p.i 24 h p.i 
SCK1 0.3 ± 0.1 0.5 ± 0.1 8.3 ± 1.5 5.4 ± 0.8 1.9 ± 0.4 1.8 ± 0.4 
SCK4 4.2 ± 0.9 1.7 ± 0.3 4.9 ± 0.3 5.1 ± 0.1 2.6 ± 0.1 2.3 ± 0.2 
SCK5 4.6 ± 0.1 2.5 ± 0.5 5.3 ± 0.2 4.7 ± 0.1 4.0± 0.4 4.5 ± 0.5 
a Data were obtained from 3D regions of interest in the selected organs, and are presented 
as mean SUV ± standard deviation.  b Post injection. 
 
Conclusions 
In summary, we have employed a facile “pre-grafting” strategy to attach mPEG 
chains and DOTA chelators onto SCKs and their in vivo behaviors have been studied 
after 64Cu radiolabeling.  It is clear that mPEGylated SCKs exhibited longer blood 
circulation, in comparison to non-mPEGylated analogs.  More importantly, the blood 
retention of these nanoparticles correlated well with the densities of mPEG grafts on the 
particle surfaces, which were controlled by the stoichiometry during the chemical 
modifications of the diblock copolymer precursors used for the construction of these 
nanoparticles.  The study of in vitro interaction of plasma protein with mPEGylated 
SCKs and the development of mPEGylated SCKs bearing radionuclides and further 
labeled with high affinity targeting ligands and filled with therapeutic agents, as multi-
functional devices for PET imaging-based diagnosis and monitoring of various disease 
states and their regression, are in progress. 
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Chapter 4 
 
A Fundamental Investigation of Cross-linking Ffficiencies within 
Discrete Nanostructures: Using the Cross-linker as a Reporting 
Molecule 
[Portions of this work have been previously published as Guorong Sun, Nam S. Lee, 
William L. Neumann, John N. Freskos, Jeng J. Shieh, Richard B. Dorshow and Karen L. 
Wooley Soft Matter 2009, accepted.] 
 
Abstract 
Various bi-functional pyrazine-based chromophores were used as cross-linkers to 
probe directly the efficiencies of their incorporation into the shell of block copolymer 
micelles.  In addition, the block copolymer micelles were made to carry pre-installed 
reactive functionalities along the central block of an amphiphilic triblock copolymer.  
Unique photo-physical characteristics were observed, depending upon the type of 
pyrazine cross-linker, the conditions used for cross-linking and the stoichiometries 
applied. 
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Introduction 
During the past decade, nano-scale micelles assembled from amphiphilic block 
copolymer precursors have attracted much attention due to their promising applications in 
the field of nanomedicine,1-12 ranging from controlled delivery of diagnostic and 
therapeutic agents, to targeting of specific diseases and reporting of biological 
mechanisms via introduction of various functionalities.6, 13  However, the thermodynamic 
stability of such nano-assemblies is only achieved above the critical micelle 
concentration and their stability in vivo is, therefore, of concern.  To overcome this 
potential limitation, covalent cross-linking throughout the shell/core domain of micelles14, 
15 has been developed and demonstrated as an effective methodology for creating robust 
nanoscale objects that are capable of sustaining dilution. 
The advantage of cross-linking is highlighted also through recent reports that core 
cross-linking could enhance the cargo “holding” ability of nanostructures16 and the 
observation that increasing shell cross-linking extents prolonged the blood retention time 
of nanoparticles.17  Moreover, the cross-linker can bring diverse functionality to the 
nanostructure, in addition to its structural role.18, 19  While utilization of cross-linking 
technology grows rapidly in nano science,20-26 the factors associated with their 
incorporation require detailed studies to provide fundamental insights for quantification 
and optimization.  Herein, we report our investigations of the reaction efficiency during 
the shell cross-linking process by varying the cross-linker structures and properties. 
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Results and Discussion 
In this current work, we were interested in building on previous studies, which 
have revealed that the surface chemistry, cross-linking extent and internal composition of 
nanoparticles are important parameters for their ultimate properties and potential 
biological utility.  We also intended to advance the chemical methodologies and improve 
the efficiencies involved in the self assembly and cross-linking of amphiphilic block 
copolymers that lead to the preparation of well-defined nanoscale objects.  Among the 
cross-linked nanostructures, shell cross-linked knedel-like (SCK) nanoparticles 
constructed from shell cross-linking with diamino cross-linkers throughout the 
poly(acrylic acid)-block-polystyrene (PAA-b-PS) micellar PAA shell domain (corona), 
via carbodiimide-mediated amidation, is one of the earliest and most highly-studied 
examples.17, 27-31  While this strategy has been highly successful under controlled 
conditions, we felt that the activation efficiency of AA residues with the carbodiimide 
reagents under aqueous conditions could be a point for refinement.  Therefore, the acrylic 
acid residues were replaced with pre-activated N-acryloxysuccinimide (NAS) groups.  
Because the NAS units are of lower hydrophilicity than are AA groups, the addition of a 
terminal hydrophilic block segment was required to create an amphiphilic block 
copolymer structure and allow for facile aqueous-phase assembly.  This design led to a 
triblock copolymer structure, poly(ethylene oxide)-block-poly(N-acryloxysuccinimide)-
block-polystyrene (PEO-b-PNAS-b-PS), containing terminal PEO and PS blocks as 
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hydrophilic and hydrophobic segments, respectively, to drive the assembly, and a central 
block segment having building blocks from AA active ester monomers (NAS) as pre-
installed and pre-activated amidation sites.  This triblock copolymer was established and 
exploited for the construction of functionalizable cross-linked nanoparticles (Figure 4.1).  
Three pyrazine-based cross-linkers with pendant functionalized amines (Figure 4.1 
insertion) were designed as unique UV-vis active probes to report the extent of their 
incorporation during the cross-linking reactions. 
 
Figure 4.1.  Schematic drawing of the synthetic route for the construction of SCK 
nanoparticles, having a PEO corona, an internal shell cross-linked via the UV-active 
pyrazine cross-linkers, and a hydrophobic PS core.  
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The triblock copolymer was synthesized by two sequential reversible addition-
fragmentation chain transfer (RAFT) polymerizations6, 7, 32 from a PEO-based 
macromolecular chain transfer agent (macro-CTA).  Beginning from a mono-methoxy-
terminated PEO45-macro-CTA, chain extension with the NAS monomer was conducted 
using azobisisobutyronitrile (AIBN) as initiator in 1,4-dioxane ([NAS]0 = 1 M, 
[macro-CTA]0:[AIBN]0:[NAS]0 = 1:0.05:100) at 60 ˚C.  This procedure was a slightly 
modified protocol from the reported RAFT polymerization of NAS.33-35  The rate of NAS 
polymerization was still found to be rapid (ca. 90% conversion after 1.5 h).  Gel 
permeation chromatography (GPC) analysis (Figure 4.2a, upper chromatogram) of the 
isolated diblock copolymer (after precipitation in diethyl ether) exhibited a mono-modal 
molecular weight distribution with a polydispersity index (PDI) of 1.3.  Successful chain 
extension of the PNAS block (resonances at 1.78 to 2.20, 2.78, and 3.17 ppm) and 
maintenance of the RAFT agent chain-end group (resonances at 0.80, 1.10, 1.20, and 1.30 
ppm) were confirmed by 1H NMR spectroscopy (Figure 4.2b).  The controlled 
polymerization was supported further by the experimental molecular weight, as measured 
by NMR spectroscopy (Mn,NMR = 18,400 Da), being consistent with the theoretical 
molecular weight (Mn,theo = 17,600 Da).  Chain extension by styrene polymerization to 
afford the triblock copolymer also proceeded with control, indicating the retention of the 
chain end activity.  The fact that no residual diblock PEO-b-PNAS macro-CTA was 
observed along the GPC profile of the triblock copolymer with PS as the third block 
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(Figure 4.2a, lower chromatogram, and Figure 4.2c, Mn,NMR = 24,700 Da and PDI = 1.2) 
demonstrated its well-defined structure. 
 
Figure 4.2.  Characterizations of PEO45-b-PNAS95 and PEO45-b-PNAS95-b-PS60 block 
copolymer precursors.  a): DMF-GPC profiles of PEO45-b-PNAS95 (top) and PEO45-b-
PNAS95-b-PS60 (bottom) block copolymers.  b): 1H NMR spectrum of PEO45-b-PNAS95.  
c): 1H NMR spectrum of PEO45-b-PNAS95-b-PS60. 
 
Micellization of the PEO45-b-PNAS95-b-PS60 triblock copolymer was conducted 
by adding water (selective solvent for PEO) to the block copolymer precursor solution in 
N,N-dimethylformamide (DMF, common solvent for all three blocks, ca. 1.0 mg/mL).  
Water was added to initialize micellization until 50 wt% of water content was achieved 
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within 2 h.  The micelles were then directly characterized through dynamic light 
scattering (DLS), transmission electron microscopy (TEM), and atomic force microscopy 
(AFM).  The results from DLS measurements showed that these micelles had narrow size 
distributions (Figure 4.3a-c) with a number-averaged hydrodynamic diameter of 74 ± 12 
nm.  By TEM (Figure 4.3d), the micelles were observed to have uniform diameters (Dav = 
25 ± 1 nm), and they also had uniform heights (Hav = 20 ± 2 nm), as observed by AFM 
imaging (Figure 4.3e). 
 
Figure 4.3.  DLS, TEM and AFM data for the PEO45-b-PNAS95-b-PS60 micelles in 
DMF/H2O (v/v = 1:1).  DLS (a-c): histograms of micelle intensity-averaged, volume-
averaged, and number-averaged hydrodynamic diameter size distributions, respectively.  
TEM (d): stained negatively with phosphotungstic acid.  AFM (e): cast onto mica by 
spin-coating.  
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Pseudo in situ cross-linking experiments were performed after the micelle 
formation (see Experimental Section for details), although some amount of hydrolysis of 
NAS had already been occurring during the micellization process.  Three nominal cross-
linking extents (20%, 50%, and 100%, based upon the stoichiometric ratios of cross-
linker vs. initial theoretical NAS residues, i.e., 0.1 eq, 0.25 eq, and 0.5 eq, respectively) 
were studied.  After incubating the micelle with the cross-linker at room temperature for 
48 h, the un-reacted cross-linker, DMF, and small molecule by-products were removed 
through extensive dialysis against pH 7.2 PBS buffer (5 mM with 5 mM NaCl).  As a 
note, a different work-up protocol was applied for the SCK nanoparticles prepared from 
cross-linker 3, which involved multiple steps of dialysis due to its cationic character and 
electrostatic attraction to the nanostructures (see Experimental Section for details and 
vide infra). 
Unusual photophysical effects were observed upon coupling of the UV-active 
cross-linkers into the micellar nanostructure framework.  As depicted in Figure 4.4, for 
all three systems, the UV-vis maximum absorbance peaks of the pyrazine units within the 
SCKs at nominal 20% cross-linking extents clearly showed blue shifts of ~ 30 nm (from 
433 nm to 400 nm) for SCKs derived from 1 and 2 vs. the small molecule cross-linkers or 
the small molecule cross-linkers mixed with PEO-b-PAA-b-PS micelles.  For 3, the blue 
shift was increased to ~ 45 nm (from 441 nm to 395 nm).  These phenomena were 
observed also for the SCKs prepared from 1 and 2 with nominally 50% cross-linking, in 
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which the blue shifts were reduced to ~ 10 nm.  For SCK3 and SCK7 at nominally 100% 
cross-linking and SCK8 (prepared from 3 at nominally 50% cross-linking), no obvious 
peak shifts were noticed.  
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Figure 4.4.  UV-vis absorbance and fluorescence emission profiles of SCKs constructed 
from cross-linking of PEO45-b-PNAS95-b-PS60 micelles with cross-linkers 1-3 at nominal 
20%, 50%, and 100% cross-linking extents.  a): UV-vis (left) and fluorescence (right) 
spectra of SCKs prepared from cross-linking with 1 at nominal 20% (solid), 50% 
(dashed), and 100% (dotted) cross-linking extents, respectively.  b): UV-vis (left) and 
fluorescence (right) spectra of SCKs prepared from cross-linking with 2 at nominal 20% 
(solid), 50% (dashed), and 100% (dotted) cross-linking extents, respectively.  c): UV-vis 
(left) and fluorescence (right) spectra of SCKs prepared from cross-linking with 3 at 
nominal 20% (solid), 50% (dashed), and 100% (dotted) cross-linking extents, 
respectively.  
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We hypothesized that the blue shift might be related to functional group 
transformations of the aromatic amines on the pyrazine moiety, if they were to participate 
in reactions with the NAS units.  While heteroaryl amines are very weakly basic and 
correspondingly weak nucleophiles, they may participate in coupling reactions due to 
effects of the nanoenvironment (e.g. proximity and potential desolvation of partially 
coupled linker arms within the shell structure).  Once the amides form with the aryl 
amines, the energy gap between the ground and excited states would be increased due to 
the excess stabilization effect applied to the ground state, caused by the decrease in 
electron density on the pyrazine ring with the appearance of electron-withdrawing 
amides.  This hypothesis was partially supported by the cross-linker incorporation 
efficiency results (vide infra) since the blue shift was only observed for SCKs in which 
less than 30% of the total NAS residues were consumed by the aliphatic amino groups 
(over 50% of NAS groups remaining) during the cross-linking process.  By contrast, the 
control SCK nanoparticle (SCK10), cross-linked at 20% with 3 through our 
“conventional” synthetic approach,17, 19, 27-30 did not exhibit the blue shift of the 
maximum absorbance peak (Figure 4.5a).  This result serves as additional evidence for 
our hypothesis, since the carbodiimide-mediated amidation was carried out under 
conditions in which the coupling reagent (1-[3’-(dimethylamino)propyl]-3-
ethylcarbodiimide methiodide, EDCI) was limited to 20 mol% of the AA residues.  
Therefore, the formed intermediates would be dominantly consumed by the cross-linker 
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terminal aliphatic amines while the aromatic amines remained intact.  For SCK9, a minor 
red shift of ~ 5 nm was observed; the origin of which was not clear. 
 
Figure 4.5.  UV-vis profiles of control experiment I.  a): UV-vis spectra of SCK10 
(solid, nominal 20% of cross-linking) and SCK11 (dashed, nominal 50% of cross-
linking), prepared through conventional carbodiimide-mediated amidation with cross-
linker 3.  UV-vis profiles of control experiment II.  b): UV-vis spectra of physical 
mixtures of PEO45-b-PAA95-b-PS60 micelles and 3 before dialysis and at stoichiometries 
of 0.1 eq. (solid) and 0.5 eq. (dashed) of 3, relative to the AA residues, respectively.  
After dialysis against high salt buffers (pH 7.2 5 mM PBS buffer with 150 mM of NaCl) 
both physical mixture samples gave no signal from 3, with their UV-vis traces 
overlapping (dotted). 
 
From a structural viewpoint, cross-linkers 1 and 2 were distinguishable only 
through the spacer lengths and hydrophilicities, which further was revealed by their 
similar extinction coefficients (ε = 5,150 M-1cm-1 and 5,750 M-1cm-1 at pH 7.2, 
respectively).  In contrast to earlier studies with coupling of large negatively-charged 
macrocycles into the nanoparticle shells,30 the spacer length was unimportant in this 
study.  No obvious incorporation efficiency differences were observed between 1 and 2 at 
each of the experimental cross-linking extents (Table 4.1).  While the total amount of 
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cross-linkers increased from 0.1 eq to 0.25 eq (relative to NAS residues), the actual 
incorporation efficiency decreased from 60% to 40%.  A plateau of the incorporation 
efficiency occurred with further increase of the cross-linker feeding ratio.  These results 
might be associated with the unique core-shell structure of the PEO-b-PNAS-b-PS 
micelles.  As soon as the micellization was initialized after water addition, the hydrolysis 
of NAS residues started simultaneously.  However, the rate of hydrolysis was much 
slower compared with the rate of phase segregation-based micellar assembly.  Therefore, 
it is expected that most of the NAS residues were “trapped” into the hydrophobic core 
domain while a “sub-shell” domain consisted of NAS and AA residues formed at the 
interface of PEO shell and PNAS/PS core domains.  It was speculated that the cross-
linking reaction dominantly occurred within this sub-shell region first because of the 
intrinsic hydrophilicity of the cross-linker, although the hydrophilicity increased from 1 
to 3, and also because of the mode of administration/transport of the cross-linker from the 
exterior inward  As the reaction proceeded and more sub-shell NAS residues were 
converted into amides and hydrolyzed to AA carboxylates, the sub-shell domain would 
become increasingly hydrophilic and gradually merge into the “final” shell domain of the 
nanoparticle.28  The framework structure would then reduce the permeability of the shell 
domain31 and restrict further access of cross-linker to the “refurbished” sub-shell domain.  
And finally, the “deep onion” PNAS/PAA sub-shell would become un-reachable for the 
cross-linkers after incorporating over ca. 40% of 1 or 2. 
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Improvement of incorporation efficiency (Table 4.1) at each nominal extent was 
achieved while using 3 (ε = 3,470 M-1cm-1 at pH 7.2), a cross-linker bearing positive 
charge.  This improvement could be attributed to strong electrostatic interactions between 
the guanidine moieties of the bifunctional bis-arginyl-pyrazine 3, and copolymer NAS-
derived carboxylates, generated by partial hydrolysis of active esters during the 
micellization process.  The electrostatic interactions could act as “driving force” for 
“pulling” 3 through the formed shell frameworks.  Thus, pre-coordination of 3 with each 
“onion-like” sub-shell of the micelles via guanidine-carboxylate complexes resulted in a 
vast enhancement of inter-strand amide cross-linking reaction efficiency. 
 
Table 4.1.  Incorporation efficiency and maximum cross-linking extents upon varying the 
cross-linker structures and stoichiometries. 
SCKsa Cross-linker Cross-linkingextentsb
Incorporation
efficiencyc
Maximum
cross-linking extentse
SCK1 1 20 % 62 % 13 %
SCK2 1 50 % 45 % 23 %
SCK3 1 100 % 44 %d 44 %
SCK4 2 20 % 60 % 12 %
SCK5 2 50 % 40 % 20 %
SCK6 2 100 % 40 %d 40 %
SCK7 3 20 % 98 % 20 %
SCK8 3 50 % 69 % 35 %
SCK9 3 100 % 56 % 56 %
SCK10f 3 20 % 58 % 12 %
SCK11f 3 50 % 57 % 29 %
a Sample concentrations were 0.20-0.30 mg/mL in 5 mM PBS buffer (pH 7.2 with 5 mM 
NaCl).  b Nominal cross-linking extents, based upon stoichiometry.  c Calculated by the 
UV-vis absorption values at 433 nm (for cross-linker 1 and 2) and 441 nm (for cross-
linker 3).  d The number was not accurate as the Abs value was over 1.0.  e See reference 
29.  f Prepared from “conventional” carbodiimide-mediated amidation by using PEO45-b-
PAA95-b-PS60 micelles. 
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To confirm the existence of the electrostatic interactions between 3 and AA 
carboxylates, the PEO45-b-PAA95-b-PS60 micelles (prepared from micellization of the 
block copolymer precursor, which was synthesized from hydrolysis of PEO45-b-PNAS95-
b-PS60, see Experimental Section for details) were simply mixed physically with 3 under 
the identical reaction conditions as had been used for the cross-linking reactions (but, 
without covalent cross-linking being possible).  After 5 days of dialysis against pH 7.2 
PBS buffer (5 mM with 5 mM of NaCl), the UV-vis spectra of the mixtures (Figure 4.5b, 
solid and dashed) surprisingly indicated that 78% and 73% of the coordination 
efficiencies were achieved for 20% and 100% non-covalent cross-linking, respectively.  
After further dialyzing against 5 mM PBS buffer with much higher salt concentration 
(150 mM NaCl), which is a common protocol for breaking electrostatic interactions, the 
UV-vis spectra showed that there was no 3 remaining (Fig 4.5b, overlapping dotted 
lines).  In fact, when SCK7-9 were exposed to the same work-up process, the difference 
of SCK7-9 (especially SCK9) UV-vis profiles before and after the high salt dialysis 
process (Figure 4.6) also supported that 3 could be incorporated into the SCKs through 
electrostatic interactions.  The physical mixing of 3 with the PEO45-b-PAA95-b-PS60 
micelles at the special stoichiometry (0.1 eq. of 3, relative to the NAS/AA residues) did 
not affect the photo-physical properties of 3.  No maximum absorbance peak shift was 
found, which serves as additional evidence for our hypothesis that the blue shift was 
caused by the covalent modifications onto the pyrazine aryl amines. 
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Another control experiment with 3 was then followed, which involved 
construction of SCKs from the PEO45-b-PAA95-b-PS60 micelles with 3 through our 
“conventional” carbodiimide-mediated amidation strategy.  Compared with the pre-
installed active ester-mediated approach, relatively lower incorporation efficiencies (ca. 
60%) were achieved at both 20% and 50% nominal cross-linking extents (SCK10 and 
SCK11 in Table 1, respectively).  Moreover, attempts at 100% cross-linking failed from 
this approach, due to the fact that significant visual precipitation was observed.  It is 
uncertain why the traditional methodology experienced this problem, while it did not 
occur with the new polymer system. 
 
Figure 4.6.  UV-vis profiles of SCK7 (green), SCK8 (blue), and SCK9 (red) before 
(solid line) and after (dashed line) dialysis against pH 7.2 5 mM PBS (with 150 mM of 
NaCl).  
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To identify if the nanoparticle morphology changed after the cross-linking, 
SCK1-12 were characterized by DLS and TEM; the results are summarized in Table 4.2, 
Figure 4.7 (the DLS histogram of particle size distribution by number-averaged Dh), and 
Figure 4.8 (TEM micrographs).  From the DLS and TEM characterizations, SCKs 
prepared from 1 and 2 at lower cross-linking extents (< 30%) showed no morphological 
variations (Figure 4.8a-b and Fig4.8d-e), compared with the micelle (Figure 4.2d).  A 
clear trend of hydrodynamic diameter decrease was observed with the increase of actual 
cross-linking extents from 0% to ca. 20%, suggesting that the nanostructures underwent 
“shrinking” after the cross-linking.  Further increase of cross-linking extents caused 
nanostructure morphological changes, as verified by TEM imaging (Figure 4.8c and 
4.8f), although the final nanostructures still displayed relatively narrow size distributions 
(Figure 4.7c and 4.7f, respectively).  
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Table 4.2.  DLS and TEM characterization results for SCK1-12. 
SCKsa Cross-linker Cross-linking extentsb Dh,number (nm)c Dav (nm)d
SCK1 1 13 % 62 ± 7 22 ± 2
SCK2 1 23 % 39 ± 2 27 ± 1
SCK3 1 44 % 56 ± 5 NAe
SCK4 2 12 % 64 ± 4 22 ± 2
SCK5 2 20 % 50 ± 2 30 ± 1
SCK6 2 40 % 56 ± 8 NAe
SCK7 3 20 % 104 ± 8 20 ± 1
SCK8 3 37 % 69 ± 5 28 ± 2
SCK9 3 69 % 91 ± 9 NAe
SCK10 3 12 % 85 ± 6 20 ± 1
SCK11 3 29 % 53 ± 4 28 ± 2
SCK12 4 100 %f 61 ± 3 28 ± 1
a Sample concentrations were 0.20-0.30 mg/mL in 5 mM PBS buffer (pH 7.2 with 5 mM 
NaCl).  b Maximum cross-linking extents, based upon incorporation efficiency.  c 
Number-averaged hydrodynamic diameter with standard deviation between 5 runs.  d Dav 
were measured by TEM for the SCK nanoparticle core domains, for at least 150 particles.  
e Not available due to the irregular shape of the nanostructures.  f Nominal 100% of cross-
linking; maximum cross-linking extent could not be determined due to the lack of a 
chromophore on 4. 
 
For cross-linker 3, the situation became more complicated:  1) For SCK8 and 
SCK11 at nominally 50% cross-linking, spherical morphologies were maintained (Figure 
4.8h and 4.8k) and their particle sizes were consistent with the hydrodynamic sizes;  2) 
For SCK7 and SCK10 at lower cross-linking extents, the obviously increased Dh (ca. 
100 nm) and the observed inter-particle association behaviour reflected by the TEM 
micrograph indicated the existence of strong inter-particle interactions;  3) For SCK9 
with the highest cross-linking extent (ca. 70%), “island-like” irregular morphology was 
noticed.  As a note, this kind of morphological alteration caused by high extents of cross-
linking was not limited to complicated cross-linkers.  For example, SCK12, prepared 
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from a simple molecule 2,2´-(ethylene-dioxy)bis(ethylamine) as cross-linker under 
similar stoichiometry (0.5 eq, relative to the NAS residues), still displayed atypical 
morphology (Figure 4.8l). 
 
Figure 4.7.  Histograms of number-averaged hydrodynamic diameter distributions for 
SCK1-12 (a-l, respectively). 
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Figure 4.8.  TEM micrographs of SCK nanoparticles at nominal 20%, 50%, and 100% 
cross-linking extents (stained negatively with PTA).  a-c): TEM micrographs of SCK1-3 
prepared from cross-linker 1 at nominal 20%, 50%, and 100% cross-linking extents, 
respectively.  d-f): TEM micrographs of SCK4-6 prepared from cross-linker 2 at nominal 
20%, 50%, and 100% cross-linking extents, respectively.  g-i): TEM micrographs of 
SCK7-9 prepared from cross-linker 3 at nominal 20%, 50%, and 100% cross-linking 
extents, respectively.  j-k): TEM micrographs of SCK10-11 prepared from cross-linker 3 
at nominal 20% and 50% cross-linking extents, respectively.  l): TEM micrograph of 
SCK12 prepared from cross-linker 4 at nominal 100% cross-linking extent. 
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Finally, the fluorescence emission properties of SCK1-9 were studied (Figure 
4.4).  The fluorescence emission intensities of these SCKs decreased as more pyrazine 
units were incorporated, which could be attributed to an amplified self-quenching effect 
between fluorophores.  Interestingly, compared with SCK1, SCK4 displayed enhanced 
fluorescence (ca. 50% of intensity increase) although they shared almost identical 
characteristic parameters (size, concentration, the amount of chromophore per 
nanoparticle, and the closely intrinsic photophysical-property of the cross-linkers 1 and 
2).  This enhancement might be related to the fact that the longer spacer of 2 enabled the 
pyrazine moiety to adapt suitable conformations within the relatively loose shell domain 
and avoid self-quenching. 
 
Conclusions 
In summary, the amphiphilic and reactive triblock copolymer, PEO-b-PNAS-b-
PS, having a well-defined structure was synthesized through RAFT polymerization and 
was then utilized for the construction of shell cross-linked nanoparticles using unique 
photo-active cross-linkers.  Three pyrazine-derived bisamino cross-linkers with different 
spacer lengths and charges were incorporated into the nanostructures to study the factors 
associated with the reaction efficiency, employing the pyrazine to act as the reporting 
probe.  It was found that the introduction of positive charges onto the cross-linker 
improved significantly the incorporation efficiency, while the length of the spacer had 
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little effect.  The photo-physical properties of these cross-linked nanostructures were also 
investigated and a blue shift of over 30 nm was observed for the maximum absorbance 
peak, for all cross-linkers at lower incorporation levels (< 20%) within the nanoscale 
frameworks.  Further studies on their pH-responsive photo-physical properties and their 
potential applications for optical imaging and monitoring, are currently underway. 
 
Experimental Section 
Materials.  The mono-methoxy terminated mono-hydroxy poly(ethylene glycol) 
(mPEG2k, MW = 2,000 Da, PDI = 1.06) was purchased from Intezyne Technologies 
(Tampa, FL) and was used for the synthesis of macro-CTA36 without further purification.  
The cross-linker 1-3 were synthesized according to the previous report.37  Other 
chemicals were purchased from Aldrich and Acrose were used without further 
purification unless otherwise noted.  Prior to use, styrene (99%), purchased from Aldrich, 
were distilled over calcium hydride and stored under N2.  The Supor 25 mm 0.1 μm 
Spectra/Por Membrane tubes (molecular weight cut-off (MWCO) 6-8 kDa), used for 
dialysis, were purchased from Spectrum Medical Industries Inc..  Nanopure water (18 
mΩ•cm) was acquired by means of a Milli-Q water filtration system (Millipore Corp.; 
Bedford, MA). 
Measurements.  1H and 13C NMR spectra were recorded on a Varian 600 MHz 
spectrometer interfaced to a UNIX computer using Mercury software.  Chemical shifts 
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are referred to the solvent proton resonance.  Infrared spectra were obtained on a Perkin-
Elmer Spectrum BX FT-IR system using diffuse reflectance sampling accessories with 
FT-IR Spectrum v2.00 software. 
The molecular weight distribution was determined by Gel Permeation 
Chromatography (GPC).  The N,N-dimethylformamide (DMF) GPC was conducted on a 
Waters Chromatography, Inc. (Milford, MA) system equipped with an isocratic pump 
model 1515, a differential refractometer model 2414, and a two-column set of Styragel 
HR 4 and HR 4E 5 µm DMF 7.8 × 300 mm columns.  The system was equilibrated at 70 
°C in pre-filtered DMF containing 0.05 M LiBr, which served as polymer solvent and 
eluent (flow rate set to 1.00 mL/min).  Polymer solutions were prepared at a 
concentration of ca. 3 mg/mL and an injection volume of 200 µL was used.  Data 
collection and analysis was performed with Empower Pro software (Waters, Inc.).  The 
system was calibrated with poly(ethylene glycol) standards (Polymer Laboratories, 
Amherst, MA) ranging from 615 to 442,800 Da. 
The atomic force microscopy (AFM) characterization of micelles was performed by 
tapping-mode AFM under ambient conditions in air.  The AFM instrumentation consisted 
of a Nanoscope III BioScope system (Digital Instruments, Veeco Metrology Group; 
Santa Barbara, CA) and standard silicon tips (type, OTESPA-70; L, 160 μm; normal 
spring constant, 50 N/m; resonance frequency, 246-282 kHz).  Samples for AFM imaging 
analysis were prepared through spin-coating ca. 1.0 μL of the micelle solution (0.5 
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mg/mL) onto freshly cleaved mica plates (Ruby clear mica, New York Mica Co.) and 
allowed to dry freely in air. 
Samples for Transmission Electron Microscopy (TEM) measurements were diluted 
with a 1 % phosphotungstic acid (PTA) stain (v/v, 1:1).  Carbon grids were exposed to 
oxygen plasma treatment to increase the surface hydrophilicity.  Micrographs were 
collected at 100,000× magnification and calibrated using a 41 nm polyacrylamide bead 
from NIST.  The number average particle diameters (Dav) and standard deviations were 
generated from the analysis of a minimum of 150 particles from at least three different 
micrographs. 
Hydrodynamic diameters (Dh) and size distributions for the vesicles in aqueous 
solutions were determined by dynamic light scattering (DLS).  The DLS instrumentation 
consisted of a Brookhaven Instruments Limited (Worcestershire, U.K.) system, including 
a model BI-200SM goniometer, a model BI-9000AT digital correlator, a model EMI-
9865 photomultiplier, and a model 95-2 Ar ion laser (Lexel Corp.) operated at 514.5 nm.  
Measurements were made at 25 ± 1 °C.  Scattered light was collected at a fixed angle of 
90°.  The digital correlator was operated with 522 ratio spaced channels, and initial delay 
of 5 μs, a final delay of 100 ms, and a duration of 6 minutes.  A photomulitplier aperture 
of 100 μm was used, and the incident laser intensity was adjusted to obtain a photon 
counting of between, 200 and 300 kcps.  Only measurements in which the measured and 
calculated baselines of the intensity autocorrelation function agreed to within 0.1 % were 
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used to calculate particle size.  The calculations of the particle size distributions and 
distribution averages were performed with the ISDA software package (Brookhaven 
Instruments Company), which employed single-exponential fitting, cumulants analysis, 
and CONTIN particle size distribution analysis routines.  All determinations were 
repeated 5 times. 
The UV-vis absorption spectra of SCKs were collected at room temperature using a 
Varian Cary 100 Bio UV-visible spectrophotometer and plastic cuvettes with 10 mm of 
light path.  For each SCK absorption spectroscopy measurement, the pH 7.2 PBS (5 mM 
with 5 mM of NaCl) buffer solution outside the dialysis tubing was used as control. 
The fluorescence spectra of SCKs were obtained at room temperature using a Varian 
Cary Eclipse fluorescence spectrophotometer.  All fluorescence spectra from SCK 
solutions were measured at optical densities at the excitation wavelength.  If not specially 
mentioned otherwise, an excitation wavelength of the observed maximum absorption 
peak was used.  Each fluorescence spectrum was normalized with respect to the absorbed 
light intensity at the excitation wavelength. 
Synthesis of PEO45-b-PNAS95.  To a 25 mL Schlenk flask equipped with a magnetic 
stir bar dried with flame under N2 atmosphere, was added the mPEG2k macro-CTA (0.24 
g, 0.10 mmol) and 1,4-dioxane (10 mL).  The reaction mixture was stirred 0.5 h at rt to 
obtain a homogeneous solution.  To this solution was added NAS (1.7 g, 10 mmol) and 
AIBN (0.8 mg, 5 μmol).  The reaction flask was sealed and stirred 10 min at rt.  The 
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reaction mixture was degassed through several cycles of freeze-pump-thaw.  After the 
last cycle, the reaction mixture was stirred for 10 min at rt before being immersed into a 
pre-heated oil bath at 60 °C to start the polymerization.  After 1.5 h, the monomer 
conversion reached ca. 90% by analyzing aliquots collected through 1H-NMR 
spectroscopy.  The polymerization was quenched by cooling the reaction flask with liquid 
N2.  The solution was diluted with 20 mL of DMSO and precipitated into 600 mL of cold 
diethyl ether at 0 °C twice.  The precipitants were collected, washed with 100 mL of cold 
ether, and dried under vacuum overnight to afford the PEO45-b-PNAS95 block copolymer 
precursor as a yellow solid (1.2 g, 65% yield based upon monomer conversion).  1H 
NMR (600 MHz, DMSO-d6, ppm): δ 0.81 (t, J = 6 Hz, 3H, dodecyl CH3), 1.09 (br, 5H, 
CH3 and dodecyl CH2), 1.20 (br, 19H, CH3 and dodecyl CH2s), 1.30 (br, 2H, dodecyl 
CH2), 1.60 (t, J = 6 Hz, 2H, dodecyl CH2), 2.01 (br, PNAS backbone protons), 2.75 (NAS 
CH2CH2s), 3.09 (br, PNAS backbone protons), 3.20 (s, mPEG terminal OCH3), 3.47 (m, 
OCH2CH2O from the PEG backbone), 4.07 (br, 2H from the PEO backbone terminus 
connected to the ester linkage); 13C NMR (150 MHz, DMSO-d6, ppm): δ 172.8, 69.8, 
41.2, 25.2; IR (NaCl, cm-1): 2925, 1811, 1780, 1735, 1361, 1206, 1070, 649. 
Synthesis of PEO45-b-PNAS95-b-PS60.  To a 10 mL Schlenk flask equipped with a 
magnetic stir bar dried with flame under N2 atmosphere, was added the PEO45-b-PNAS95 
macro-CTA (0.55 g, 30 μmol), 1,4-dioxane (2.2 mL), and DMF (2.2 mL).  The reaction 
mixture was stirred 0.5 h at rt to obtain a homogeneous solution.  To this solution was 
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added styrene (0.94 g, 9.0 mmol) and AIBN (0.24 mg, 1.5 μmol).  The reaction flask was 
sealed and stirred 10 min at rt.  The reaction mixture was degassed through several cycles 
of freeze-pump-thaw.  After the last cycle, the reaction mixture was stirred for 10 min at 
rt before being immersed into a pre-heated oil bath at 60 °C to start the polymerization.  
After 16.5 h, the monomer conversion reached ca. 19% by analyzing aliquots collected 
through 1H-NMR spectroscopy.  The polymerization was quenched by cooling the 
reaction flask with liquid N2.  The polymer was purified by precipitation into 250 mL of 
cold diethyl ether at 0 °C twice.  The precipitants were collected and dried under vacuum 
overnight to afford the block copolymer precursor as a yellow solid (0.58 g, 77% yield 
based upon monomer conversion).  1H NMR (600 MHz, CD2Cl2, ppm): δ 0.81 (br, 
dodecyl CH3), 1.10-2.40 (br, dodecyl Hs, PNAS, and PS backbone protons), 2.75 (NAS 
CH2CH2s), 3.15 (br, PNAS backbone protons), 3.28 (s, mPEG terminal OCH3), 3.60 (m, 
OCH2CH2O from the PEG backbone), 6.20-7.30 (br, Ar Hs); 13C NMR (150 MHz, 
DMSO-d6, ppm): δ 172.8, 145.2, 128.0, 125.7, 69.8, 41.6, 25.2; IR (NaCl, cm-1): 2925, 
1810, 1779, 1732, 1452, 1362, 1208, 1070, 813, 699, 648. 
General Procedure for Micellization of PEO45-b-PNAS95-b-PS60.  To a solution of 
PEO45-b-PNAS95-b-PS60 block copolymer in DMF (ca. 1.0 mg/mL), was added dropwise 
an equal volume of nano-pure H2O via a syringe pump at a rate of 15.0 mL/h, and the 
mixture was further stirred for 1 h at rt before using for characterizations and cross-
linking reactions. 
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General Procedure for Cross-linking of PEO45-b-PNAS95-b-PS60 Micelles.  To a 
solution of PEO45-b-PNAS95-b-PS60 micelles (15.0 mg of block copolymer precursor, 
57.7 μmol of NAS residues) in 30.0 mL of DMF/H2O (v:v = 1:1) at rt, was added 
dropwise over 10 min, a solution of cross-linker (5.8 μmol for nominal 20% of cross-
linking, 14.5 μmol for nominal 50% of cross-linking, and 29.0 μmol for nominal 100% of 
cross-linking, respectively) in nano-pure H2O.  The reaction mixture was allowed to stir 
for 48 h at rt.  For reactions involving cross-linker 1, 2, and 4, the mixture was transferred 
to pre-soaked dialysis tubing (MWCO 6,000-8,000 Da) and dialyzed against 5.0 mM 
PBS (pH 7.2, with 5.0 mM NaCl) for 7 days to remove DMF, un-reacted cross-linker, 
and the small molecule by-products and afford an aqueous solution of cross-linked 
nanoparticles.  For reactions involving cross-linker 3, the mixture was transferred to pre-
soaked dialysis tubing (MWCO 6,000-8,000 Da) and sequentially dialyzed against 5.0 
mM PBS (pH 7.2, with 5.0 mM NaCl) for 3 days, 5.0 mM PBS (pH 7.2, with 150 mM 
NaCl) for 2 days, and 5.0 mM PBS (pH 7.2, with 5.0 mM NaCl) for 2 days to remove 
DMF, un-reacted cross-linker, and the small molecule by-products and afford an aqueous 
solution of cross-linked nanoparticles. 
Synthesis of PEO45-b-PAA95-b-PS60.  A 25 mL round bottom flask equipped with a 
stir bar was charged with PEO45-b-PNAS95-b-PS60 (100 mg, 4.05 μmol), 10 mL of 
CH2Cl2 and 1 mL of trifluoroacetic acid (TFA).  After adding 0.1 mL of water, the 
reaction mixture was stirred vigorously for 24 h at rt and then, was concentrated under 
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vacuum.  The crude product was dissolved into 10 mL of DMF, transferred into pre-
soaked dialysis tubing (MWCO 6,000–8,000 Da) and dialyzed against nano-pure H2O 
(18.0 MΩ cm) for 4 days to remove small molecule impurities.  The aqueous solution 
was lyophilized to afford the product as slightly yellow solid (60 mg, 95 % yield).  1H-
NMR (600 MHz, DMSO-d6, ppm): δ 0.81-2.40 (br, docecyl Hs and polymer backbone 
Hs), 3.37 (s, 3H, mPEG terminal OCH3), 3.42-3.82 (br, mPEG backbone -OCH2CH2O- 
Hs), 6.22-7.30 (br, Ar Hs), 12.25 (br, -COOH); 13C NMR (150 MHz, DMSO-d6, ppm): δ 
175.8, 145.2, 128.0, 125.7, 69.8, 41.6; IR (NaCl, cm-1): 3450-2900, 2925, 1718, 1458, 
1258, 1183, 1103, 954, 794, 699. 
Micellization of PEO45-b-PAA95-b-PS60.  To a solution of PEO45-b-PAA95-b-PS60 
(30 mg) in 30 mL of DMF, was added dropwise 30 mL of nano-pure H2O via a syringe 
pump at a rate of 15.0 mL/h, and the mixture was further stirred for 16 h at rt.  Finally, 
the mixture was transferred into pre-soaked dialysis tubing (MWCO 6,000-8,000 Da) and 
dialyzed against nano-pure water for 5 days to afford the micelle solution. 
Cross-linking of PEO45-b-PAA95-b-PS60 Micelle with 3 through “Conventional” 
Amidation.  To a solution of PEO45-b-PAA95-b-PS60 micelle (10 mg of PEO45-b-PAA95-
b-PS60 block copolymer precursor, 62 μmol of AA residues) in 40 mL of nano-pure 
water, was added dropwise over 30 min, a solution of 3 (3.7 mg, 6.2 μmol for SCK10 
and 9.2 mg, 15 μmol for SCK11, respectively) in nano-pure water.  The mixture was 
stirred 2 h at rt and a freshly prepared EDCI solution (3.8 mg, 13 μmol for SCK10 and 
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9.2 mg, 31 μmol for SCK11, respectively) in nano-pure water was then added over 1 h.  
The reaction mixture was further stirred 48 h at rt before transferring into a pre-soaked 
dialysis tubing (MWCO 6,000-8,000 Da) and sequentially dialyzing against 5 mM pH 7.2 
PBS (with 5 mM NaCl) for 3 days, 5 mM pH 7.2 PBS (with 150 mM NaCl) for 2 days, 
and 5 mM pH 7.2 PBS (with 5 mM NaCl) for 2 days to afford an aqueous solution of the 
cross-linked nanoparticles. 
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Chapter 5 
 
Reversible Addition Fragmentation Chain Transfer (RAFT) 
Polymerization of 4-Vinylbenzaldehyde 
[Portions of this work have been published previously as Guorong Sun, Chong Cheng 
and Karen L. Wooley Macromolecules 2007, 40(4), 793-795.] 
 
Abstract 
The direct reversible addition-fragmentation chain transfer (RAFT) 
polymerization of 4-vinylbenzaldehyde (VBA) was established as a new synthetic 
method for the preparation of well-defined poly(vinylbenzaldehyde) (PVBA), a polymer 
having reactive aldehyde side chain substiuents.  RAFT polymerization of VBA was 
investigated using S-1-dodecyl-S΄-(α,α´-dimethyl-α´´-acetic acid)trithiocarbonate as chain 
transfer agent and 2,2'-azobis(isobutyronitrile) as initiator in 1,4-dioxane or 2-butanone at 
70-75 °C for 7.5-22.5 h.  With 45-76% of monomer conversion, the resulting PVBA had 
well controlled number-average molecular weight (Mn) and low polydispersity (PDI < 
1.17).  The living characteristic of the RAFT polymerization process was confirmed by 
the linearity between the Mn values of PVBA and monomer conversions.  Well-defined 
PVBA was further used as a macromolecular chain transfer agent in RAFT 
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polymerization of styrene (St), and a block copolymer PVBA-b-PSt with relatively low 
polydispersity (PDI = 1.20) was successfully synthesized. 
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Introduction 
Construction of polymers with highly reactive functionalities that allow for 
further diverse functional group transformation (FGT) is an emerging research area in 
modern polymer chemistry.1  Among these polymers, polymers bearing aldehyde 
functionalities are attractive because aldehydes are among the most reactive substrates for 
FGT under mild reaction conditions.2  Conventional radical polymerization  of aldehyde-
functionalized monomers has been studied since 1950s,3 however, the resulting polymers 
lacked well-defined structures, due to the non-living nature of the polymerization 
technique.4-7  Anionic polymerization provided an alternative synthetic pathway for the 
preparation of aldehyde-functionalized polymers,8-13 but the stringent polymerization 
conditions and tedious preparation procedures (protection of monomer, polymerization, 
and deprotection of the resulting polymers were required) significantly restrict the 
applicability of this synthetic route. 
To efficiently prepare well-defined aldehyde-functionalized polymers, we 
investigated living radical polymerization of aldehyde-functionalized monomers.  In the 
past decade, reversible addition fragmentation chain transfer (RAFT) polymerization has 
been developed and demonstrated as a powerful tool in living radical polymerization.14,15  
Relative to other living radical polymerization techniques, one important advantage of 
RAFT is that it provides facile and homogenous living polymerization systems applicable 
for a wide variety of monomers under relatively mild reaction conditions.  In this 
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communication, we report our recent work of RAFT polymerization of 4-
vinylbenzaldahyde (VBA), as a new methodology for the construction of well-defined 
aldehyde-functionalized polymers 
 
Results and Discussion 
Several synthetic pathways for the synthesis of VBA have been reported in the 
literature, including transition metal-catalyzed cross-coupling of 4-bromobenzaldehyde 
with ethylene or vinyl reagents, Grignard addition to N,N-dimethyl formamide (DMF) 
followed by acid hydrolysis, and Wittig olefination.5-7  We prepared VBA by Wittig 
olefination of 4-(diethoxymethyl)benzaldehyde, a commercially available mono-
protected benzene-1,4-dicarboxaldehyde, followed by deprotection (Scheme 5.1, a slight 
modification from Dhal’s method6), because this reliable synthetic pathway had 
satisfactory yield (82% over 2-steps) with feasible scale-up and simple work-up 
protocols.  As demonstrated by Dhal et al.,6 radical polymerization of the intermediate 
monomer (diethyl acetal-protected styrene) followed by deprotection can also yield 
PVBA.  However, we prefer to directly introduce aldehyde functionalities by using VBA 
as a (co)monomer because of our intention to avoid deprotection of polymers and also the 
key concern that the post-polymerization deprotection step may result in deconstruction 
of useful functionalities presented on the polymers, including the terminal RAFT 
functionalities. 
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Scheme 5.1.  RAFT polymerization of VBA. 
 
RAFT polymerization of VBA was then conducted, and as a result, well-defined 
PVBA was synthesized (Table 5.1).  Relative to other chain transfer agents (CTAs) for 
RAFT polymerization systems, S-1-dodecyl-S΄-(α,α´-dimethyl-α´´-acetic 
acid)trithiocarbonate (DDMAT)16 can be prepared readily and has less unfavorable odor 
and therefore, it was used as the CTA in our study ([VBA]0/[CTA]0 = 100/1.0).  A typical 
thermal initiator 2,2'-azobis(isobutyronitrile) (AIBN) was used as initiator 
([CTA]0/[AIBN]0 = 1.0/0.1-0.2), and the polymerization temperature was chosen at 70-75 
°C to maintain a suitable decomposition rate of AIBN to provide initiating radicals.  
Because of the poor solubility of PVBA in its monomer, either 1,4-dioxane or 2-butanone 
was used as the polymerization solvent, and 2-butanone was further found as a better 
solvent than 1,4-dioxane for PVBA.17  For each trial, the monomer conversion was 
determined by 1H-NMR analysis of the final polymerization solution based on 
comparison of the integration area of resonances of aldehyde protons of PVBA at 9.8 
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ppm and the integration area of resonances of aldehyde protons of VBA at 10.0 ppm 
corresponding to the aldehyde proton signals from both polymer and monomer, 
respectively.  PVBA was obtained by precipitation of the final polymerization solution 
twice into cold pentane and drying under vacuum.18 
 
Table 5.1.  Reversible addition fragmentation chain transfer polymerization of 4-
vinylbenzaldehyde (VBA). 
Entry [VBA]0:[DDMAT]0:[AIBN]0 Solvent  
T 
(°C) 
t 
(h) Conversion
a Mn, calcd (Da) 
Mn, GPC 
(Da) PDI
b 
1 100:1.0:0.1 1,4-dioxane (71 vol %) 70 11 56% 7,800 8,800 1.14 
2 100:1.0:0.1 1,4-dioxane (71 vol %) 70 22.5 76% 10,400 10,300 1.17 
3 100:1.0:0.2 1,4-dioxane (50 vol %) 70 7.5 45% 6,300 7,900 1.09 
4 100:1.0:0.1 2-butanone (50 vol %) 75 10 62% 8,500 9,100 1.07 
5 100:1.0:0.1 2-butanone (50 vol %) 75 17.5 73% 10,000 10,500 1.06 
Mn, calcd: Calculated number-average molecular weight based upon monomer conversion.  
Mn, GPC: Number-average molecular weight measured by Gel Permeation 
Chromatography (GPC).  PDI: Polydispersity index.  a By 1H-NMR.  b By GPC. 
 
The well-defined structure of PVBA was verified by 1H NMR and Gel 
Permeation Chromatography (GPC) analyses (Figure 5.1).  As shown in Figure 5.1(a), 
the integration area ratio of aldehyde protons vs. aromatic protons in PVBA was 
1.00:2.12:2.03, illustrating the essential absence of side reactions on the aldehyde 
functionality of VBA during the RAFT process and the quantitative presence of aldehyde 
functionalities in PVBA.  The presence of the ω-trithiocarbonate RAFT functionality in 
PVBA was indicated by its 1H NMR resonances at 0.88 and 3.22 ppm (for CH3 and 
SCH2, respectively), and the 1H NMR resonances of the benzylic proton of the terminal 
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VBA unit at 4.84 ppm with an integration area ratio of 1.00:1.93 with the SCH2 at 3.22 
ppm.  The number-average degree of polymerization was obtained by 1H NMR 
spectroscopy (DPNMR), by comparing the intensity of the benzylic proton of the terminal 
VBA unit at 4.84 ppm with that of the aldehydic proton signal at 9.8 ppm, and was found 
to agree with the number-average degree of polymerization obtained by GPC (DPGPC) 
within the error range (for example for sample entry 5 (Table 5.1), the DPNMR and DPGPC 
values were 78 and 75, respectively).  Molecular weight and molecular weight 
distribution data for the PVBA samples were determined by GPC using THF as eluent 
(Figure 5.1(b)).  All PVBA samples have not only excellent agreements between the GPC 
and calculated (based on monomer conversion) molecular weights but also monomodal 
molecular weight distributions with low polydispersties (PDI = 1.06-1.17), indicating 
well-controlled chain growth and very high chain transfer efficiency of the 
trithiocarbonate RAFT functionality in the polymerization process. 
 
Figure 5.1.  RAFT polymerization of 4-vinylbenaldehyde: (a) 1H-NMR spectrum of 
PVBA (500 MHz, CD2Cl2; Table 5.1 entry 5).  (b) GPC curve for PVBA (Table 5.1 entry 
5).  (c) GPC curve for PVBA (Table 5.1 entry 2) and PVBA-b-PSt (polymerization 
conditions: [Styrene]0/[macro-CTA]0/[Initiator]0 = 150/1.0/0.1, 70 vol % of 2-butanone, 
60 °C, 12 h). 
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To confirm the living characteristic of this RAFT polymerization system, the 
relationships between polymer molecular weights and monomer conversions were 
studied and the polymerization kinetics was also investigated (Figure 5.2).  During 
polymerization, aliquots were withdrawn from the reaction vessel at predetermined times 
and analyzed by 1H-NMR spectroscopy for determination of the monomer conversions 
and by GPC for determination of the polymer molecular weights and polydispersities. 
 
Figure 5.2.  Kinetic plots for RAFT polymerization of 4-vinylbenzaldehyde: (a) 
relationship of number-average molecular weight (Mn, ■) and polydispersity index (PDI, 
□) versus monomer conversion; (b) time dependence of monomer conversion [M] and 
ln([M]0/[M]t). (polymerization conditions: [VBA]0/[Chain Transfer Agent]0/[Initiator]0 = 
100/1.0/0.1, 50 vol % of 2-butanone, 75 °C). 
 
As shown in Figure 5.2(a), excellent linear agreement (R2 = 0.9976) between 
polymer molecular weight and monomer conversion was obtained, and the resulting 
polymers also maintained narrow molecular weight distributions (PDI = 1.07 to 1.11).  
Such results verified the living characteristics of the RAFT polymerization process.  As 
shown in Table 5.1, similar to conventional radical polymerization of VBA,4,5,7a RAFT 
polymerization of VBA proceeded relatively slowly.  Figure 5.2(b) depicts the kinetic 
plot of the polymerization.  Pseudo first-order kinetics were maintained at the initial 
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polymerization stage (~4 h), and then the kinetics deviated from linearity.  Because 
AIBN has a short half-life of ca. 3 h at 75 °C, such retardation in polymerization might 
essentially be the result of the decreased radical concentration due to the depletion of 
AIBN. 
The living characteristics of RAFT polymerization has allowed ready preparation 
of a broad variety of block copolymers.19  We also investigated the chain extension of the 
well-defined PVBA having terminal RAFT functionality by RAFT polymerization as a 
synthetic method for the preparation of aldehyde-functionalized block copolymers.  
Although copolymerizations of vinylbenzaldehydes with styrene have already been 
extensively studied,5,7 so far there is no literature report on the synthesis of block 
copolymers bearing pendant aldehyde functionalities by radical polymerization.  Using 
PVBA (Mn, GPC = 10,300 Da, PDI = 1.17) as macro-CTA and AIBN as initiator, RAFT 
polymerization of styrene ([St]0/[macro-CTA]0/[AIBN]0 = 150/1.0/0.1) was conducted at 
60 °C in 2-butanone (70 vol%).  The polymerization was allowed to proceed for 12 h, 
and 17% conversion of styrene was obtained, as measured by 1H NMR spectroscopy.  As 
shown in Figure 5.1(c), the formation of diblock copolymer PVBA-b-PSt (Mn,GPC = 
12,500 Da, PDI = 1.19) by chain extension from the PVBA-based macro-CTA was 
verified by GPC analysis.  Moreover, the good agreement between the experimental and 
calculated molecular weights (Mn,calcd = 12,900 Da) and the mono-modal molecular 
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weight distribution of the PVBA-b-PSt illustrates the quantitative chain transfer 
efficiency of the PVBA-based macro-CTA. 
 
Conclusions 
In summary, we have established RAFT homopolymerization of 4-
vinylbenzaldehyde as a new and facile synthetic method for the preparation of PVBAs 
with predictable molecular weights and low polydispersities.  The chain extension from 
PVBA for the preparation of block copolymers also has been explored and PVBA-b-PSt 
has been constructed.  To our knowledge, this is the first example of block copolymer 
bearing multiple aldehydes by direct polymerization without protected monomer, which 
was possible by applying radical polymerization.  We believe that these homo- and block 
(co)polymers can serve as templates for feasible access of polymers with more complex 
architectures or conjugates with bio-active substrates for biological and medicinal 
applications via well-developed carbonyl chemistry. 
 
Experimental Section 
All chemicals were purchased from Aldrich or Acros and were used as received 
without further purifications unless noted.  THF was distilled over sodium and stored 
under N2.  Styrene was distilled over CaH2 and stored under N2.  AIBN was recrystallized 
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from methanol and stored at 0 °C before use.  The chain-transfer agent DDMAT was 
synthesized as reported in the literature16 and stored at room temperature. 
1H NMR and 13C NMR spectra were recorded on solutions in CDCl3 on a Varian 
Mercury 300 spectrometer with the residual solvent signal as an internal standard.  Gel 
permeation chromatography (GPC) was conducted on a Waters 1515 HPLC (Waters 
Chromatography, Inc.) equipped with a Waters 2414 differential refractometer, a PD2020 
dual-angle (15° and 90°) light scattering detector (Precision Detectors, Inc.), and a 
three-column series PL gel 5μm Mixed C, 500 Å, and 104 Å, 300 × 7.5 mm columns 
(Polymer Laboratories Inc.).  The system was equilibrated at 35 °C in anhydrous THF, 
which served as the polymer solvent and eluent with a flow rate of 1.0 mL/min.  Polymer 
solutions were prepared at a known concentration (ca. 3 mg/mL) and an injection volume 
of 200 μL was used.  Data collection and analysis were performed, respectively, with 
Precision Acquire software and Discovery 32 software (Precision Detectors, Inc.).  
Interdetector delay volume and the light scattering detector calibration constant were 
determined by calibration using a nearly monodispersed polystyrene standard (Pressure 
Chemical Co., Mp = 90 kDa, Mw/Mn < 1.04).  The differential refractometer was 
calibrated with standard polystyrene reference material (SRM 706 NIST), of known 
specific refractive index increment dn/dc (0.184 mL/g).  The dn/dc values of the analyzed 
polymers were then determined from the differential refractometer response. 
132 
 
Synthesis of 4-Vinylbenzaldehyde.  To a 250 mL RB flask equipped with a 
magnetic stir bar dried with flame under N2 atmosphere at room temperature, was added 
methyltriphenylphosphonium bromide (10.8 g, 30.0 mmol) and 75.0 mL of dried THF.  
The reaction flask was cooled to -78 °C.  To this suspension, was added dropwise a 
solution of n-BuLi (1.6 M in hexane, 18.3 mL, 29.2 mmol) over 20 min.  The reaction 
mixture was stirred 30 min at -78 °C, then slowly was allowed to warm to room 
temperature and stirred for an additional 10 min at room temperature. 
The orange-red solution was cooled to -78 °C.  To this solution, a solution of the 
terephthaldehyde monodiethylacetal (5.0 g, 24 mmol) in 15.0 mL of dry THF was added 
dropwise over 1 h.  The reaction mixture was stirred 30 min at -78 °C, 3 h at 0 °C, and 
allowed to warm to room temperature over 2 h. 
The reaction was quenched by adding 10.0 mL of saturated NaHCO3 solution.  Water 
(100 mL) was added, the organic layer was collected and the aqueous layer was extracted 
with diethyl ether (20.0 mL × 3).  The combined organic layers were washed with brine, 
dried with anhydrous Na2SO4, and concentrated in vacuo.  The residue was used directly 
in the next reaction step without purification. 
To a solution of the residue in 70.0 mL of THF at 0 °C, was added dropwise, 15.0 mL 
of 0.1 N HCl solution over 15 min.  The reaction mixture was stirred for 1 h at 0 °C, 
slowly allowed to warm to room temperature, and then stirred for an additional 3 h at 
room temperature. 
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The THF was removed in vacuo, CH2Cl2 (50 mL) was added, and the aqueous layer 
was extracted three times with 15.0 mL of CH2Cl2.  The combined organic layers were 
washed with brine, dried over anhydrous Na2SO4, and concentrated.  Purification by 
column chromatography afforded the final product as a colorless oil (1:20 Et2O/hexane, 
v/v).  Yield 2.7 g, 82%.  1H-NMR (300 MHz, CDCl3, ppm): δ 5.45 (dd, J = 11.0 Hz, 0.6 
Hz, 1H), 5.92 (dd, J = 17.4 Hz, 0.6 Hz, 1H), 6.78 (dd, J = 11.0 Hz, 17.4 Hz, 1H), 7.56 
(½ABq, J = 6.8 Hz, 1.8 Hz, 2H), 7.85(½ABq, J = 6.8 Hz, 1.8 Hz, 2H), 10.00 (s, 1H); 13C-
NMR (75 MHz, CDCl3, ppm): δ 117.6, 126.9, 130.3, 135.8, 136.1, 143.6, 191.9. 
Polymerization of 4-Vinylbenzaldehyde.  A general procedure of 
homopolymerization of 4-vinylbenzaldehyde under optimized reaction conditions was 
performed as follows. 
To a 25 mL Schlenk flask equipped with a magnetic stir bar dried with flame under 
N2 atmosphere, was added sequentially the DDMAT (45.8 mg, 0.125 mmol), 4-
vinylbenzaldehyde (1.7 g, 13 mmol), 2-butanone (2.5 mL), and AIBN (2.1 mg, 0.013 
mmol).  The reaction flask was sealed and stirred 10 min at room temperature.  The 
reaction mixture was degassed through several cycles of freeze-pump-thaw.  After the 
last cycle, the reaction mixture was recovered back to room temperature and stirred for 
10 min before immersing into a pre-heated oil bath at 75 °C to start the polymerization.  
The polymerization was monitored by analyzing aliquots collected at pre-determined 
times by 1H-NMR spectroscopy.  As the expected monomer conversion was reached, the 
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polymerization was quenched by quick immersion of the reaction flask into liquid N2.  
THF (5.0 mL) was added to the reaction flask and the polymer was purified by 
precipitation into 150 mL of cold pentane at 0 °C twice.  The precipitants were collected, 
washed with another 50 mL of cold pentane, and dried under vacuum overnight to afford 
the PVBA as yellow solid.  1H-NMR (300 MHz, CDCl3, ppm): δ 0.88 – 1.24 (br, dodecyl 
Hs), 1.52 – 2.06 (br, polymer backbone Hs), 3.22 (br, SCH2 of the chain terminus), 4.84 
(br, 1H from the polymer backbone benzylic terminus connected to trithiocarbonate), 
6.58 – 6.85 (br ½ABq, aromatic Hs), 7.33 – 7.62 (br ½ABq, aromatic Hs), 9.88 (br, 
aldehyde Hs); 13C-NMR (75 MHz, CDCl3, ppm): δ 41.1, 128.2, 130.0, 135.1, 151.1, 
191.8. 
Synthesis of PVBA-b-PS.  To a 10 mL Schlenk flask equipped with a magnetic stir 
bar dried with flame under N2 atmosphere, was added the PVBA as macro-CTA (1.02 g, 
0.1 mmol) and 2-butanone (4.0 mL).  The reaction mixture was stirred 1 h at room 
temperature to obtain a homogeneous solution.  To this solution was added styrene (1.56 
g, 15.0 mmol) and AIBN (1.6 mg, 0.01 mmol).  The reaction flask was sealed and stirred 
10 min at room temperature.  The reaction mixture was degassed through several cycles 
of freeze-pump-thaw.  After the last cycle, the reaction mixture was recovered back to 
room temperature and stirred for 10 min before immersing into a pre-heated oil bath at 60 
°C to start the polymerization.  The polymerization was monitored by analyzing aliquots 
collected at pre-determined times by 1H-NMR spectroscopy.  As the expected monomer 
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conversion was reached, the polymerization was quenched by quick immersion of the 
reaction flask into liquid N2.  THF (5.0 mL) was added to the reaction flask and the 
polymer was purified by precipitation into 150 mL of cold pentane at 0 °C twice. The 
precipitants were collected, washed with another 50 mL of cold pentane, and dried under 
vacuum overnight to afford the PVBA-b-PS as yellow solid. 
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Chapter 6 
 
Benzaldehyde-functionalized Polymer Vesicles 
[Portions of this work have been published previously as Guorong Sun, Huafeng Fang, 
Chong Cheng, Peng Lu, Ke Zhang, Amy V. Walker, John-Stephen Taylor and Karen L. 
Wooley ACS Nano 2009, 3(3), 673-681.] 
 
Abstract 
Polymer vesicles with diameters of ca. 100-600 nm and bearing benzaldehyde 
functionalities within the vesicular walls were constructed through self assembly of an 
amphiphilic block copolymer PEO45-b-PVBA26 in water.  The reactivity of the 
benzaldehyde functionalities was verified by crosslinking the polymersomes, and also by 
a one-pot crosslinking and functionalization approach to further render the vesicles 
fluorescent, each via reductive amination.  In vitro studies found these labelled 
nanostructures to undergo cell association. 
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Introduction 
Polymer vesicles, also known as “polymersomes”,1-6 are supramolecular 
assemblies of amphiphilic block copolymers7-14 or complementary random copolymers15 
with sizes ranging from tens of nanometers to several hundreds of microns (“giant 
vesicles”).  Similar to liposomes, polymersomes are composed of closed bilayer 
membranes with hollow cavities and, therefore, have tremendous potential for 
encapsulation and controlled delivery.16-20  Moreover, their structures can be manipulated 
on both polymeric and supramolecular levels to afford tunability of their properties, 
including size control over nanoscale to microscale dimensions,21-24 external stimulus 
responses,25-32 mechanical properties,33-35 membrane permeability,36-39 and in vivo fate.40, 
41 
Starting from the middle of the 1990s, a variety of polymer vesicles have been 
developed and studied as efficient and promising candidates for the delivery of both 
hydrophilic (encapsulated inside the hollow cavity) and hydrophobic (loaded within the 
bilayer membrane wall) molecules.  However, most of them consisted of amphiphilic 
block copolymers with limited functionalities for chemical transformations after vesicle 
construction.  While polymersome surface functionalizations have been reported through 
reactions with the functionalities installed at the chain ends of the hydrophilic 
segments,42, 43 there are limited literature reports associated with modifications of wall 
domains of polymersomes.  Up to date, only radical polymerization,33, 44 photo-induced 
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[2+2] cyclo-addition,15, 45-47 base-catalyzed self condensation of siloxanes,28, 48 and ring-
opening of epoxides49 have been employed to crosslink the walls of polymer vesicles. 
With the increasing interests in potential biomedical applications that utilize the 
membrane of polymersomes as a functional unit,18, 41, 50-53 introduction of highly reactive 
functionalities into polymer vesicles is being explored to expand the scope of chemistries 
that can be incorporated within such nanostructures.  Herein, we report our approach for 
constructing size-tunable polymersomes with benzaldehyde functionalities (a diverse 
electrophile that undergoes reaction under mild conditions), as well as their crosslinking 
and fluorophore-functionalization via reductive amination (Scheme 6.1). 
 
Scheme 6.1.  Construction and functionalization of PEO45-b-PVBA26 vesicles through 
reductive amination. 
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Results and Discussion 
Synthesis of Amphiphilic Block Copolymer Precursor.  Poly(ethylene oxide)-
b-poly(4-vinyl benzaldehyde) (PEO45-b-PVBA26), the amphiphilic diblock copolymer 
precursor for benzaldehyde-functionalized polymersomes, was prepared following our 
previously established method of reversible addition-fragmentation chain transfer 
(RAFT) polymerization of VBA.54  The synthesis was conducted by using a mono-
methoxy terminated PEO-based macro-chain transfer agent (macro-CTA, Mn = 2,360 Da, 
Figure 6.1a) and azobisisobutyronitrile (AIBN) in dry DMF heated at 75 °C for 3 h ( 
[VBA]0:[CTA]0:[AIBN]0 = 55:1:0.25; 55% conversion of VBA).  1H NMR spectroscopic 
analysis of the isolated block copolymer (Figure 6.1b) confirmed successful chain 
extension for the formation of the PVBA block (resonances at 1.5 to 2.5, 4.8, 6.5 to 7.5, 
and 9.8 ppm) and maintenance of the RAFT agent chain-end group (resonances at 0.8 to 
1.0, 1.3, and 3.2 ppm).  The copolymer had a well-defined block structure of PEO45-b-
PVBA26, which was supported by agreement between the number-average molecular 
weights by GPC (6,200 Da) and by 1H NMR spectroscopy (5,800 Da, based upon 
comparison of the intensities of the resonances of the aldehyde proton of the VBA units 
at 9.8 ppm and methylene protons of EO units at 3.6 ppm with the characteristic 
resonances of the methine proton of the terminal monomer unit at 4.8 ppm and the SCH2 
protons from the RAFT functionality at 3.2 ppm).  GPC analysis further showed that the 
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block copolymer has a narrow and mono-modal molecular weight distribution (Figure 
6.1c) with a polydispersity index (PDI) of 1.2. 
 
Figure 6.1.  Synthesis of and characterizations of PEO45-b-PVBA26 block copolymer 
precursor.  a) Schematic drawing of the synthesis of PEO45-b-PVBA26.  b) 1H NMR 
spectrum of PEO45-b-PVBA26.  c) GPC profile of PEO45-b-PVBA26. 
 
Construction and Characterization of PEO-b-PVBA Vesicles.  General 
conditions under which amphiphilic block copolymers with a glassy hydrophobic 
segment (Tg = 86 ºC for PVBA) can be assembled in aqueous solutions were then 
applied.7, 20, 23, 36, 47  The PEO45-b-PVBA26 block copolymer precursor was first dissolved 
into N,N-dimethylformamide (DMF, a good solvent for both PEO and PVBA blocks, ca. 
1.0 mg/mL), followed by addition of nanopure water (a selective solvent for the PEO 
block) until the water content reached 50 wt%.  Finally, the DMF was removed by 
extensive dialysis against water. 
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The vesicles were characterized by transmission electron microscopy (TEM, 
Figure 6.2a-b), scanning electron microscopy (SEM, Figure 6.2c-d), and dynamic light 
scattering (DLS, Figure 6.2e).  The vesicular structure was confirmed by TEM and SEM.  
DLS analyses showed the hydrodynamic diameters of these vesicles were in the range of 
ca. 100 to 600 nm, with an intensity-average hydrodynamic diameter distribution 
centered at 290 nm and number-average hydrodynamic diameter distribution centered at 
250 nm. 
 
Figure 6.2.  Characterization of polymer vesicles prepared from PEO45-b-PVBA26 block 
copolymer.  a-b) TEM images of vesicles (stained negatively with PTA).  c-d) SEM 
images of vesicles.  e) DLS histograms of vesicle size distributions (left: intensity-
average hydrodynamic diameter; right: number-average hydrodynamic diameter). 
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It is well-known that the formation of polymersomes usually passes through a 
morphological transformation of sphere-rod-vesicle.4  To test whether this general trend 
also applied to our system, D2O was added to a solution of PEO45-b-PVBA26 in DMF-d7 
(2.0 mg/mL) and aliquots were taken at predetermined water contents (9, 17, 23, and 33 
wt%, respectively) for 1H NMR and TEM measurements, the results are summarized in 
Figure 6.3. 
 
Figure 6.3.  Morphological transformation during the self assembly process of PEO45-b-
PVBA26.  a) 1H NMR spectra of aliquots in DMF-d7 with different D2O contents.  b-d) 
TEM micrographs of particles and vesicles (stained negative with phosphotungstic acid) 
at 9, 17, and 23 wt% of water content, respectively. 
 
At a low water content of 9 wt%, the 1H NMR spectrum (Figure 6.3a) showed no 
obvious difference with the spectrum of the block copolymer in neat DMF.  However, the 
TEM image (Figure 6.3b) clearly indicated the formation of nano-sized objects with 
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multiple morphologies including spherical particles, semi-closed membranes, and 
vesicles, but no rods were observed.  As the water content was increased to 17 wt%, the 
resonance signals corresponding to PEO backbone at 3.5 ppm became broader and the 
intensities of PVBA resonances (0.8-2.5, 6.7-7.6, and 9.9 ppm) decreased, indicating the 
reduced flexibility of both structural blocks.  TEM imaging (Figure 6.3c) revealed the 
formation of small nanoparticles whose morphology could not be unambiguously 
distinguished, and large aggregates (> 200 nm, Figure 6.3c insertion), which displayed 
large-compound vesicular morphology.  Finally, clear vesicular morphology appeared at 
23 wt% of water content with varied size ranging from 100 to 600 nm (Figure 6.3d).  At 
this point, essentially no proton resonances from PVBA blocks were observed in the 1H 
NMR spectrum, presumably because they were “tightly” packed into the vesicle walls 
without significant mobility.  Meanwhile, the resonances of PEO backbone protons were 
further broadened, likely due to the restricted mobility of the EO units, especially those in 
close proximity to the PVBA-based vesicle walls. 
Interestingly, when the “intermediate” sample with a low water content of 9 wt% 
was directly dialyzed against water, smaller vesicles with number-average hydrodynamic 
diameter of ca. 90 nm were produced (Figure 6.4).  These small vesicles were stable over 
eight months, with no apparent growth in size.  Although such size variation could not be 
interpreted quantitatively at this stage, these findings indicated kinetic control of self-
assembled nanostructures of block copolymers and might provide new insight for 
147 
 
adjusting vesicle size without changing the chemical composition of their polymer 
precursors. 
 
Figure 6.4.  Characterization of small PEO45-b-PVBA26 vesicles.  a-b) TEM images of 
vesicles (stained negatively with PTA).  c) DLS histograms of vesicle size distributions 
(number-average hydrodynamic diameter). 
 
Crosslinking of PEO-b-PVBA Vesicles via Reductive Amination.  The 
chemical accessibility of the aldehyde functionality in the vesicular wall was verified by 
reductive amination-based crosslinking with 2,2´-(ethylene-dioxy)bis(ethylamine) (0.3 
eq. relative to the aldehyde residues) and sodium cyanoborohydride (0.6 eq. relative to 
the aldehyde residues).  No significant aggregation of vesicles was observed, based upon 
the DLS analysis (Figure 6.5a) and TEM imaging (Figure 6.5b), suggesting that only 
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intra-vesicular crosslinking reactions occurred.  It is noteworthy that after crosslinking, 
the vesicles required buffer (5 mM pH 7.2 PBS with 5 mM of NaCl was used in our 
experiments) to remain suspended in aqueous solution.  The zeta potential (ζ) 
measurement showed a dramatic decrease of surface negative charge (-65.3 ± 0.7 mV vs. 
-25.7 ± 0.8 mV), which might be associated with protonation of amines that were 
incorporated into the vesicles as a result of the reductive amination chemistry.  The need 
for buffer and the less negative zeta potential value suggested that the structure of vesicle 
was chemically changed after crosslinking, which was confirmed by 1H NMR 
spectroscopy (Figure 6.5e).  New resonances corresponding to the diamino crosslinker 
appeared at 3.3 ppm and the ratio of aldehyde protons vs. aromatic protons was decreased 
from 1.0:4.6 to 1.0:6.2, indicating ca. 26% of aldehyde residues were consumed during 
the reaction (i.e., 43% incorporation efficiency based upon reaction stoichiometry, which 
was close to the results obtained by utilizing chromophores through the same chemistry, 
vide infra).  Typically, crosslinking leads to shorter relaxation times and broadening and 
losses of solution-state NMR signal intensities.  The observation of the new diamino 
crosslinker resonance may indicate covalent mono-attachment within the vesicles, 
providing a relatively low degree of crosslinking.  However, crosslinking indeed 
occurred, as was observed by the changes in the robust physical characteristics for the 
product vesicles.  Of the 26% consumption of aldehydes, only a small fraction would be 
required to effectively crosslink an entire vesicle.  Crosslinking significantly increased 
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the vesicle stability, and no appreciable variations in size or size distribution were found 
after lyophilization and re-suspension of these vesicles (Figure 6.5d). 
 
Figure 6.5.  Characterization of crosslinked PEO45-b-PVBA26 vesicles through reductive 
amination.  a) DLS histograms of non-crosslinked (blue) and crosslinked (red) vesicle 
distributions.  b-c) TEM (b) and SEM (c) images of crosslinked vesicles in 5 mM pH 7.2 
PBS.  d) TEM image of lyophilized crosslinked vesicles after re-suspension in 5 mM pH 
7.2 PBS.  e) 1H NMR spectra (DMSO-d6) of lyophilized crosslinked vesicles (red) and 
polymer precursor (black).  f) IR spectra (KBr) of lyophilized crosslinked vesicles (red) 
and polymer precursor (black). 
 
In Vitro Cellular Studies.  Amine-derived dyes were then incorporated into the 
vesicles either sequentially or coincidentally with the crosslinking reaction via the same 
chemistry, to demonstrate multiple couplings within a single nanostructure and to label 
the vesicles for biological studies.  The vesicles were functionalized with fluorecein and 
crosslinked (0.02 eq. of dye, 0.5 eq. of crosslinker, 1 eq. of NaCNBH3 relative to the 
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aldehydes, respectively), each via reductive amination in a one-pot approach.  UV-vis 
spectroscopy (Figure 6.6a) showed an absorption at 488 nm corresponding to the 
fluorescein, with an incorporation efficiency of ca. 35 %.  And again, no obvious size and 
morphological variations were observed for the fluorescein-functionalized non-
crosslinked and crosslinked vesicles, as confirmed by TEM (Figure 6.6b). 
 
Figure 6.6.  a) UV-vis profile of fluorescein dye-functionalized crosslinked vesicles.  b) 
TEM images of non-crosslinked (top) and crosslinked (bottom) fluorescent vesicles. 
 
In vitro CHO and HeLa cell experiments were then conducted for crosslinked and 
non-crosslinked fluorescein dye-labeled vesicles.  By fluorescence confocal microscopy, 
the vesicles were observed to undergo association with the cells, in a time-dependent 
manner.  No apparent fluorescence signal was detected after 1 and 4 h of incubation at 37 
ºC.  After 24 h, vesicles were visible under confocal microscopy (Figure 6.7e-h) and 
quantified by flow cytometry (Figure 6.7i) for both cell lines.  Interestingly, an increased 
fraction of vesicles was observed to be associated with HeLa cells after the vesicles were 
crosslinked, while the opposite trend was noticed for CHO cells, with a greater fraction of 
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non-crosslinked vesicles undergoing strong cellular interactions.  It is uncertain whether 
the vesicles are internalized within the cells.  Although flow cytometry data confirmed 
that the vesicles remained associated with the cells under demanding conditions, the 
confocal microscopy images suggest that the vesicles are localized preferentially near the 
cell membrane.  We hypothesize that such behavior may be the result of physical 
association or that it could be due to covalent coupling reactions between the aldehyde-
loaded vesicles and amino-groups on (membrane bound) proteins.  Although equimolar 
amounts of aldehyde and reducing agent were employed during the preparation of the 
fluoroescein-labeled, crosslinked vesicles, a portion of aldehydes still remain, as 
indicated by the 1H NMR (Figure 6.5e) and IR data (Figure 6.5f) collected during the 
crosslinking experiments (vide supra). 
The cytotoxicity of the crosslinked vesicles was also tested, using the cationic 
dendrimer polyfect as a positive control.  Compared with polyfect, these vesicles had 
insignificant cytotoxicity for both cell lines (Figure 6.7j-k), indicating their bio-
compatibility and making them promising materials for fundamental studies in 
biotechnology. 
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Figure 6.7.  In vitro evaluations of fluorescein-labeled vesicles.  a-b) Fluorescent 
confocal and bright-field images of CHO cells, respectively, without incubation with 
fluorescent vesicles.  c-d) Fluorescent confocal and bright-field images of HeLa cells, 
respectively, without incubation with fluorescent vesicles.  e-f)  Overlay of bright field 
and fluorescent confocal images of CHO cells incubated with crosslinked and non-
crosslinked vesicles, respectively.  g-h) Overlay of bright field and fluorescent confocal 
images of HeLa cells incubated with crosslinked and non-crosslinked vesicles, 
respectively.  i) Flow cytometry results.  j-k) Cytotoxicity results for CHO and HeLa 
cells, respectively. 
 
Conclusions 
In summary, we have synthesized polymer vesicles bearing benzaldehyde 
functionalities in the vesicular walls from self assembly of the block copolymer PEO45-b-
PVBA26.  The aldehyde functionalities were shown to allow for modifications through 
facile and practical chemistry.  Further investigations of the chemistry of these synthetic 
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and reactive vesicles, including optimizing the reaction efficiency, exploring its scope, 
and incorporating other labels and ligands, are ongoing now.  These robust 
nanostructures, with their ability to associate with the cell membrane, may find 
application as a nanoscopic device for repair or modification of cellular membrane 
functions. 
 
Experimental Section 
Materials.  Mono-methoxy terminated mono-hydroxy poly(ethylene glycol) 
(mPEG2k, MW = 2,000 Da, PDI = 1.06) was purchased from Intezyne Technologies 
(Tampa, FL) and was used without further purification.  S-1-dodecyl-S΄-(α,α´-dimethyl-
α´´-acetic acid)trithiocarbonate (DDMAT),55 4-(Dimethy1amino)pyridinium 4-
Toluenesulfonate (DTPS),56 and VBA54 were synthesized according to literature reports.  
Other reagents and solvents were purchased from commercial sources (Sigma-Aldrich, 
Acrose, and Fluka) and were used without further purification unless otherwise noted.  
Methylene chloride (CH2Cl2) was distilled from calcium hydride and stored under N2 
before using. 
Cell Culture.  Chinese Hamster Ovary cells (CHO-K1) and human cervix carcinoma 
(HeLa) cells were cultivated in DMEM containing 10% FBS, streptomycin (100 μg/mL), 
and penicillin (100 units/mL) at 37 °C in a humidified atmosphere containing 5% CO2. 
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Measurements.  1H NMR spectra were recorded on a Varian 500 MHz spectrometer 
interfaced to a UNIX computer using Mercury software.  Chemical shifts were referred to 
the solvent proton resonance.  Infrared spectra were obtained on a Perkin-Elmer 
Spectrum BX FT-IR system using diffuse reflectance sampling accessories with FT-IR 
Spectrum v2.00 software. 
Absolute molecular weight and molecular weight distribution were determined by Gel 
Permeation Chromatography (GPC).  GPC was performed on a Waters 1515 HPLC 
system (Water Chromatography Inc.), equipped with a Waters 2414 differential 
refractometer, a PD2020 dual-angle (15 and 90) light scattering detector (Precision 
Detectors Inc.), and a three-column series PL gel 5 μm Mixed columns (Polymer 
Laboratories Inc.).  The eluent was anhydrous tetrahydrofuran (THF) with a flow rate of 
1 mL/min.  All instrumental calibrations were conducted using a series of nearly 
monodispersed polystyrene standards.  Data were collected upon an injection of a 200 μL 
of polymer solution in THF (ca. 5 mg/mL), and then analyzed using Discovery 32 
software (Precision Detectors Inc.). 
Samples for Transmission electron microscopy (TEM) measurements were diluted 
with a 1 % phosphotungstic acid (PTA) stain (v/v, 1:1).  Carbon grids were exposed to 
oxygen plasma treatment to increase the surface hydrophilicity.  Micrographs were 
collected at 10,000, 20,000, 50,000, and 100,000 × magnification and calibrated using a 
41 nm polyacrylamide bead from NIST. 
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Scanning electron microscopy (SEM) measurements were performed on a Field 
Emission Scanning Electron Microscope (Hitachi s-4500), equipped with a NORAN 
Instruments energy dispersive x-ray (EDX) microanalysis system, a back scattering 
detector and a mechanical straining stage.  SEM samples were prepared with the 
following procedure.  Silica native oxide wafers (Addison Engineering Inc.) were cleaned 
with nitric acid and hydrochloride acid (1:3) and then cut into 5 mm × 5 mm square.  For 
each sample, 50 μL of aqueous solution was applied directly on the cleaned Si surface, 
and the solvent was kept in fume hood to evaporate at ambient temperature (21 ± 2 °C).  
The samples were immediately transferred to SEM instrument for measurement after 
completely dried. 
Hydrodynamic diameters (Dh) and size distributions for the vesicles in aqueous 
solutions were determined by dynamic light scattering (DLS).  The DLS instrumentation 
consisted of a Brookhaven Instruments Limited (Worcestershire, U.K.) system, including 
a model BI-200SM goniometer, a model BI-9000AT digital correlator, a model EMI-
9865 photomultiplier, and a model 95-2 Ar ion laser (Lexel Corp.) operated at 514.5 nm.  
Measurements were made at 25 ± 1 °C.  Scattered light was collected at a fixed angle of 
90°.  The digital correlator was operated with 522 ratio spaced channels, and initial delay 
of 5 μs, a final delay of 100 ms, and a duration of 6 minutes.  A photomulitplier aperture 
of 100 μm was used, and the incident laser intensity was adjusted to obtain a photon 
counting of between, 200 and 300 kcps.  Only measurements in which the measured and 
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calculated baselines of the intensity autocorrelation function agreed to within 0.1 % were 
used to calculate particle size.  The calculations of the particle size distributions and 
distribution averages were performed with the ISDA software package (Brookhaven 
Instruments Company), which employed single-exponential fitting, cumulants analysis, 
and CONTIN particle size distribution analysis routines.  All determinations were 
repeated for 5 times. 
Zeta potential (ζ) values for the vesicle solution samples in 5 mM phosphate buffered 
saline (PBS) were determined with a Brookhaven Instrument Co. (Holtsville, NY) model 
Zeta Plus zeta potential analyzer.  Data were acquired in the phase analysis light 
scattering (PALS) mode following solution equilibration at 25 °C.  Calculation of ζ from 
the measured nanoparticle electrophoretic mobility (μ) employed the Smoluchowski 
equation: μ = εζ/η, where ε and η are the dielectric constant and the absolute viscosity of 
the medium, respectively.  Measurements of ζ were reproducible to within ± 2 mV of the 
mean value given by 16 determinations of 10 data accumulations. 
The confocal microscopy was collected by using a Leica TCS SP2 confocal 
microscopy following excitation with an argon laser (488 nm).  5×105 cells were 
incubated on 35 mm MatTek glass bottom microwell dishes (MatTek Co.) for 24 h.  Then 
the medium was replaced with 2 mL of fresh medium containing with non-crosslinked or 
crosslinked vesicles (10 μg/mL of polymer) and incubated for another 24 h.  Cells were 
washed twice with PBS and the live cells were imaged. 
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Flow cytometric analysis for the strong association of the vesicles to the cells was 
performed using a FACS-calibur (Becton Dickinson) equipped with an argon laser 
exciting at a wavelength of 488 nm.  The cells were treated same as above.  For each 
sample, 20,000 events were collected by list-mode data that consisted of side scatter, 
forward scatter, and fluorescence emission centered at 530 nm.  The fluorescence was 
collected at a logarithmic scale with a 1024 channel resolution.  CellQuest software 
(Becton Dickinson) was applied for the analyses. 
The cytotoxicity of crosslinked vesicles was examined by CellTiter-Glo® Luminescent 
Cell Viability Assay (Promega Co.).  The CHO-K1 cells and HeLa cells were seeded 
respectively in the 96-well plate at a density of 1×104 cells/well and cultured for 24 h in 
100 µL DMEM containing 10% FBS.  Thereafter, the medium was replaced with 100 µL 
of fresh medium containing with different concentration particles.  After 24 h of 
incubation, 100 μL of the CellTiter-Glo® reagent was added.  Mixed contents and 
allowed the plate to incubate at rt for 10 min to stabilize luminescent signal, recorded the 
luminescence at Luminoskan Ascent® luminometer (Thermo Scientific) with integration 
time 1 second per well.  The relative cell viability was calculated as: cell viability (%) = 
(luminescence (sample)/luminescence (control)) × 100, where luminescence (control) was 
obtained in the absence of particles and luminescence (sample) was obtained in the presence 
of particles. 
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Synthesis of mPEG2k Macro-CTA.  To a solution of mPEG2000 (4.0 g, 2.0 mmol) 
in 40 mL of dry CH2Cl2 at room temperature (rt), was added DDMAT (1.2 g, 3.0 mmol) 
and dicyclohexylcarbodiimide (0.60 g, 2.9 mmol), the reaction mixture was stirred 10 
min.  After the additions of 4-di(methylamino)pyridine (36.6 mg, 0.3 mmol) and DPTS 
(375.0 mg, 1.2 mmol), the reaction mixture was further stirred 20 h at rt.  Then the 
reaction mixture was filtered with celite and the filtrate was placed at 4 ºC overnight, 
filtered with celite, and concentrated to ca. 15 mL.  After the solution was precipitated 
into 250 mL of dry ether at 0 ºC twice, the crude product obtained was further purified by 
flash column chromatography (2-3% MeOH/CH2Cl2, v/v) to afford mPEG2k macro-CTA 
as a yellow solid (3.2 g, 68% yield).  1H NMR (500 MHz, CD2Cl2, δ): 0.88 (t, J = 6.5 Hz, 
3H), 1.26 (m, 16H), 1.38 (t, J = 6.5 Hz, 2H), 1.66 (t, J = 7.5 Hz, 2H), 1.68 (s, 6H), 3.27 
(t, J = 7.2 Hz, 2H), 3.33 (s, 3H), 3.40-3.80 (m, 166H), 4.21 (t, J = 5.0 Hz, 2H). 
Synthesis of PEO45-b-PVBA26.  To a 10 mL Schlenk flask equipped with a magnetic 
stir bar dried with flame under N2 atmosphere, was added the mPEG2k macro-CTA (0.48 
g, 0.20 mmol) and dry DMF (2.5 mL).  The reaction mixture was stirred 1 h at rt to 
obtain a homogeneous solution.  To this solution was added VBA (1.46 g, 11.0 mmol) 
and AIBN (8.1 mg, 50 μmol).  The reaction flask was sealed and stirred 10 min at rt.  The 
reaction mixture was degassed through several cycles of freeze-pump-thaw.  After the 
last cycle, the reaction mixture was stirred for 10 min at rt before immersing into a pre-
heated oil bath at 75 °C to start the polymerization.  After 3.5 h, the monomer conversion 
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reached ca. 55% by analyzing aliquots collected through 1H-NMR spectroscopy.  The 
polymerization was quenched by cooling the reaction flask with liquid N2.  CH2Cl2 (5.0 
mL) was added to the reaction flask and the polymer was purified by precipitation into 
300 mL of cold diethyl ether at 0 °C twice. The precipitants were collected, washed with 
100 mL of cold ether, and dried under vacuum overnight to afford the block copolymer 
precursor as a yellow solid (1.18 g, 90% yield based upon monomer conversion).  1H 
NMR (500 MHz, CD2Cl2, δ): 0.88-1.24 (br, dodecyl Hs), 1.52-2.06 (br, PVBA backbone 
protons), 3.22 (br, SCH2 of the chain terminus), 3.33 (s, mPEG terminal OCH3), 3.34-
3.78 (m, OCH2CH2O from the PEG backbone), 4.84 (br, 1H from the PVBA backbone 
benzylic terminus connected to trithiocarbonate), 6.58-6.85 (br, Ar H), 7.33-7.62 (br, Ar 
H), 9.88 (br, CHO);  13C NMR (150 MHz, DMSO-d6, δ): 192.3 , 151.3, 134.4, 129.4, 
128.0, 69.8, 42.3, 40.4, 29.0; IR (KBr): 3433, 2923, 2856, 2732, 1699, 1604, 1575, 1453, 
1425, 1386, 1354, 1306, 1258, 1214, 1171, 1103, 1017, 951, 837, 726, 674, 552. 
General Procedure for Construction of PEO45-b-PVBA26 Vesicles.  To a solution 
of PEO45-b-PVBA26 block copolymer in DMF (ca. 1.0 mg/mL), was added dropwise an 
equal volume of nano-pure H2O via a syringe pump at a rate of 15.0 mL/h, and the 
mixture was further stirred for 16 h at rt.  The solution was then transferred to pre-soaked 
dialysis tubing with Molecular Weight Cut Off (MWCO) of ca. 3,500 Da and dialyzed 
against nano-pure H2O for 4 d to afford a solution of vesicles. 
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Crosslinking of PEO45-b-PVBA26 Vesicles.  To a solution of PEO45-b-PVBA26 
vesicles (7.4 mg of polymer, 33 μmol of aldehyde residues) in 30.0 mL of nano-pure 
H2O, was added a solution of 2,2'-(ethylenedioxy)-bis(ethylamine) (1.5 mg, 10 μmol) in 
1.0 mL of nano-pure H2O dropwise over 10 min.  The reaction mixture was allowed to 
stir for 24 h at rt.  NaBH3CN (1.3 mg, 20 μmol) in 1.3 mL of nano-pure H2O was then 
added to the reaction solution and further stirred for 16 h at rt.  Finally, the mixture was 
transferred to pre-soaked dialysis tubing (MWCO: ca. 3,500 Da) and dialyzed against 5.0 
mM PBS (pH 7.2, with 5.0 mM NaCl) for 5 d to remove the small molecule by-products 
and afford an aqueous solution of crosslinked vesicles. 
One-pot Functionalization and Crosslinking of PEO45-b-PVBA26 Vesicles.  To a 
solution of PEO45-b-PVBA26 vesicles (3.2 mg of polymer, 14 μmol of aldehyde residues) 
in 10.0 mL of nano-pure H2O, was added a solution of fluorescein-5-thiosemicarbazide 
(126.3 μg, 0.30 μmol) in 90.0 μL of DMF.  The reaction mixture was allowed to stir for 2 
h at rt in the absence of light.  To this reaction mixture, was added a solution of 2,2'-
(ethylenedioxy)-bis(ethylamine) (1.1 mg, 7.2 μmol) in 1.6 mL of nano-pure H2O 
dropwise over 10 min.  The reaction mixture was further stirred for 24 h at rt in the 
absence of light.  NaBH3CN (907.2 μg, 14.4 μmol) in 0.4 mL of nano-pure H2O was then 
added to the reaction solution and further stirred for 16 h at rt in the absence of light.  
Finally, the mixture was transferred to pre-soaked dialysis tubing (MWCO ca. 3,500 Da) 
and dialyzed against 5.0 mM PBS (pH 7.2, with 5.0 mM NaCl) for 5 d to remove the 
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small molecule by-products and afford an aqueous solution of functionalized and 
crosslinked vesicles. 
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Chapter 7 
 
Optimizations of Quantum Yield of Fluorescent Nanoparticles for 
Development of Potential Optical Imaging Contrast Agents 
 
Guorong Sun, Mikhail Y. Berezin, Jinda Fan, Ke Zhang, 
Samuel Achilefu, and Karen L. Wooley 
 
Introduction 
During the past decades, in vivo fluorescence imaging has experienced a 
renaissance with the “opening” of near-infrared (NIR) window (wavelength between 650 
and 900 nm) of electromagnetic spectrum.1-7  By utilizing fluorescent probes such as 
quantum dots,8-10 fluorescent proteins,11, 12 and organic NIR dyes,13-20 two main problems 
(i.e. tissue autofluorescense and attenuation) associated with deep tissue imaging have 
been partially overcome, and now, in vivo optical imaging of a few centimeters depth has 
been achieved. 
Among the organic NIR fluorophores (NIRFs), carbocyanine-based dyes are 
particularly of interest due to their high molar extinction coefficients (usually on the 
order of 105 M-1 cm-1) and tunability of photo-physical properties.19  These fluorophores 
are also facile to be functionalized with bioactive ligands to enable targeted imaging.15, 21-
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23  However, the in vivo application of cyanine dyes generally suffers from high 
degradation rate, short blood circulation times, non-specific tissue/organ 
accumulations.24-27  One practical and promising approach for prevailing over the above 
drawbacks is to encapsulate/couple cyanine dyes within/onto nanoscale platforms, which 
can provide protection and “stealth” properties from the blood clearance systems.14, 28-45  
The nanoscale platform can further be decorated with multiple homo- or heterogeneous 
targeting agents to improve targeting efficiency by taking advantage of the multivalent 
interactions with cell-surface receptors.  Furthermore, this approach may allow for the 
“hybridization” of different probes within a single nanoparticle to enable multimodal 
imaging for increased of the diagnostic accuracy.42, 46-50 
Spherical nanoparticles (NPs) represent the most widely applied nanostructures in 
molecular imaging.  To date, cyanine NIRF-functionalized dendrimers,37, 48 silica NPs,30, 
34, 35, 39, 44, 51, 52 and natural/engineered viruses29, 33 have been reported from academic and 
industrial research groups.  It is well-known that fluorescent tags often suffer from the 
fluorescence “self quenching” when placed in close proximity.  In order to obtain 
maximized fluorescence, the distance between fluorophores should be greater than the 
Forster radius to avoid the non-radiative energy transfer of the same fluorophores.  In this 
work, we investigated the stoichiometry dependence of fluorophores (fluorescein and 
cypate, respectively) per nanoparticle by calculating the distance of two adjacent 
fluorophores through both steady-state and dynamic emission spectra, in comparison with 
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the Forster radius.  We also proposed and examined a semi-quantitative model (vide 
infra) for estimating the maximum number of fluorophores per spherical nanoparticle 
while retaining satisfactory QY of the fluorophores. 
 
Experimental Section 
Materials.  Mono-methoxy terminated mono-hydroxy poly(ethylene glycol) 
(mPEG2k and mPEG5k, MW = 2,000 and 5,000 Da, respectively, PDI = 1.06 and 1.07, 
respectively) was purchased from Intezyne Technologies (Tampa, FL) and was used 
without further purification.  Cypate,14 HL-800,17 S-1-dodecyl-S΄-(α,α´-dimethyl-α´´-
acetic acid)trithiocarbonate (DDMAT),53 4-(Dimethy1amino)pyridinium 4-
Toluenesulfonate (DTPS),54 VBA,55 mPEG2k macro-chain transfer agent (macro-
CTA),56 and poly(ethylene oxide)-block-poly(N-acryloxysuccinimide)-block-polystyrene 
(PEO45-b-PNAS95-b-PS60)57 were synthesized according to literature reports.  Other 
reagents and solvents were purchased from commercial sources (Sigma-Aldrich, Acrose, 
and Fluka) and were used without further purification unless otherwise noted.  Methylene 
chloride (CH2Cl2) was distilled from calcium hydride and stored under N2 before using. 
Measurements.  1H NMR spectra were recorded on a Varian 500 MHz spectrometer 
interfaced to a UNIX computer using Mercury software.  Chemical shifts were referred to 
the solvent proton resonance.  Infrared spectra were obtained on a Perkin-Elmer 
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Spectrum BX FT-IR system using diffuse reflectance sampling accessories with FT-IR 
Spectrum v2.00 software. 
Absolute molecular weight and molecular weight distribution were determined by Gel 
Permeation Chromatography (GPC).  GPC was performed on a Waters 1515 HPLC 
system (Water Chromatography Inc.), equipped with a Waters 2414 differential 
refractometer, a PD2020 dual-angle (15 and 90) light scattering detector (Precision 
Detectors Inc.), and a three-column series PL gel 5 μm Mixed columns (Polymer 
Laboratories Inc.).  The eluent was anhydrous tetrahydrofuran (THF) with a flow rate of 
1 mL/min.  All instrumental calibrations were conducted using a series of nearly 
monodispersed polystyrene standards.  Data were collected upon an injection of a 200 μL 
of polymer solution in THF (ca. 5 mg/mL), and then analyzed using Discovery 32 
software (Precision Detectors Inc.). 
The N,N-dimethylformamide (DMF) GPC was conducted on a Waters 
Chromatography, Inc. (Milford, MA) system equipped with an isocratic pump model 
1515, a differential refractometer model 2414, and a two-column set of Styragel HR 4 
and HR 4E 5 µm DMF 7.8 × 300 mm columns.  The system was equilibrated at 70 °C in 
pre-filtered DMF containing 0.05 M LiBr, which served as polymer solvent and eluent 
(flow rate set to 1.00 mL/min).  Polymer solutions were prepared at a concentration of ca. 
3 mg/mL and an injection volume of 200 µL was used.  Data collection and analysis was 
performed with Empower Pro software (Waters, Inc.).  The system was calibrated with 
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poly(ethylene glycol) standards (Polymer Laboratories, Amherst, MA) ranging from 615 
to 442,800 Da. 
Samples for Transmission electron microscopy (TEM) measurements were diluted 
with a 1 % phosphotungstic acid (PTA) stain (v/v, 1:1).  Carbon grids were exposed to 
oxygen plasma treatment to increase the surface hydrophilicity.  Micrographs were 
collected at 100,000 × magnification and calibrated using a 41 nm polyacrylamide bead 
from NIST.  The number average particle diameters (Dav) and standard deviations were 
generated from the analysis of a minimum of 150 particles from at least three different 
micrographs.  The aggregation number (Naggr) was calculated based upon the diameter 
measured from TEM by using the following equation: 
Naggr = A
n
N
M
r
×
ρπ 3
3
4
     (1) 
where r is the radius of the NP core domain, ρ is the density of poly(4-vinyl 
benzaldehyde) (PVBA), Mn is the number-average molecular weight of PVBA block 
segment, and NA is the Avogadro constant. 
Hydrodynamic diameters (Dh) and size distributions for the nanoparticles in aqueous 
solutions were determined by dynamic light scattering (DLS).  The DLS instrument 
consisted of a Brookhaven Instruments Limited (Worcestershire, U.K.) system, including 
a model BI-200SM goniometer, a model BI-9000AT digital correlator, a model EMI-
9865 photomultiplier, and a model 95-2 Ar ion laser (Lexel Corp.) operated at 514.5 nm.  
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Measurements were made at 25 ± 1 °C.  Scattered light was collected at a fixed angle of 
90°.  The digital correlator was operated with 522 ratio spaced channels, and initial delay 
of 5 μs, a final delay of 100 ms, and a duration of 8 minutes.  A photomulitplier aperture 
of 400 μm was used, and the incident laser intensity was adjusted to obtain a photon 
counting of between, 150 and 200 kcps.  Only measurements in which the measured and 
calculated baselines of the intensity autocorrelation function agreed to within 0.1 % were 
used to calculate particle size.  The calculations of the particle size distributions and 
distribution averages were performed with the ISDA software package (Brookhaven 
Instruments Company), which employed single-exponential fitting, cumulants analysis, 
and CONTIN particle size distribution analysis routines.  All determinations were 
repeated for 5 times and the data were represented as mean values ± standard deviations 
between runs. 
For optical measurements, the fluorescein-based NPs were diluted with 0.1 M NaOH 
solution.  Cypate-based nanoparticles were measured in PBS buffer at pH 7.2 (5 mM with 
5 mM of NaCl).  Both samples were diluted to a concentration where the absorbance 
value at maximum absorption peak was less than 0.1 to avoid self-quenching between 
nanoparticles and photon re-absorption. 
The UV-vis absorption spectra of NPs were collected at room temperature using 
Varian Cary 500 Bio UV-visible spectrophotometer and quartz cuvette with 10 mm of 
light path. 
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The fluorescence spectra of NPs were obtained at room temperature using a Varian 
Cary Eclipse and Fluorolog III fluorescence spectrophotometer.  Fluorescence lifetime 
was measured using TCSPS method as described previously.  For NPs bearing 
fluoresceins, the fluorescence decays were measured in aqueous media using excitation 
source Nanoled® 460 nm, monitored emission at 570 nm with bandpass 20 nm.  For NPs 
bearing cypate, the fluorescence lifetimes were determined in aqueous media using 
excitation source Nanoled® 773 nm, monitored emission 820 nm with bandpass 20 nm.  
In both measurements, a two-exponential decay analysis was applied. 
The Foster radius of a homoFRET pair (R0) was calculated using previously 
developed FRET calculator from steady-state absorption and emission spectra using 
known equations: 
ܴ0 ൌ 0.211 ቀ݇2݊-4ܳDܬሺߣሻቁ
ଵ/଺
  Å   (2) 
where n is the refraction index typically assumed to be 1.4 for biomolecules in aqueous 
solutions; k2 is the orientation factor typically equal to 2/3 for random distributed 
fluorophores; QD is the quantum yield of the donor; ܬሺߣሻ is the spectral overlap integral, 
which is calculated by the following equation: 
ܬሺߣሻ ൌ ׬ ܨ஽ሺߣሻߝ஺
∞
଴ ሺߣሻߣ
ସ ݀ߣ  M-1 cm-1 nm4  (3) 
where λ represents the wavelength in nm; ܨ஽ሺߣሻ represents the normalized fluorescence 
intensity at wavelength λ; ߝ஺ሺߣሻ represents molar absorptivity of the acceptor at given 
wavelength. 
177 
 
Synthesis of cypate-diamine.  To a DMF solution of Cypate (12.5 mg, 17.7 μmol) 
and 1-hydroxybenzotriazole (HOBt, 9.6 mg, 70.8 μmol) was added N,N´-
diisopropylcarbodiimide (DIC) (11.0 μL, 70.8 μmol), the resulting mixture was stirred for 
10 min.  Boc-ethylene diamine (6.7 μL, 42.3 μmol) was then added and the mixture was 
stirred overnight at room temperature (rt).  After removing the DMF in vacuo, a solution 
of trifluoroacetic acid (TFA), H2O, phenol, and thioanisole (85:5:5:5, v/v) was added and 
stirred for 1 h at rt.  The volatiles were removed under reduced pressure and the crude 
product was washed with diethyl ether (3 × 5mL) and purified by medium pressure 
chromatography with a C-18 reverse phase column (acetonitrile/water as eluent).  A 
green solid was obtained as pure product (10.9 mg, 60.6% yield).  MS (EI): 709.0 (M + 
1)+. 
Synthesis of HL-800-amine.  To a solution of HL-800 (10.4 mg, 11.2 μmol) and 2-
(1H-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate 
methanaminium (HATU, 6.4 mg, 16.8 μmol) in DMF, was added diisopropylethyl amine 
(DIEA, 2.9 μL, 16.8 μmol), the resulting mixture was stirred at rt for 10 min.  Boc-
ethylene diamine (2.1 μL, 20.1 μmol) was added and the mixture was stirred overnight at 
rt.  The reaction mixture was then poured into 150 mL of diethyl ether.  Collect the solid 
precipitated out and a solution of TFA, H2O, phenol, and thioanisole (85:5:5:5, v/v) was 
added following by stirring for 1 h at rt.  The crude product was precipitated out by 
diethyl ether, washed with diethyl ether (3×5 mL) and purified by medium pressure 
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chromatography with a C-18 reverse phase column (acetonitrile/water as eluent).  The 
solvents were evaporated to give HL-800-amine (3.18mg, 29.2% yield) as a green solid.  
MS (EI): 955.2 (M + 1)+. 
Synthesis of mPEG5k macro-CTA.  To a solution of mPEG5000 (1.80 g, 0.36 
mmol) in 20 mL of dry CH2Cl2 at rt, was added DDMAT (0.20 g, 0.54 mmol) and 
dicyclohexylcarbodiimide (0.12 g, 0.54 mmol), the reaction mixture was stirred 10 min.  
After the additions of 4-di(methylamino)pyridine (13.2 mg, 0.11 mmol) and DPTS (68.6 
mg, 0.22 mmol), the reaction mixture was further stirred 20 h at rt.  Then the reaction 
mixture was filtered with celite and the filtrate was placed at 4 ºC overnight, filtered with 
celite, and concentrated to ca. 8 mL.  After the solution was precipitated into 150 mL of 
dry ether at 0 ºC twice, the crude product obtained was further purified by flash column 
chromatography (2-3% MeOH/CH2Cl2, v/v) to afford mPEG5k macro-CTA as a yellow 
solid (1.2 g, 60% yield).  1H NMR (500 MHz, CD2Cl2, δ): 0.88 (t, J = 6.5 Hz, 3H), 1.26 
(m, 16H), 1.38 (t, J = 6.5 Hz, 2H), 1.66 (t, J = 7.5 Hz, 2H), 1.68 (s, 6H), 3.27 (t, J = 7.2 
Hz, 2H), 3.33 (s, 3H), 3.40-3.80 (m, 440H), 4.21 (t, J = 5.0 Hz, 2H). 
Synthesis of PEO45-b-PVBA18.  To a 10 mL Schlenk flask equipped with a magnetic 
stir bar dried with flame under N2 atmosphere, was added the mPEG2k macro-CTA (0.24 
g, 0.10 mmol) and dry DMF (2.5 mL).  The reaction mixture was stirred 1 h at rt to 
obtain a homogeneous solution.  To this solution was added VBA (0.66 g, 5.0 mmol) and 
AIBN (3.2 mg, 20 μmol).  The reaction flask was sealed and stirred 10 min at rt.  The 
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reaction mixture was degassed through several cycles of freeze-pump-thaw.  After the 
last cycle, the reaction mixture was stirred for 10 min at rt before immersing into a pre-
heated oil bath at 75 °C to start the polymerization.  After 4 h, the monomer conversion 
reached ca. 30% by analyzing aliquots collected through 1H-NMR spectroscopy.  The 
polymerization was quenched by cooling the reaction flask with liquid N2.  CH2Cl2 (5.0 
mL) was added to the reaction flask and the polymer was purified by precipitation into 
300 mL of cold diethyl ether at 0 °C twice.  The precipitants were collected, washed with 
100 mL of cold ether, and dried under vacuum overnight to afford the block copolymer 
precursor as a yellow solid (0.35 g, 80% yield based upon monomer conversion).  1H 
NMR (500 MHz, CD2Cl2, δ): 0.88-1.24 (br, dodecyl Hs), 1.52-2.06 (br, PVBA backbone 
protons), 3.22 (br, SCH2 of the chain terminus), 3.33 (s, mPEG terminal OCH3), 3.34-
3.78 (m, OCH2CH2O from the PEG backbone), 4.84 (br, 1H from the PVBA backbone 
benzylic terminus connected to trithiocarbonate), 6.58-6.85 (br, Ar H), 7.33-7.62 (br, Ar 
H), 9.88 (br, CHO);  13C NMR (150 MHz, DMSO-d6, δ): 192.3 , 151.3, 134.4, 129.4, 
128.0, 69.8, 42.3, 40.4, 29.0; IR (KBr): 3433, 2923, 2856, 2732, 1699, 1604, 1575, 1453, 
1425, 1386, 1354, 1306, 1258, 1214, 1171, 1103, 1017, 951, 837, 726, 674, 552. 
Synthesis of PEO113-b-PVBA46.  To a 25 mL Schlenk flask equipped with a 
magnetic stir bar dried with flame under N2 atmosphere, was added the mPEG5k macro-
CTA (0.58 g, 0.11 mmol) and dry DMF (7.0 mL).  The reaction mixture was stirred 1 h at 
rt to obtain a homogeneous solution.  To this solution was added VBA (1.5 g, 11.0 mmol) 
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and AIBN (3.4 mg, 21 μmol).  The reaction flask was sealed and stirred 10 min at rt.  The 
reaction mixture was degassed through several cycles of freeze-pump-thaw.  After the 
last cycle, the reaction mixture was stirred for 10 min at rt before immersing into a pre-
heated oil bath at 75 °C to start the polymerization.  After 5.5 h, the monomer conversion 
reached ca. 47% by analyzing aliquots collected through 1H-NMR spectroscopy.  The 
polymerization was quenched by cooling the reaction flask with liquid N2.  CH2Cl2 (5.0 
mL) was added to the reaction flask and the polymer was purified by precipitation into 
300 mL of cold diethyl ether at 0 °C twice. The precipitants were collected, washed with 
100 mL of cold ether, and dried under vacuum overnight to afford the block copolymer 
precursor as a yellow solid (0.92 g, 75% yield based upon monomer conversion).  1H 
NMR (500 MHz, CD2Cl2, δ): 0.88-1.24 (br, dodecyl Hs), 1.52-2.06 (br, PVBA backbone 
protons), 3.22 (br, SCH2 of the chain terminus), 3.33 (s, mPEG terminal OCH3), 3.34-
3.78 (m, OCH2CH2O from the PEG backbone), 4.84 (br, 1H from the PVBA backbone 
benzylic terminus connected to trithiocarbonate), 6.58-6.85 (br, Ar H), 7.33-7.62 (br, Ar 
H), 9.88 (br, CHO);  13C NMR (150 MHz, DMSO-d6, δ): 192.3 , 151.3, 134.4, 129.4, 
128.0, 69.8, 42.3, 40.4, 29.0; IR (KBr): 3433, 2923, 2856, 2732, 1699, 1604, 1575, 1453, 
1425, 1386, 1354, 1306, 1258, 1214, 1171, 1103, 1017, 951, 837, 726, 674, 552. 
General procedure for construction of PEO-b-PVBA micelles.  To a solution of 
PEO-b-PVBA block copolymer in DMF (ca. 1.0 mg/mL), was added dropwise an equal 
volume of nano-pure H2O via a syringe pump at a rate of 15.0 mL/h, and the mixture was 
181 
 
further stirred for 16 h at rt.  The solution was then transferred to pre-soaked dialysis 
tubing with Molecular Weight Cut Off (MWCO) of ca. 3,500 Da and dialyzed against 
nano-pure H2O for 4 d to afford a solution of micelles. 
General procedure for one-pot functionalization and crosslinking of PEO-b-
PVBA micelles with fluorescein-5-thiosemicarbazide.  To a solution of PEO-b-PVBA 
micelles in 10.0 mL of nano-pure H2O, was added a solution of fluorescein-5-
thiosemicarbazide (20 mol%, 2 mol%, 1 mol%, and 0.5 mol%, relative to the aldehyde 
residues, respectively) in DMF.  The reaction mixture was allowed to stir for 2 h at rt in 
the absence of light.  To this reaction mixture, was added a solution of 2,2'-
(ethylenedioxy)-bis(ethylamine) (150 mol%, relative to the aldehyde residues) in nano-
pure H2O dropwise over 10 min.  The reaction mixture was further stirred for 48 h at rt in 
the absence of light.  NaBH3CN (200 mol%, relative to the aldehyde residues) in nano-
pure H2O was then added to the reaction solution and further stirred for 16 h at rt in the 
absence of light.  Finally, the mixture was transferred to pre-soaked dialysis tubing 
(MWCO ca. 3,500 Da) and dialyzed against 5.0 mM PBS (pH 7.2, with 5.0 mM NaCl) 
for 7 d to remove the small molecule by-products and afford an aqueous solution of 
fluorescein-functionalized crosslinked nanoparticles. 
General procedure for one-pot functionalization and crosslinking of PEO113-b-
PVBA46 micelles with cypate-diamine.  To a solution of PEO113-b-PVBA46 micelles 
(2.7 mg of polymer, 10.8 μmol of aldehyde residues) in 10.0 mL of nano-pure H2O, was 
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added a solution of cypate-diamine (1 mol%, 0.5 mol%, and 0.2 mol%, relative to the 
aldehyde residues, respectively) in DMF.  The reaction mixture was allowed to stir for 2 
h at rt in the absence of light.  To this reaction mixture, was added a solution of 2,2'-
(ethylenedioxy)-bis(ethylamine) (2.4 mg, 16.2 μmol) in nano-pure H2O dropwise over 10 
min.  The reaction mixture was further stirred for 48 h at rt in the absence of light.  
NaBH3CN (1.4 mg, 21.6 μmol) in nano-pure H2O was then added to the reaction solution 
and further stirred for 16 h at rt in the absence of light.  Finally, the mixture was 
transferred to pre-soaked dialysis tubing (MWCO ca. 6,000-8,000 Da) and dialyzed 
against 5.0 mM PBS (pH 7.2, with 5.0 mM NaCl) for 7 d to remove the small molecule 
by-products and afford an aqueous solution of functionalized and crosslinked 
nanoparticles. 
Micellization of PEO45-b-PNAS95-b-PS60.  To a solution of PEO45-b-PNAS95-b-PS60 
block copolymer in DMF (ca. 1.0 mg/mL), was added dropwise an equal volume of 
nano-pure H2O via a syringe pump at a rate of 15.0 mL/h, and the mixture was further 
stirred for 1 h at rt before using for the following reactions. 
Functionalization and crosslinking of PEO45-b-PNAS95-b-PS60 micelles with 
cypate-diamine or HL-800 amine.  To a solution of PEO45-b-PNAS95-b-PS60 micelles 
(4.8 mg of block copolymer precursor, 27.0 μmol of NAS residues) in 10 mL of 
DMF/H2O (v:v = 1:1) at rt, was added the solution of cypate-diamine (38.3 μg, 0.054 
μmol) or HL-800 amine (51.6 μg, 0.054 μmol) in 50 μL of DMF.  The reaction mixture 
183 
 
was allowed to stir for 2 h at rt in the absence of light.  To this reaction mixture, was 
added a solution of 2,2'-(ethylenedioxy)-bis(ethylamine) (1.0 mg, 6.8 μmol) in nano-pure 
H2O dropwise over 10 min.  The reaction mixture was further stirred for 24 h at rt in the 
absence of light and transferred to pre-soaked dialysis tubing (MWCO 6,000-8,000 Da) 
and dialyzed against 5.0 mM PBS (pH 7.2, with 5.0 mM NaCl) for 7 days to remove 
DMF, un-reacted crosslinker, and the small molecule by-products and afford an aqueous 
solution of crosslinked nanoparticles. 
One-pot functionalization and crosslinking of PEO113-b-PVBA46 micelle with 
HL-800-amine.  To a solution of PEO113-b-PVBA46 micelles (2.7 mg of polymer, 10.8 
μmol of aldehyde residues) in 10.0 mL of nano-pure H2O, was added a solution of HL-
800-amine (20.7 μg, 0.022 μmol) in DMF.  The reaction mixture was allowed to stir for 2 
h at rt in the absence of light.  To this reaction mixture, was added a solution of 2,2'-
(ethylenedioxy)-bis(ethylamine) (2.4 mg, 16.2 μmol) in nano-pure H2O dropwise over 10 
min.  The reaction mixture was further stirred for 48 h at rt in the absence of light.  
NaBH3CN (1.4 mg, 21.6 μmol) in nano-pure H2O was then added to the reaction solution 
and further stirred for 16 h at rt in the absence of light.  Finally, the mixture was 
transferred to pre-soaked dialysis tubing (MWCO ca. 6,000-8,000 Da) and dialyzed 
against 5.0 mM PBS (pH 7.2, with 5.0 mM NaCl) for 7 d to remove the small molecule 
by-products and afford an aqueous solution of functionalized and crosslinked 
nanoparticles. 
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Results and Discussion 
To construct fluorescent NPs, diblock copolymer (poly(ethylene oxide)-block-
poly(4-vinyl benzaldehyde, PEO-b-PVBA) and triblock copolymer (poly(ethylene 
oxide)-block-poly(N-acryloxysuccinimide)-block-polystyrene, PEO-b-PNAS-b-PS) 
micelles were functionalized with fluorescein-5-thiosemicarbazide and amine-terminated 
carbocyanine dyes through either reductive amination or amidation chemistry.  The PEO-
b-PVBA diblock copolymers I (PEO45-b-PVBA18, Mn, NMR = 4,700 Da, Mn, GPC = 3,900 
Da, PDI = 1.2, Figure 7.1A) and II (PEO113-b-PVBA46, Mn, NMR = 12,600 Da, Mn, GPC = 
12,400 Da, PDI = 1.4, Figure 7.1B)58 were used for construction of core functionalizable 
crosslinked nanoparticles while the PEO-b-PNAS-b-PS triblock copolyper III (PEO45-b-
PNAS95-b-PS60, Mn, NMR = 18,400 Da, PDI = 1.2, Figure 7.1C) was utilized as precursor 
for shell crosslinked nanoparticles.  All block copolymers were prepared through 
reversible addition-fragmentation chain transfer (RAFT) polymerization,59-61 based upon 
our previous reports.56, 57  The PEO (MW = 2, 000 and 5,000 Da, respectively) was 
selected as hydrophilic segment because of its good water solubility, well-known 
biocompatibility, and low immunogenic response.62  PVBA was used as the hydrophobic 
and reactive segment due to the broad reaction scope and the mild reaction condition of 
aldehyde functionality, especially under aqueous conditions.  PNAS acted as pre-installed 
active ester for reaction with amine-functionalized fluorophores. 
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Figure 7.1.  Characterizations of PEO45-b-PVBA18 (I), PEO113-b-PVBA46 (II), and 
PEO45-b-PNAS95-b-PS60 (III) block copolymer precursors.  A): 1H NMR spectrum (left, 
500 MHz, CD2Cl2) and THF-GPC profile (right) of PEO45-b-PVBA18 block copolymer.  
B): 1H NMR spectrum (left, 500 MHz, CD2Cl2) and THF-GPC profile (right) of PEO45-b-
PVBA18 block copolymer.  C): A): 1H NMR spectrum (left, 600 MHz, CD2Cl2) and 
DMF-GPC profile (right) of PEO45-b-PNAS95-b-PS60 block copolymer. 
 
Aqueous assembly of block copolymer I and II followed conventional methods 
for micellization of amphiphilic block copolymers with a glassy hydrophobic block 
segment.  PEO selective solvent, i.e. water, was slowly (ca. 15 mL/h) added to the 
solution of PEO-b-PVBA in organic solvent (DMF, ca. 1.0 mg/mL) to induce the 
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micellization and further stabilize the formed aggregates.  Finally, the organic solvent 
was removed through dialysis against water to afford PEO-b-PVBA micelles with PEO 
shell and PVBA core domains.  The uniformity and narrow size distribution of the 
assembled micelles were demonstrated through the combination of DLS and TEM 
(Figure 7.2).  The DLS measurements showed that these micelles had intensity-averaged 
hydrodynamic diameter (Dh, intensity) of 23 ± 2 nm (from PEO45-b-PVBA18) and 26 ± 2 nm 
(from PEO113-b-PVBA46), respectively.  TEM micrograph revealed their globular shape 
with an average core domain diameter (Dav) of 13 ± 1 nm and 19 ± 1 nm, respectively, 
depending upon the length of PVBA block segment. 
 
Figure 7.2.  Characterization of PEO-b-PVBA micelles.  A) Intensity-average weighted 
hydrodynamic diameter distribution histogram by DLS (top) and TEM micrograph 
(bottom, stained with PTA) of PEO45-b-PVBA18 micelle.  B) Intensity-average weighted 
hydrodynamic diameter distribution histogram by DLS (top) and TEM micrograph 
(bottom, stained with PTA) of PEO113-b-PVBA46 micelle. 
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One-pot chemical functionalization with fluorescein-5-thiosemicarbazide and 
crosslinking with diamine crosslinker of the PEO45-b-PVBA18 micelles were achieved, 
following our previously established reductive amination protocol (Scheme 7.1A).56  
Similar to our previous reports,56 buffer solutions with certain ionic strength (pH 7.2 5 
mM PBS with 5 mM of NaCl in this study) were found to be required to prevent the 
precipitation of the crosslinked nanoparticles.  For NP1 (prepared with a feeding ratio of 
fluoresceins/aldehydes = 0.2:1), the DLS (Dh, intensity = 21 ± 1 nm) and TEM (Dav = 13 ± 1 
nm) characterizations of the functionalized crosslinked NPs showed no obvious 
morphology, size, and size distribution variations (Figure 7.3A), compared with the 
micelle precursors (Figure 7.2A).  UV-Vis measurement of the fluorescein-NP solutions 
revealed that a slight red-shift of ca. 8 nm (Figure 7.3E left) occurred for the maximum 
absorption peak (λmax, 496 nm for the fluorescein-functionalized NPs v.s. 488 nm for the 
unconjugated fluorescein), which might be related to the change of fluorescein local 
environment before and after incorporation into the nanostructure.  Although the 
thiosemicarbazide is a strong nucleophile, the coupling efficiency of fluorescein into NP 
was only ca. 12%.  This might be associated with the low accessibility of hydrophilic 
fluoresein to the hydrophobic benzaldehyde functionalities (packed inside the 
hydrophobic core domain of the micelle). 
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Scheme 7.1.  Construction of fluorescent nanoparticles through reductive amination (A) 
and amidation (B). 
 
Steady state fluorescence spectrum of the diluted NP solution was recorded at the 
excitation wavelength of 450 nm over the range of 465-650 nm and shown in Figure 
7.3E.  Compared with small fluorescein molecule, much lower fluorescence emission 
intensity of the NP1 sample (200-fold drop at the same concentration magnitude) was 
observed.  We attributed the decrease in fluorescence of attached fluorescein moieties to 
intra-nanoparticle self-quenching, i.e., the combined effects of homoFRET (non-radiative 
energy transfer of the same fluorophores located in close proximity to each other) caused 
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by incorporating ca. 150 dyes into a confined space with ca. 13 nm of diameter (vide 
infra). 
We also conducted the R0 measurement (see Experimental Section for details) and 
the result was 4.67 nm, similar to the literature value (4.4 nm).  The distance between two 
fluorescein moieties on the NPs (r) were calculated from both steady-state and dynamic 
emission spectra by using the following equations: 
ݎ ൌ ܴ଴ ቀ
ி೏ೌ ஺௕௦೏ೌ⁄
ி೏ ஺௕௦೏⁄
ቁ
ଵ/଺
  nm for steady-state emission  (4) 
where Fda is the fluorescence intensity of the donor in the presence of acceptor, and Fd is 
the fluorescence intensity of the donor in the absence of acceptor, Absda is absorbance of 
the donor in the presence of acceptor, Absd is absorbance of the donor in the absence of 
acceptor. 
and ݎ ൌ ܴ଴ ቀ
ఛ೏ೌ
ఛ೏
ቁ
ଵ/଺
  nm for dynamic emission   (5) 
where τda represents the relative fluorescence lifetime of the donor in the presence of 
acceptor, and τd in the absence of acceptor.  The calculated results, together with the 
experimentally optical characteristics of the samples, were summarized in Table 7.1. 
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Figure 7.3.  Characterizations of NP1-4.  A-D) Intensity-average weighted 
hydrodynamic diameter distribution by DLS (top) and TEM micrograph (bottom, stained 
with PTA) of NP1-4, respectively.  E) UV-Vis (left) and fluorescence emission (middle 
and right) spectra of Control1 (Fluorescein, dashed) and NP1 (solid).  F) UV-Vis (left) 
and fluorescence emission (middle and right) spectra of Control2 (Fluorescein, dashed) 
and NP2 (solid).  G) UV-Vis (left) and fluorescence emission (middle and right) spectra 
of Control3 (Fluorescein, dashed), NP3 (short dashed) and NP4 (solid). 
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Table 7.1.  Calculated distance between two adjacent fluorescein moieties incorporated 
into nanoparticles and the optical characteristics of fluorescent nanoparticles. 
Sample Dh, intensity (nm) 
Dav 
(nm) Nagg Dyes/NP
a D (nm) 
τb 
(ns) 
r(τ)c 
(nm) Φ
d r(Φ)
e 
(nm) 
Control1f ─ ─ ─ ─ ─ 3.95 ─ 0.79 ─ 
NP1 21 ± 1 13 ± 1 350 150 1.88 2.07 4.75 0.005 2.0 
Control2f ─ ─ ─ ─ ─ 3.88 ─ 0.79 ─ 
NP2 22 ± 2 13 ± 1 350 15 5.95 2.97 5.69 0.088 3.3 
Control3f ─ ─ ─ ─ ─ 3.92 ─ 0.79 ─ 
NP3 24 ± 2 19 ± 1 430 15 8.69 3.33 6.23 0.233 4.04 
NP4 24 ± 2 19 ± 1 430 30 6.15 3.11 5.84 0.215 3.97 
a Calculated based upon ε = 66,000 M-1 cm-1.  b Fluorescence average lifetime.  c Distance 
between two fluorophores based upon lifetime measurement.  d Fluorescence quantum 
yield.  e Distance between two fluorophores based upon quantum yield.  f Fluorescein as 
control (Control1 for NP1 measurement, Control 2 for NP2 measurement, and 
Control3 for NP3 and NP4 measurements, respectively). 
 
We have previously established a semi-quantitative model for evaluation of the 
nanoparticle surface coverage density.63  Because only ~ 2.5% of the VBA units were 
actually “decorated” with fluorescein, the fluorescein molecules should be attached to the 
most accessible VBA units, i.e. benzaldehydes around the periphery of the core domain.  
Therefore, the previous model could be easily revised to estimate the distance between 
adjacent fluorecein molecules (depicted as D in Scheme 7.1 insertion) through the 
following equation: 
D = 
N
D 2)( avπ   nm      (6) 
where N denotes the number of fluorophores per NP (obtained from the number of 
fluorophores per polymer chain and the aggregation number of polymer chains estimated 
to be within each NP, see Experimental Section for details), and Dav is the averaged 
diameter of the core domain of NP. 
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Theoretically, no energy would be transferred and therefore no quenching would 
occur if the distance between two fluororeceins exceeds 9 nm.  For NP1, the calculated 
distances between two fluorescein molecules, both from our model prediction using eq. 
(6) (1.88 nm) and from the experimental calculations (2.00 nm from steady state and 4.75 
nm from dynamic state, respectively), were far below 9 nm and substantial self-
quenching (over 45% of the emission energy was transferred to acceptors) were expected.  
The variation of the distance between steady-state and dynamic emission spectra was 
attributed to the more complex decay of NP1.  In fact, the average lifetime results in 
Table 7.1 were the results of deconvolution of decays using two-exponential decay laws 
and the multiexponentiality of decays suggested the presence of many distance between 
fluorescein moieties. 
To reduce the homoFRET effect, the easiest method was to decrease the number 
of fluorophores per nanoparticle.  Therefore, NP2 with ca. 15 fluoreceins per NP was 
prepared from the same block copolymer micelle as NP1, maintaining similar size (Dh, 
intensity = 22 ± 2 nm and Dav = 13 ± 1 nm) and size distribution (Figure 7.3B).64  
Significant improvement of QY was observed by a factor of 18 (Table 7.1), due to the 
increase of the distance between fluorescein moieties, as calculated from experimental 
data and the proposed model (Table 7.1). 
However, the QY for NP2 was still below 0.1.  Also, ca. 25% of the energy was 
non-radiatively transferred to other fluoresceins, based upon the lifetime measurement.  
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Further decrease of fluorescein density is expected to enhance QY, but the overall 
fluorescence intensity per NP still would not reach a desired level due to the lack of 
fluorophores.  Theoretical estimation indicated that, for the PEO45-b-PVBA18 system (13 
nm diameter core), there can be no more than 5 fluoresceins per particle that are 
separated by at least 9 nm.  The prediction made this system less attractive for further 
optimization because at such a small loading capacity, even the QY for each fluorophore 
can be enhanced, the overall fluorescence cannot be indefinitely improved due to the 
fewer number of fluorophores per particle. 
From equation (6), there exists a linear relationship between D and Dav at fixed 
dye loadings, which indicates that the size increase of nanoparticle core domain would 
facilitate the enhancement of luminescence efficiency.  Therefore, it is desired to use 
particles with larger cores for fluorophore functionalization.  NP3 and NP4 with larger 
core sizes (19 vs. 13 nm, Table 7.1 and Figure 7.3C-D) were then prepared from PEO113-
b-PVBA46 block copolymer micelles.65 
With a core size of 19 nm and 15 fluorescein molecule/NP, the calculated D for 
NP3 was 8.69 nm, which was close to the “9 nm requirement”.  In fact, only 15.7% of the 
absorbed energy was non-radiatively transferred between fluorescein moieties (based 
upon lifetime measurement).  As a result, QY of NP3 was increased to 0.233, a 2.5-fold 
enhancement compared with NP2.  For NP4, which bears 30 fluoreceins per particle, a 
slight drop of QY (0.215) was observed, likely due to the relative proximity between 
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fluorophores (D = 6.15 nm).  However, the slightly decreased QY was compensated by 
the much increased number of fluorophores, rendering its overall fluorescence intensity 
190% as large as than that of NP3 (Figure 7.3G right). 
The PEO113-b-PVBA46 micelle system and the optimized stoichiometry of 
fluorescein loading (less than 1 mol%, relative to the aldehydes) were then extend to 
construct NIR fluorescent nanoparticles.  NP5-7 with ca. 70, 45, and 10 cypates per 
particle, respectively, were synthesized and subjected to photo-physical studies.  
Compared with the coupling yields of fluoresceins at ~ 12% to 15%, the cypate exhibited 
~ 36% to 47% incorporation efficiencies.  This improvement could to be attributed to the 
fact that cypate was much more hydrophobic than fluorescein and had more preference 
for the hydrophobic PVBA core. 
As shown in Figure 7.4A-C, NP5-7 displayed well-defined globular shape and 
narrow size distributions.  Interestingly, although the UV-Vis spectra (Figure 7.4D) 
showed that NP5-7 had the identical maximum absorption wavelength at 800 nm, the 
fluorescence emission spectrum of NP7 bearing the least number of cypates exhibited a 
clear blue-shift of ca. 11 nm (813 nm vs. 824 nm for NP5 and 6, Figure 7.4E).  The origin 
of this blue-shift was believed to be associated with the increased molecular asymmetry20 
of cypate-diamine after incorporation into the nanostructures at lower stoichiometry, i.e., 
some of the cypate-diamines had both amine groups reacted while some only had one 
reacted. 
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Figure 7.4.  A-C) Intensity-average weighted hydrodynamic diameter distribution 
histogram by DLS (top) and TEM micrograph (bottom, stained with PTA) of NP5, NP6, 
and NP7, respectively.  D-E) UV-Vis and fluorescence profiles of NP5 (dashed), NP6 
(short dashed), and NP7 (solid), respectively. 
 
Based upon the model prediction equation (eq. (6)), the distance between 
neighboring cypate molecules for NP5-7 was 4.0 nm, 5.0 nm, and 10.7 nm, respectively 
(Table 7.2).  Compared with the general “non-homoFRET criterion” (> 12 nm), it could 
speculate that NP5 and NP6 would exhibit very low QYs, which were further confirmed 
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through the steady-state (QY = 0.001 and 0.004, respectively) and dynamic (lifetime less 
than 0.3 ns) measurements.  For NP7, increased QY value was expected due to the 
increased D value (over 10 nm).  The actual QY value was measured by steady state 
fluorescence to be 0.019, very close to free cypate in water (0.021). 
 
Table 7.2.  Characterizations and optical characteristics of NIR fluorescent nanoparticles 
from PEO113-b-PVBA46 system. 
Sample Dh, intensity (nm) 
Dav 
(nm) Nagg Dyes/NP
a D (nm) Φ
b τ
c 
(ns) 
NP5 23 ± 1 19 ± 1 430 70 4.0 0.001 0.2d 
NP6 23 ± 1 19 ± 1 430 45 5.0 0.004 0.2d 
NP7 22 ± 2 19 ± 1 430 10 10.7 0.019 0.6 
a Calculated based upon ε = 200,000 M-1 cm-1.  b Relative to ICG in methanol (QY=0.09).  c 
Fluorescence average lifetime.  d Due to the limitation of instrument, the lifetime below 0.3 ns 
was not accurate. 
 
The lifetime and quantum yield of carbocyanine dye were also related with the 
property of local environment, i.e., the micropolarity of the media.66  For example, the 
lifetime of cypate was markedly increased from less than 0.2 ns to 1 ns as the solvent was 
switched from water to chloroform.  QY could also be affected but was less predictable.  
For the core crosslinked PEO-b-PVBA system, since the reactive aldehydes were located 
inside the core and the core-shell interfacial domains, the covalently conjugated NIR dyes 
were also confined to core periphery and core-shell interface areas and were theoretically 
exposed to relatively less polar surroundings, compared with the pure water molecules.  
To test whether the QY of cypate-functionalized NPs was affected by fluorophore 
location, shell-crosslinked NIR fluorescent nanoparticles (NIR-SCKs, SCK1-2) were 
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prepared, in which the carbocyanine molecules (Cypate for SCK1 and HL-800 for 
SCK2, respectively) were distributed throughout the shell domain (Scheme 7.1B). 
As mentioned earlier, the NIR-SCKs were synthesized through functionalization 
and crosslinking the PEO45-b-PNAS95-b-PS60 micelle with pendent NAS functionalities 
as pre-installed amidation sites along the polymer backbone for amine-terminated 
cyanine dyes and diamine crosslinkers.  After the work-up process (extensive dialysis 
against PBS buffer), the unreacted NAS residues were hydrolyzed to acrylic acids and 
then became components of shell domain of nanoparticles.  The cypate incorporation 
efficiency (ca. 15%) was lower compared with the PEO-b-PVBA system under similar 
cypate-diamine feeding ratio (0.2 mol%, relative to the reactive functionalities).  The 
particles showed relatively narrow size distributions and globular shape observed through 
DLS and TEM (Figure 7.5A-B).  The physical characteristics of SCK1 and SCK2 were 
summarized in Table 7.3. 
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 Figure 7.5.  Characterizations and photo-physical properties of shell crosslinked NIR 
fluorescent nanoparticles.  A-B) Intensity-average weighted hydrodynamic diameter 
distribution histogram by DLS (top) and TEM micrograph (bottom, stained with PTA) of 
SCK1 and SCK2, respectively.  C) UV-Vis (left) and fluorescence (right) profiles of 
SCK1 (dashed) and SCK2 (solid), respectively. 
 
Table 7.3.  Characterizations and optical characteristics of NIR-SCKs from PEO45-b-
PNAS95-b-PS60 micelles. 
Sample Dh, intensity (nm) 
Dav 
(nm) Nagg Dyes/NP
a Φb 
SCK1 59 ± 3 30 ± 1 1450 40 0.005 
SCK2 56 ± 2 30 ± 1 1450 20 0.036 
a Calculated based upon ε = 200,000 M-1 cm-1.  b Relative to ICG in methanol (QY=0.09). 
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Similar to NP7, the fluorescence emission spectrum of SCK1 showed a 10 nm 
blue-shift for the maximum emission peak (dashed curve in Figure 7.5D).  The blue-shift 
could also be attributed to the raise of cypate molecular asymmetry after conjugation.  
Although the particle size increased in both core and shell domains (59 nm vs. 23 nm for 
hydrodynamic diameter and 30 nm vs. 19 nm for core diameter), and NIR dye loading 
was decreased (40 vs. 45), the QY of SCK1 (0.005, Table 7.3) was still low.  Based upon 
our model prediction, the D value was between the range of 8.41 nm and 15.63 nm, 
where 8.41 nm represented the extreme that all dyes were located to the periphery of core 
domain and 15.63 nm represented the other extreme that all dyes were placed on the 
margin of shell domain.  And therefore, it was speculated that the limited enhancement of 
luminance efficiency might be originated from the increased environmental micropolarity 
after incorporation into the more hydrophilic shell domain. 
NIR-SCKs with improved optical characteristics were achieved while the cypate 
was replaced by HL-800 at a loading capacity of 20 HL-800s/SCK (SCK2, and the D 
value was between the range of 11.89 nm to 22.19 nm).  The QY of SCK2 (0.036, Table 
7.3) was enhanced by a factor of 7 and the overall fluorescence intensity gained a 2-fold 
increase, relative to SCK1.  HL-800 was further introduced into the PEO113-b-PVBA46 
system for synthesis of NP8 bearing 5 dyes/NP while keeping similar size as NP5-7 
(Figure 7.6A, Dh, intensity = 22 ± 1 nm and Dav = 19 ± 1 nm) and comparable D as SCK2 
(D = 15.06 nm).  Dramatic decrease of QY was observed (0.002 vs. 0.019), even though 
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the error of NP8 calculation was high due to the unreliable level of absorption intensity 
(Figure 7.6B).  These results suggested that the HL-800 might exhibit a reversed solvent-
polarity response as cypate and the mechanism was not clear now. 
 
Figure 7.6.  A) Intensity-average weighted hydrodynamic diameter distribution by DLS 
(top) and TEM micrograph (bottom) of NP8.  B-C) UV-Vis and fluorescence spectrum of 
NP8, respectively. 
 
Conclusions 
In summary, we have tested the photo-physical properties of crosslinked 
nanoparticles functionalized with fluoresceins or NIR carbocyanine (Cypate and HL-800) 
dyes at different stoichiometric loadings.  It is clear that the nanoparticle QY and 
fluorescence lifetime was determined by the distance between adjacent fluorophores.  
More importantly, the NP maximum dye loading capacity for retaining sufficient QY 
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could be predicted through a semi-quantitative model, which correlated well with the 
experimental results.  These fundamental results could be applied to the development of 
nanoparticle-based NIR optical devices for fluorescence imaging. 
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Chapter 8 
Conclusions 
 
Design and synthesis of discrete and robust polymeric nanostructures bearing the 
characteristic of serving as chemoselectively functionalizable platform for biomedical 
applications is an area of long-term interest in material science.  This desire becomes 
emergent as the significantly positive impacts of nanotechnology to traditional healthcare 
has been heightened in nearly every medical district, including diagnostics, therapy, and 
clinical applications. 
The efforts to achieve precise and facile manipulations over the functionalization 
of existed shell crosslinked (SCK) nanoparticle platform formed the first portion of this 
dissertation (chapter 2 and 3).  The general strategy exerted in these works was to design 
synthetic pathway of functionalized SCKs from a “more Bottom-up” approach, i.e., 
coupling functionalities to block polymer precursor before assembly into nanostructures.  
The efficiency of this approach was confirmed by the construction of DOTA-SCKs, with 
high loading capacity of radionuclide 64Cu (chapter 2, ca. 400 copper per spherical 
nanoparticle).  Extension of the “pre-grafting” strategy to build PEGylated SCKs (chapter 
3) with tunable biodistributions and the following targeting SCKs under developing now 
demonstrated the supremacy and versatility of this synthetic methodology.  Meanwhile, 
in vivo positron emission tomography (PET) imaging at low-dose administration was 
realized by the characteristic of enhanced labeling efficiency, provided by the SCKs 
prepared through this pathway. 
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Fundamental investigations in chapter 4 addressed the utilization of active ester 
(N-acryloxysuccinimide, NAS) and probing crosslinkers for better understanding the 
chemical and physical factors involved during the shell crosslinking process.  In the 
meantime, interesting photo-physical properties of pyrazine-based chromophores were 
discovered including the blue shift of maximum absorption and dual-emission of 
fluorescence, which strictly relied upon the internal nanostructure environment.  The pre-
installation of NAS as amidation site across the micellar structures not only reduced the 
reaction complexity entailed in carbodiimide mediated amidation, but also enabled 
selectivity for conjugation of functionalities bearing “critical” activity-related carboxylic 
acids, for example, the aspartic acid in RGD peptide motif. 
While amidation dominated half portion of this dissertation, the left-over part of 
this dissertation (chapter 5 to 7) was focus on one of the most reactive electrophiles, 
benzaldehyde, to exploit its controlled polymerization and applications of the form 
polymers as building component in supramolecular assembly and functionalization. 
Reversible addition-fragmentation chain transfer (RAFT) polymerization of 4-
vinyl benzaldehyde (VBA) was described in chapter 5.  The PVBAs were confirmed with 
predictable molecular weight, narrow molecular weight distribution, and well-define 
architectures.  Successful chain extension from PVBA based macro chain transfer agent 
(macro-CTA) afforded well-defined block copolymers with PVBA as reactive block 
segments allowing for post-polymerization modifications.  These studies actually 
initialized the implements of controlled radical polymerization of carbonyl-bearing 
monomers. 
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PVBA-based amphiphilic block copolymer systems (poly(ethylene oxide)-block-
poly(4-vinyl benzaldehyde), PEO-b-PVBA) were then established and their aqueous 
assemblies were studied (chapter 6 and 7).  Dramatic self assembly behavior was noticed 
between two block copolymers (PEO45-b-PVBA18 and PEO45-b-PVBA26) having small 
structural difference.  As characterized through a combination of transmission electron 
microscopy (TEM) and dynamic light scattering (DLS), uniform spherical micelles with 
narrow size distribution were formed from the PEO45-b-PVBA18 block copolymer 
precursor (chapter 7) while polymer vesicles (polymersomes, chapter 6) with tunable 
sizes were obtained from the PEO45-b-PVBA26 block copolymer, although the 
mechanism behind the difference was not clear at this stage. 
The reactivity of the benzaldehyde functionalities was verified by crosslinking the 
polymersomes, and also by a one-pot crosslinking and functionalization approach to 
further render them fluorescent, each via reductive amination.  The mechanic properties 
of croslinked vesicles have been significantly improved and the in vitro studies found 
these labelled vesicles to undergo cell association (chapter 6). 
In chapter 7, the one-pot sequential crosslinking and functionalization protocol 
through reductive amination was utilized for installation of fluorescent probes (regular 
fluorescein and near-infrared cypate) onto micelles from PEO-b-PVBA block 
copolymers.  The luminescence effiency of nanoparticles was evaluated and a clear 
relationship between quantum yield and the stoichiometry of loaded fluorophores was 
established. 
As mentioned earlier in the Introduction section, nanomaterials prepared from the 
Bottom-up approach have grown dramatically during the past decades.  The reason is 
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multifactorial but the ultimate goal is very clear, i.e., continuous providing better 
nanoscale platforms for variety of applications. 
  
 
 
 
 
 
 
 
 
 
Appendix 
NMR Spectra of Compounds 
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